
<html lang="en"     class="pb-page"  data-request-id="562a327e-fc4f-4e47-8bd6-31d38f2522d3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2013.56.issue-16;wgroup:string:ACHS website Group;article:article:10.1021/jm400807n;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of NVP-TNKS656: The Use of Structure–Efficiency Relationships To Generate a Highly Potent, Selective, and Orally Active Tankyrase Inhibitor" /></meta><meta name="dc.Creator" content="Michael D.  Shultz" /></meta><meta name="dc.Creator" content="Atwood K.  Cheung" /></meta><meta name="dc.Creator" content="Christina A.  Kirby" /></meta><meta name="dc.Creator" content="Brant  Firestone" /></meta><meta name="dc.Creator" content="Jianmei  Fan" /></meta><meta name="dc.Creator" content="Christine Hiu-Tung  Chen" /></meta><meta name="dc.Creator" content="Zhouliang  Chen" /></meta><meta name="dc.Creator" content="Donovan N.  Chin" /></meta><meta name="dc.Creator" content="Lucian  DiPietro" /></meta><meta name="dc.Creator" content="Aleem  Fazal" /></meta><meta name="dc.Creator" content="Yun  Feng" /></meta><meta name="dc.Creator" content="Pascal D.  Fortin" /></meta><meta name="dc.Creator" content="Ty  Gould" /></meta><meta name="dc.Creator" content="Bharat  Lagu" /></meta><meta name="dc.Creator" content="Huangshu  Lei" /></meta><meta name="dc.Creator" content="Francois  Lenoir" /></meta><meta name="dc.Creator" content="Dyuti  Majumdar" /></meta><meta name="dc.Creator" content="Etienne  Ochala" /></meta><meta name="dc.Creator" content="M. G.  Palermo" /></meta><meta name="dc.Creator" content="Ly  Pham" /></meta><meta name="dc.Creator" content="Minying  Pu" /></meta><meta name="dc.Creator" content="Troy  Smith" /></meta><meta name="dc.Creator" content="Travis  Stams" /></meta><meta name="dc.Creator" content="Ronald C.  Tomlinson" /></meta><meta name="dc.Creator" content="B. Barry  Touré" /></meta><meta name="dc.Creator" content="Michael  Visser" /></meta><meta name="dc.Creator" content="Run Ming  Wang" /></meta><meta name="dc.Creator" content="Nigel J.  Waters" /></meta><meta name="dc.Creator" content="Wenlin  Shao" /></meta><meta name="dc.Description" content="Tankyrase 1 and 2 have been shown to be redundant, druggable nodes in the Wnt pathway. As such, there has been intense interest in developing agents suitable for modulating the Wnt pathway in vivo ..." /></meta><meta name="Description" content="Tankyrase 1 and 2 have been shown to be redundant, druggable nodes in the Wnt pathway. As such, there has been intense interest in developing agents suitable for modulating the Wnt pathway in vivo ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 13, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400807n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400807n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400807n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400807n" /></link>
        
    
    

<title>Identification of NVP-TNKS656: The Use of Structure–Efficiency Relationships To Generate a Highly Potent, Selective, and Orally Active Tankyrase Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400807n" /></meta><meta property="og:title" content="Identification of NVP-TNKS656: The Use of Structure–Efficiency Relationships To Generate a Highly Potent, Selective, and Orally Active Tankyrase Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0023.jpeg" /></meta><meta property="og:description" content="Tankyrase 1 and 2 have been shown to be redundant, druggable nodes in the Wnt pathway. As such, there has been intense interest in developing agents suitable for modulating the Wnt pathway in vivo by targeting this enzyme pair. By utilizing a combination of structure-based design and LipE-based structure efficiency relationships, the core of XAV939 was optimized into a more stable, more efficient, but less potent dihydropyran motif 7. This core was combined with elements of screening hits 2, 19, and 33 and resulted in highly potent, selective tankyrase inhibitors that are novel three pocket binders. NVP-TNKS656 (43) was identified as an orally active antagonist of Wnt pathway activity in the MMTV-Wnt1 mouse xenograft model. With an enthalpy-driven thermodynamic signature of binding, highly favorable physicochemical properties, and high lipophilic efficiency, NVP-TNKS656 is a novel tankyrase inhibitor that is well suited for further in vivo validation studies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400807n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400807n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400807n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400807n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400807n&amp;href=/doi/10.1021/jm400807n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 6495-6511</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400778d" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm4008449" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of NVP-TNKS656: The Use of Structure–Efficiency Relationships To Generate a Highly Potent, Selective, and Orally Active Tankyrase Inhibitor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+D.++Shultz">Michael D. Shultz</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Atwood+K.++Cheung">Atwood K. Cheung</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christina+A.++Kirby">Christina A. Kirby</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brant++Firestone">Brant Firestone</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianmei++Fan">Jianmei Fan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine+Hiu-Tung++Chen">Christine Hiu-Tung Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhouliang++Chen">Zhouliang Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donovan+N.++Chin">Donovan N. Chin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lucian++DiPietro">Lucian DiPietro</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aleem++Fazal">Aleem Fazal</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yun++Feng">Yun Feng</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascal+D.++Fortin">Pascal D. Fortin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ty++Gould">Ty Gould</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bharat++Lagu">Bharat Lagu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huangshu++Lei">Huangshu Lei</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francois++Lenoir">Francois Lenoir</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dyuti++Majumdar">Dyuti Majumdar</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Etienne++Ochala">Etienne Ochala</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=M.+G.++Palermo">M. G. Palermo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ly++Pham">Ly Pham</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Minying++Pu">Minying Pu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Troy++Smith">Troy Smith</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Travis++Stams">Travis Stams</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronald+C.++Tomlinson">Ronald C. Tomlinson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=B.+Barry++Tour%C3%A9">B. Barry Touré</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Visser">Michael Visser</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Run+Ming++Wang">Run Ming Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nigel+J.++Waters">Nigel J. Waters</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenlin++Shao">Wenlin Shao</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Novartis Institutes for Biomedical Research, Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 617-871-7551. E-mail: <a href="/cdn-cgi/l/email-protection#88e5e1ebe0e9ede4a6fbe0fde4fcf2c8e6e7fee9fafce1fba6ebe7e5"><span class="__cf_email__" data-cfemail="cea3a7ada6afaba2e0bda6bba2bab48ea0a1b8afbcbaa7bde0ada1a3">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400807n&amp;href=/doi/10.1021%2Fjm400807n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 6495–6511</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 11, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 May 2013</li><li><span class="item_label"><b>Published</b> online</span>13 August 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 August 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400807n" title="DOI URL">https://doi.org/10.1021/jm400807n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6495%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichael%2BD.%2BShultz%252C%2BAtwood%2BK.%2BCheung%252C%2BChristina%2BA.%2BKirby%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D16%26contentID%3Djm400807n%26title%3DIdentification%2Bof%2BNVP-TNKS656%253A%2BThe%2BUse%2Bof%2BStructure%25E2%2580%2593Efficiency%2BRelationships%2BTo%2BGenerate%2Ba%2BHighly%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BActive%2BTankyrase%2BInhibitor%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6511%26publicationDate%3DAugust%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400807n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3607</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">73</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400807n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of NVP-TNKS656: The Use of Structure–Efficiency Relationships To Generate a Highly Potent, Selective, and Orally Active Tankyrase Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;D. Shultz&quot;},{&quot;first_name&quot;:&quot;Atwood&quot;,&quot;last_name&quot;:&quot;K. Cheung&quot;},{&quot;first_name&quot;:&quot;Christina&quot;,&quot;last_name&quot;:&quot;A. Kirby&quot;},{&quot;first_name&quot;:&quot;Brant&quot;,&quot;last_name&quot;:&quot;Firestone&quot;},{&quot;first_name&quot;:&quot;Jianmei&quot;,&quot;last_name&quot;:&quot;Fan&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Hiu-Tung Chen&quot;},{&quot;first_name&quot;:&quot;Zhouliang&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Donovan&quot;,&quot;last_name&quot;:&quot;N. Chin&quot;},{&quot;first_name&quot;:&quot;Lucian&quot;,&quot;last_name&quot;:&quot;DiPietro&quot;},{&quot;first_name&quot;:&quot;Aleem&quot;,&quot;last_name&quot;:&quot;Fazal&quot;},{&quot;first_name&quot;:&quot;Yun&quot;,&quot;last_name&quot;:&quot;Feng&quot;},{&quot;first_name&quot;:&quot;Pascal&quot;,&quot;last_name&quot;:&quot;D. Fortin&quot;},{&quot;first_name&quot;:&quot;Ty&quot;,&quot;last_name&quot;:&quot;Gould&quot;},{&quot;first_name&quot;:&quot;Bharat&quot;,&quot;last_name&quot;:&quot;Lagu&quot;},{&quot;first_name&quot;:&quot;Huangshu&quot;,&quot;last_name&quot;:&quot;Lei&quot;},{&quot;first_name&quot;:&quot;Francois&quot;,&quot;last_name&quot;:&quot;Lenoir&quot;},{&quot;first_name&quot;:&quot;Dyuti&quot;,&quot;last_name&quot;:&quot;Majumdar&quot;},{&quot;first_name&quot;:&quot;Etienne&quot;,&quot;last_name&quot;:&quot;Ochala&quot;},{&quot;first_name&quot;:&quot;M.&quot;,&quot;last_name&quot;:&quot;G. Palermo&quot;},{&quot;first_name&quot;:&quot;Ly&quot;,&quot;last_name&quot;:&quot;Pham&quot;},{&quot;first_name&quot;:&quot;Minying&quot;,&quot;last_name&quot;:&quot;Pu&quot;},{&quot;first_name&quot;:&quot;Troy&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Travis&quot;,&quot;last_name&quot;:&quot;Stams&quot;},{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;C. Tomlinson&quot;},{&quot;first_name&quot;:&quot;B.&quot;,&quot;last_name&quot;:&quot;Barry Touré&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Visser&quot;},{&quot;first_name&quot;:&quot;Run&quot;,&quot;last_name&quot;:&quot;Ming Wang&quot;},{&quot;first_name&quot;:&quot;Nigel&quot;,&quot;last_name&quot;:&quot;J. Waters&quot;},{&quot;first_name&quot;:&quot;Wenlin&quot;,&quot;last_name&quot;:&quot;Shao&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;6495-6511&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400807n&quot;},&quot;abstract&quot;:&quot;Tankyrase 1 and 2 have been shown to be redundant, druggable nodes in the Wnt pathway. As such, there has been intense interest in developing agents suitable for modulating the Wnt pathway in vivo by targeting this enzyme pair. By utilizing a combination of structure-based design and LipE-based structure efficiency relationships, the core of XAV939 was optimized into a more stable, more efficient, but less potent dihydropyran motif 7. This core was combined with elements of screening hits 2, 19, and 33 and resulted in highly potent, selective tankyrase inhibitors that are novel three pocket binders. NVP-TNKS656 (43) was identified as an orally active antagonist of Wnt pathway activity in the MMTV-Wnt1 mouse xenograft model. With an enthalpy-driven thermodynamic signature of binding, highly favorable physicochemical properties, and high lipophilic efficiency, NVP-TNKS656 is a novel tankyrase inhibitor that is well suited for further in vivo validation studies.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400807n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400807n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400807n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400807n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400807n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400807n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400807n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400807n&amp;href=/doi/10.1021/jm400807n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400807n" /></input><a href="/doi/pdf/10.1021/jm400807n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400807n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400807n%26sid%3Dliteratum%253Aachs%26pmid%3D23844574%26genre%3Darticle%26aulast%3DShultz%26date%3D2013%26atitle%3DIdentification%2Bof%2BNVP-TNKS656%253A%2BThe%2BUse%2Bof%2BStructure%25E2%2580%2593Efficiency%2BRelationships%2BTo%2BGenerate%2Ba%2BHighly%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BActive%2BTankyrase%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D16%26spage%3D6495%26epage%3D6511%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292161" title="Modification">Modification</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292304" title="Optimization">Optimization</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jmcmar.2013.56.issue-16/production/jmcmar.2013.56.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0023.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Tankyrase 1 and 2 have been shown to be redundant, druggable nodes in the Wnt pathway. As such, there has been intense interest in developing agents suitable for modulating the Wnt pathway in vivo by targeting this enzyme pair. By utilizing a combination of structure-based design and LipE-based structure efficiency relationships, the core of XAV939 was optimized into a more stable, more efficient, but less potent dihydropyran motif <b>7</b>. This core was combined with elements of screening hits <b>2</b>, <b>19</b>, and <b>33</b> and resulted in highly potent, selective tankyrase inhibitors that are novel three pocket binders. NVP-TNKS656 (<b>43</b>) was identified as an orally active antagonist of Wnt pathway activity in the MMTV-Wnt1 mouse xenograft model. With an enthalpy-driven thermodynamic signature of binding, highly favorable physicochemical properties, and high lipophilic efficiency, NVP-TNKS656 is a novel tankyrase inhibitor that is well suited for further in vivo validation studies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tankyrase (TNKS) proteins are multifunctional poly(ADP-ribose) polymerases (PARPs), which are enzymes utilizing NAD<sup>+</sup> as a substrate to generate ADP-ribose polymers onto target proteins (PARsylation).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Both isoforms of TNKS, TNKS1 and TNKS2, share overlapping functions and similar structures, including the ankyrin (ANK) repeat domain, the SAM domain (<u class="uu">s</u>terile <u class="uu">a</u>lpha <u class="uu">m</u>olecule), and the catalytic PARP domain.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The ankyrin domain is important for mediating protein–protein interactions, and the SAM domain mediates mono- and heteromultimerization of TNKS. Through binding and modulating substrate proteins, TNKS plays a role in regulating a variety of cellular processes, including telomere regulation, mitotic spindle pole function, membrane translocation of Golgi-associated vesicles upon insulin stimulation, and B cell antigen receptor activation.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> Previous findings from our group have shown that TNKS could regulate the activity of the Wnt/β-catenin pathway in colon cancer cells through PARsylation and destabilization of the axin proteins.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In addition to the aforementioned substrates, an array of proteins representing diverse biological functions have been predicted to be TNKS targets on the basis of structural and sequence information of TNKS targeting proteins.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The broad biological role of TNKS thus offers an opportunity for its therapeutic intervention in diseases where TNKS substrates become dysregulated, such as telomere elongation in cancer, Wnt pathway activation in cancer, and cardiovascular and neurodegenerative diseases.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Indeed, multiple groups have reported identification of TNKS inhibitors from high throughput screens and chemical optimization (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref4 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref4 ref8 ref9 ref10">(4, 8-10)</a> These inhibitors have been investigated for their utilities in the treatment of cancer, fibrosis, herpes simplex virus replication, and remyelination, providing important insight on therapeutic indications of targeting TNKS.<a onclick="showRef(event, 'ref4 ref10 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref4 ref10 ref11 ref12 ref13 ref14 ref15">(4, 10-15)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Select TNKS inhibitors that have been reported in the literature.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We recently described the characterization of a novel series of selective dual inhibitors of TNKS1/2 (<b>2</b>) that are devoid of activity against PARP1 or PARP2 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> These inhibitors exhibit low nanomolar TNKS inhibition and submicromolar activity in inhibiting Wnt pathway signaling. Others have recently published optimization efforts that have resulted in G007-LK and compound <b>44</b>.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> In this report, we explore a novel use of lipophilic efficiency (LipE = pIC<sub>50</sub> – log <i>P</i>)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> to survey a diverse range of chemical structures to more effectively understand what are the most efficient interactions favored by TNKS. With this information, we were able to develop TNKS inhibitors with improved activity, selectivity, and pharmacokinetic profiles for in vivo testing.</div><div class="NLM_p">Following our identification of XAV939 (<b>1</b>), our initial hit finding efforts discovered several series of TNKS inhibitors that were evaluated and prioritized for further optimization.<a onclick="showRef(event, 'ref5 ref9'); return false;" href="javascript:void(0);" class="ref ref5 ref9">(5, 9)</a> In parallel, we evaluated <b>1</b> to identify potential liabilities and devise an optimization strategy. There are several attributes of <b>1</b> which make it an attractive starting point including low nanomolar biochemical activity, 78 nM cellular activity, high ligand efficiency<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (LE = 0.55), and good lipophilic efficiency (LipE = 4.2 based on measured log <i>D</i> of 4.1). Unfortunately, <b>1</b> is not without liabilities which include low selectivity versus other PARP family members (10–100 fold), low microsomal stability (rat liver microsomal extraction ration, rLMER = 0.88), and low solubility (10 μM at pH1, < 5 μM at pH 6.8) which hampered the use of reasonable formulations for in vivo studies. For a preclinical proof of concept on the impact of TNKS inhibition in model systems, a potent, selective, and in vivo active TNKS inhibitor was required; therefore, the highest priority for this series was to increase potency, selectivity, solubility, and metabolic stability. Because compound <b>1</b> had a measured log <i>D</i> of 4.1, it was hypothesized that by reducing the lipophilicity the off-target liabilities and poor properties could be improved.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">Lipophilic efficiency<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (LipE = pIC<sub>50</sub> – log <i>D</i>) provides a convenient measure of the differential between potency and lipophilicity and therefore was ideally aligned with our optimization goals. It should be noted in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> that early on we identified a significant disconnect between calculated logP and measured log <i>P</i>/<i>D</i> for this series (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figures 1 and 2">Supporting Information Figures 1 and 2</a>), and therefore the LipE calculations throughout this manuscript will be artificially high relative to those based on measured log <i>D</i>. There are several points that should be made at the outset to better understand how the LipE tool might best be used. First, because there can be errors in clogP calculations, comparison of highly dissimilar structural classes should be performed with caution and preferably utilizing measured log <i>D</i> values. Second, for structure–efficiency relationships (SER), it is the change in LipE (ΔLipE) between matched pairs that is meaningful in decision making. If a change between a molecular matched pair (MMP)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> is unlikely to introduce an ionizable group or affect the p<i>K</i><sub>a</sub> of an existing one, then ΔclogP can be calculated with high accuracy and should correlate very well with changes in measured log <i>P</i> and log <i>D</i>, and therefore may be used with confidence (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure 2">Supporting Information Figure 2</a>). Finally, although it has been reported that there are target LipE values for optimization,<a onclick="showRef(event, 'ref19 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref19 ref23 ref24">(19, 23, 24)</a> these are highly theoretical and likely target dependent. Thus, we do not support using an absolute LipE value to determine if sufficient optimization has been achieved. We were very interested in evaluating the utility of LipE for enhanced decision making based on SER and describe herein the results of using LipE for making nonobvious choices during an iterative optimization process. While we report ligand efficiency for <b>1</b>, we did not use this parameter during our optimization efforts and only SER utilizing LipE will be discussed.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. A-Ring Modifications of <b>1</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0014.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">LipE = pIC<sub>50</sub> (TNKS2) – clogP.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">HEK293 SuperTopFlash reporter gene assay.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Rat liver microsome extraction ratio.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Measured log <i>D</i>.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">LipE = pIC<sub>50</sub> (TNKS2) – log <i>D</i>.</p></div></div><div></div></div><div class="NLM_p last">For all compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and throughout this manuscript (with the exception of compound <b>4</b>), potency against TNKS2 was typically 2–10 fold greater than TNKS1. No significant selectivity between these isoforms was observed for compounds in this manuscript; therefore, this data is not reported in subsequent tables.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17637" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17637" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Computational programs that predict oxidative metabolism such as Metasite and Stardrop support the concern that we had at the outset of the optimization process that the A-ring sulfur was a likely soft spot for oxidative metabolism (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure 3">Supporting Information Figure 3</a>), and so replacement of this moiety was our initial goal.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26">(23-26)</a> Modification of the XAV939 A-ring was accomplished by the condensation of keto ester derivatives with an appropriate amidine moiety (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Compound <b>1</b>, a nicotinamide mimetic, is structurally similar to many previously reported PARP antagonists,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and we generated a series of analogues where the sulfur-containing ring was altered (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). For the nonaromatic A-rings analogues (<b>3</b>–<b>5</b>), it became clear that all changes were not well tolerated as potency and LipE decreased. Aromatization of ring A (<b>6</b>) did improve the microsomal stability but was a less efficient inhibitor.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of A-Ring Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) K<sub>2</sub>CO<sub>3</sub>, MeOH, 75 °C; (b) DIEA, THF; (c) KOEt, 140 °C, 20 min.</p></p></figure><div class="NLM_p">We hypothesized that an oxygen-containing A-ring, such as a dihydropyran, could improve solubility and metabolic stability; therefore, we synthesized several of these analogues (e.g., <b>7</b> and <b>8</b>). All analogues were more polar than <b>1</b> but also less potent. Compound <b>7</b> is 33-fold less potent in the cellular assay than <b>1</b>, a result that would typically remove this modification from further consideration; however, these two compounds have identical LipE values and therefore <b>7</b> was evaluated further. With a solubility improvement of at least 10-fold and an even more substantial improvement in microsomal stability, <b>7</b> was able to be formulated for a rat pharmacokinetic (PK) study via intravenous (iv) administration. After iv administration to Sprague–Dawley rats, good exposure of compound <b>7</b> with low clearance (8.9 mL/min/kg) and a high volume of distribution (Vdss = 2.7 L/kg) was observed. The PK profile 2 h postdose suggests the possibility of enterohepatic recirculation, which is plausible because of the available hydroxyl for direct conjugation and biliary elimination. However, this hypothesis would need to be further evaluated in mechanistic studies.</div><div class="NLM_p">With the higher selectivity toward PARP 1 and 2 (50–1300 fold,) we decided to preserve the dihydropyran motif and shift optimization to the other side of the molecule. The synthesis of C-ring modifications is outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. In an attempt to identify the minimal pharmacophore required for inhibition, the phenyl ring was removed or replaced with heterocycles which led to the complete loss of activity with the exception of <b>9</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The improved LipE of <b>9</b>, relative to the other analogues, suggests that the phenyl ring was suboptimal. We next explored a series of trifluoromethyl replacements (<b>10</b>–<b>17</b>) to probe this region. Replacement of the trifluoromethyl group with a methyl group did not affect potency but resulted in improved LipE due to a reduction in lipophilicity, perhaps an indication that more optimal groups could be identified. A broad range of analogues were tested and significant improvements in LipE with several compounds (<b>13</b>, <b>14</b>, <b>16</b>, and especially <b>17</b>) were observed. However, this diverse range of substitutions all resulted in similar activity (20–200 nM). Closer examination of the crystal structure revealed that most of the substituents in this subseries are solvent-exposed and have very little interaction with the TNKS protein. In contrast, modifications at the ortho position of the C-ring obliterates activity (data not shown). We observed that LipE values can be increased with polar groups that interact with the bulk solvent, and while this may improve a compound’s overall profile, in the context of efficient binding it has little to do with direct interactions with TNKS.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Dihydropyran C-Ring Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>K<sub>2</sub>CO<sub>3</sub>, MeOH, reflux overnight.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure–Efficiency Relationships of C-Ring Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0016.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0017.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">LipE = pIC<sub>50</sub> (TNKS2) – clogP.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">HEK293 SuperTopFlash reporter gene assay.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Rat liver microsome extraction ratio.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Measured log <i>D</i>.</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">LipE = pIC<sub>50</sub> (TNKS2) – log <i>D</i>.</p></div></div><div></div></div><div class="NLM_p">The optimization appeared to have entered a structural cul-de-sac where the vectors off of the C-ring were not favorable for further optimization but did allow for modulation of the overall properties of the molecule. While most of this position was solvent-exposed, we hypothesized that an amphipathic group might allow for some hydrophobic TNKS–ligand interactions while also assisting in overall properties by lowering log <i>D</i>. Whereas compound <b>17</b> has two polar oxygens and one methyl group, we sought an analogue with a single hydrophobic and hydrophilic group. The additional methyl group of <b>18</b> improved LipE relative to <b>7</b> (7.1 based on measured log <i>D</i>) and apparently efficiency peaked at <b>17</b> and <b>18</b> as other analogues (not shown) had slightly improved potency but significantly lower LipE. Compound <b>18</b> was further evaluated and found to be extremely stable in liver microsomes (rER = 0.23), over 500-fold more soluble than <b>1</b>, and on the basis of measured log <i>D</i> values had significantly greater lipophilic efficiency (ΔLipE = +2.9). Suitable formulations for multiple dose pharmacokinetic (PK)/pharmacodynamic (PD)/efficacy studies with compound <b>18</b> were achieved, and further in vivo characterization was performed.</div><div class="NLM_p">The pharmacokinetics of compound <b>18</b> was evaluated in both rats and mice. After oral administration in Sprague–Dawley rats, compound <b>18</b> showed good overall exposure and bioavailability (<i>F</i> = 46%) where an initial rapid phase of absorption was observed, followed by a second peak at 6 h postdose. After iv administration, compound <b>18</b> again displayed good exposure and low clearance (12 mL/min/kg), in line with the low in vitro clearance prediction in rat liver microsomes (ER = 0.24). Similar to the iv profile of compound <b>7</b>, the concentration versus time profile of compound <b>18</b> after oral administration also displayed a second peak 4–6 h postdose, further supporting the earlier hypothesis for enterohepatic recirculation of either parent or a direct glucuronidation of the free hydroxyl. In mice, compound <b>18</b> showed dose-proportional exposure after oral dosing and good bioavailability (<i>F</i> = 32%). <b>18</b> also showed moderate iv clearance in good agreement with the in vitro clearance prediction from mouse liver microsomes. While high oral doses (300 mg/kg) were tolerated, the low cellular potency only allowed for total drug concentrations to exceed the cellular IC<sub>50</sub> values for 4–5 h.</div><div class="NLM_p">It was becoming increasingly clear that modifications based on the ABC rings of <b>1</b> would not be able to achieve the low nanomolar potency we required, and therefore we sought a more favorable scaffold where the C ring was completely replaced. At this time, we obtained a crystal structure of the TNKS1 PARP domain in complex with an interesting screening hit (<b>19</b>) to 2.1 Å resolution. The compound bound to the NAD<sup>+</sup> donor site, occupying the nicotinamide and diphosphate pockets. Its interactions with TNKS1 mimic those seen in the structure of TNKS1 in complex with XAV939<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> which include stacking interactions of the pyrimidine ring with Tyr1224 and hydrogen bonds between the hydroxyl of Ser1221 and Gly1185 with the pyrimidine hydroxyl and pyrimidine nitrogen, respectively. Additionally, <b>19</b> takes advantage of a previously defined hydrophobic nook<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> where the thiophene moiety makes van der Waals interactions with Cβ of Ser1186, Pro1187, and Ile1228. Additionally, the phenyl ring makes van der Waals interactions with His1184, Ser1186, and Phe1188. Unfortunately, <b>19</b> had poor solubility and low microsomal stability, consistent with the lower LipE (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). By converting the A ring into the dihydropyran motif (compound <b>20</b>), the LipE (4.5 based on measured log <i>D</i>) and solubility improved dramatically, but microsomal stability remained low. We began by stepwise deletion of the thiophene and the phenpropanamide moieties to investigate their importance in binding efficiency and microsomal stability with the synthesis of this series described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Truncation to the <i>N</i>-ethyl derivative <b>21</b> or to the secondary amide <b>22</b> resulted in lower binding efficiency and cellular activity but improved microsomal stability. Deletion of the amide moiety (<b>23</b>) also improved microsomal stability but also increased LipE significantly, suggesting this was an inefficient binding motif. The 3-thiophenyl analogue <b>24</b> was 5-fold less active, and activity was lost with other linker modifications (data not shown).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Dihydropyran C-Ring Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TEA, 2-chloroacetamidine, MeOH; (b) i. NaN<sub>3</sub>, H<sub>2</sub>O/acetone, ii. Ph<sub>3</sub>P, THF; (c) R<sup>2</sup>-CHO, SiCNBH<sub>3</sub>, AcOH, EtOH; RSO<sub>2</sub>Cl, TEA, DCM or RCO<sub>2</sub>Cl, TEA, DCM or RCO<sub>2</sub>H, EDCI, HOBt, TEA, DCM; (d) i. BocNHR<sup>2</sup>, NaH, THF or DMF; ii. HCl, dioxane, MeOH; (e) R<sub>3</sub>NH<sub>2</sub>, TEA, 120 °C, 5 min, or R<sub>3</sub>NH<sub>2</sub>, TEA or DIEA, EtOH, 65 °C; (f) RCO<sub>2</sub>Cl, TEA, DCM; (g) RCO<sub>2</sub>H, EDCI, HOBt, TEA, DCM.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structure–Efficiency Relationships of Compounds <b>1</b>, <b>7</b>, and <b>19</b> Tribrid Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0018.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">LipE = pIC<sub>50</sub> (TNKS2) – clogP.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">HEK293 SuperTopFlash reporter gene assay.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Rat liver microsome extraction ratio.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Measured log <i>D</i>.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">LipE = pIC<sub>50</sub> (TNKS2) – log <i>D</i>.</p></div></div><div></div></div><div class="NLM_p">We next kept the thiophene constant and surveyed analogues of the amide group (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Examination of the crystal structure of <b>19</b> suggested that there were potential polar interactions that might be gained, as the hydroxyl of Ser1186 and the backbone carbonyl of D1198 were in close proximity to the phenyl ring (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Additionally, a crystallographic water molecule was bound via the backbone NH of D1198, and we sought to make a hydrogen bond with this water molecule. Both compounds <b>25</b> and <b>26</b> were less potent than <b>20</b>; however, <b>25</b> had significantly improved LipE. For a ΔclogP of −1.52, both analogues would be expected to be about 33-fold less potent than <b>20</b> from a LipE perspective. Compound <b>25</b> maintains similar LipE and is 37-fold less potent, and the in vitro stability improves somewhat, presumably because of the lower lipophilicity. For analogue <b>26</b>, however, the 4-fold decrease in potency is much better than the expected 33-fold drop and is consistent with the formation of a hydrogen bond with the bound water. Fluorine derivatives (<b>27</b>–<b>29</b>) were tested, and compounds <b>27</b> and <b>29</b> were both more potent and had improved LipE, however were unstable in microsomes. We next sought to replace the structural water with hydroxyl substituents to make direct interactions with Asp1198. Each of these analogues are more polar than <b>20</b> (ΔclogP = −0.7), and therefore because of the desolvation penalty these analogues would be expected to be less potent unless a compensating hydrogen bond was made. Although compound <b>30</b> is less active than <b>20</b> but with similar LipE, compounds <b>31</b> and <b>32</b> have similar biochemical activity and increased LipE relative to <b>20</b>. In the case of <b>31</b> we speculate that the increased LipE may be diagnostic of the formation of a hydrogen bond with the TNKS protein, and the strength of this hydrogen bond is of similar strength to that which was lost upon desolvation. From this subset of compounds, we concluded that more specific interactions with the TNKS protein and improved cellular activity were possible, but the thiophene remained a key liability that needed to be addressed. Yet again a more dramatic change to the structure was needed, and we focused on completely replacing the phenethyl moiety because of its low contribution to the overall LipE of the scaffold.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Structure–Efficiency Relationships of Tribrid Phenpropyl Amide Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0019.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">LipE = pIC<sub>50</sub> (TNKS2) – clogP.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">HEK293 SuperTopFlash reporter gene assay.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Rat liver microsome extraction ratio.</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">Measured log <i>D</i>.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">LipE = pIC<sub>50</sub> (TNKS2) – log <i>D</i>.</p></div></div><div></div></div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of <b>19</b> (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI6">4LI6</a>) suggested potential polar interactions that might be gained, as (1) the hydroxyl of Ser1186 and the backbone carbonyl of D1198 were in close proximity to the phenyl ring and (2) a crystallographic water molecule was bound via the backbone NH of D1198.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our screening and structural biology efforts identified a diverse range of TNKS binders such as <b>1</b>, which bound to the nicotinamide pocket,<sup>249</sup> compounds which bound exclusively to the adenosine pocket,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and also compounds, such as <b>33</b>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> which simultaneously occupied the nicotinamide and adenosine pockets (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). A crystal structure of TNKS1 in complex with <b>33</b> was determined to 2.2 Å resolution to understand the binding mode. For this compound, a cyanobenzamide sits in place of the A and B rings of <b>1</b> with the nitrile group forming polar interactions with the hydroxyl of Ser1221 and the backbone amide of Gly1185. Compound <b>33</b> extends through the diphosphate binding region and reaches into the adenosine pocket where the fluorophenyl group forms van der Waals interactions with the side chains of Phe1188, Ala1191, and Ile1192 on one side of the groove, and a stacking interaction with the side chain of His1201 on the opposite side. A hydrogen bond is also formed between <b>33</b> and the backbone amide of Asp1198.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Superposition of crystal structures <b>19</b> (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI6">4LI6</a>, cyan), <b>33</b> (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI7">4LI7</a>, green), and <b>35</b> (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI8">4LI8</a>, magenta) bound to TNKS1. Grafting of the nicotinamide/nook binding portion of <b>19</b> with the adenosine binding portion of <b>33</b> led to <b>35</b>, the first known three-pocket tankyrase binder, a compound with excellent potency, highly favorable physicochemical properties, and metabolic stability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Relative to <b>1</b> and <b>20</b>, compound <b>33</b> has much lower LipE but has moderate biochemical and cellular activity. The cyanobenzamide represented another novel nicotinamide isostere that we found in our screens, and we hypothesized that if we retained the high LipE fragment <b>23</b> it might be possible to find improvements by grafting on a new substructure, such as the (4-fluorophenyl)piperidin-4-ylmethanone moiety of <b>33</b>. The synthesis of these analogues was accomplished following the approach outlined in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. To our great satisfaction, the first two hybrid molecules based on this design (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, <b>34</b> and <b>35</b>) had excellent potency, substantially improved LipE, and, in the case of <b>34</b> (LipE = 6.6 based on measured log <i>D</i>), highly favorable physicochemical properties and metabolic stability. While recent examples exist of compounds that bind in the nicotinamide and adenosine pockets,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> or to the adenosine and “nook” pockets,<a onclick="showRef(event, 'ref18 ref28'); return false;" href="javascript:void(0);" class="ref ref18 ref28">(18, 28)</a> to our knowledge, this is the first example of a tankyrase inhibitor that binds simultaneously to the nicotinamide, adenosine, and “nook” pockets. We benchmarked these compounds in multiple in vitro and in vivo assays while further optimization continued.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Ethyl 2-bromoacetate, Et<sub>3</sub>N, CH<sub>3</sub>CN, reflux 5 h; (b) NaOH, H<sub>2</sub>O, EtOH, 24 h; (c) EDCI, HOBt or HATU, TEA or DIPEA, DCM or DMF.</p></p></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Incorporation of Compound <b>33</b> into the Design of Three-Point Binders</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0020.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">LipE = pIC<sub>50</sub> (TNKS2) – clogP.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">HEK293 SuperTopFlash reporter gene assay.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">Rat liver microsome extraction ratio.</p></div><div class="footnote" id="t5fn4"><sup>Table d</sup><p class="last">Measured log <i>D</i>.</p></div><div class="footnote" id="t5fn5"><sup>Table e</sup><p class="last">LipE = pIC<sub>50</sub> (TNKS2) – log <i>D</i>.</p></div></div><div></div></div><div class="NLM_p">The oral and intravenous pharmacokinetics of <b>34</b> and the <i>N</i>-methylthiophene analogue, <b>35</b>, were evaluated in mice. After intravenous administration, both compounds showed low CL with a moderate volume of distribution. <b>34</b> was given orally over a dose range from 5 to 800 mg/kg as a solution (5 and 25 mg/kg) or a suspension (200–800 mg/kg) dose. <b>34</b> exhibited good oral exposure with a bioavailability of 40–60% over the dose range. The exposure was slightly overproportional over the range as evidenced by the dose normalized AUC’s ranging from 400 to 704 for the 5 and 800 mg/kg doses, respectively. The oral pharmacokinetics of <b>35</b> was evaluated as a solution dose of 30 and 100 mg/kg. <b>35</b> showed significantly lower oral exposure as a result of the lower oral bioavailability of approximately 12%.</div><div class="NLM_p">We explored various substitution patterns on the thiophene (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), none of which improved the microsomal stability or improved potency. The benzyl derivative (<b>36</b>) had a very slight improvement in microsomal stability, however lost 18-fold activity in the cellular assay. The heterocyclic replacements (e.g., <b>37</b>) had improvements in LipE, but as was the case for compounds <b>13</b>, <b>14</b>, <b>16</b> and <b>17</b>, these modifications are solvent-exposed, modulate compound properties but do not represent any improvement in binding efficiency to TNKS. We then moved away from aromatic ring systems and then looked at a series of alkyl substituents (<b>38</b>–<b>41</b>). For these analogues LipE appeared inversely correlated with the bulkiness of the alkyl substituent. Another trend appeared that rat liver microsomal extraction ratio (rLMER) decreased as the compounds became less lipophilic. Compounds <b>40</b> and <b>41</b> had a good combination of LipE, potency, and rLMER. Because <b>38</b> was the most potent of the alkyl derivatives, the <i>N</i>-cyclopropylmethyl analogue <b>42</b> was made and found to be equipotent but with improved rLMER. The oral exposure of compound <b>42</b> in rat was 10-fold greater than <b>34</b> (data not shown) and represented a suitable thiophene replacement to enable further in vivo studies. Turning once again to our structural data from our previously reported TNKS inhibitor which binds exclusively to the adenosine binding pocket, we noted that the fluorophenyl ring of <b>34</b> is in close proximity to the methoxyphenyl ring of <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) and, despite not being an exact overlay, we wondered if the methoxy would be a more favorable substituent because the methoxy group significantly improved LipE in the previous series.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Replacing the fluorine of <b>42</b> with a methoxy group led to TNKS656 (compound <b>43</b>) that was a highly potent and efficient inhibitor of TNKS1&2 (LipE = 7.0 based on measured log <i>D</i>), with over 5,000-fold selectivity versus PARPs 1 and 2. With low to moderate microsomal ER values across species and high solubility, compound <b>43</b> was progressed into advanced in vivo studies.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Superposition of the crystal structures of <b>35</b> (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI8">4LI8</a>, magenta) and <b>2</b> (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UDD">3UDD</a>, yellow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To assess the potential for in vivo inhibition of Tankyrase signaling by <b>43</b>, we first examined the pharmacokinetics in mice (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). After intravenous administration, <b>43</b> displayed low clearance and volume of distribution (<i>V</i><sub>Dss</sub>) (10 mL/min/kg and 0.6 L/kg, respectively). After oral administration of either a 30 or 100 mg/kg dose, <b>43</b> exhibited good exposure and moderate oral bioavailability of 32% and 53%, respectively. Some slight overproportional increase in oral exposure was observed between 30 and 100 mg/kg with the dose normalized AUC for the 100 mg/kg dose being 2-fold higher than for the 30 mg/kg dose. With a cell potency of 3.5 nM and a free fraction of 16% in mouse from rapid equilibrium dialysis, <b>43</b> should have unbound drug concentrations exceeding the IC<sub>50</sub> for at least 12 h.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Mouse Pharmacokinetic Properties of Compound <b>43</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">po</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">iv, 1 mg/kg</th><th class="colsep0 rowsep0" align="center">30 mg/kg</th><th class="colsep0 rowsep0" align="center">100 mg/kg</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (μM·h)</td><td class="colsep0 rowsep0" align="left">3.46</td><td class="colsep0 rowsep0" align="left">33.4</td><td class="colsep0 rowsep0" align="left">183.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">9.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i>1/2 (h)</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>dss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μM)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">16.8</td><td class="colsep0 rowsep0" align="left">79.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">53</td></tr></tbody></table></div></div><div class="NLM_p">To investigate the in vivo PK/PD activity of <b>43</b>, we utilized mammary adenocarcinomas derived from the mouse mammary tumor virus (MMTV)-Wnt1 transgenic model resulting in Wnt signaling activation (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Tumor fragments from these mice were allografted subcutaneously into recipient nude mice and grown to approximately 250–300 mm.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> To determine if <b>43</b> could modulate Wnt/beta-catenin signaling, cohorts of MMTV-Wnt1 tumor bearing mice (<i>n</i> = 3) were treated with either vehicle or a single oral dose of <b>43</b> at 350 mg/kg over a 24-h time course. Mice treated with <b>43</b> showed good plasma and tumor exposures corresponding to AUC<sub>0–24h</sub> of 515 and 325 μM·h, respectively. Consistent with the proposed mechanism of action of TNKS inhibition, <b>43</b>-treated tumors showed a stabilization of Axin1 protein (data not shown) and a corresponding 70–80% reduction in the Wnt/beta-catenin target gene Axin2 mRNA level compared to vehicle control animals. The decrease in Axin2 mRNA expression was detected as early as 4 h post treatment and persisted through the 24 h time course, suggesting once daily dosing may be sufficient for sustained target inhibition. Additional studies will be needed to further model the dose–effect relationship in this model.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. PK/PD relationship of <b>43</b> in MMTV-Wnt1 tumor bearing athymic nude mice. Following a single oral dose of <b>43</b> at 350 mg/kg, plasma and tumor samples were collected at various time points (0.5, 1, 2, 4, 8, 16, and 24 h; <i>n</i> = 3) for PK and PD analysis. The data are represented as <b>43</b> concentration in plasma (nM) and %Axin2 mRNA in tumor relative to untreated controls (mean ± SEM, <i>n</i> = 3 animals/time point). <i>p</i> < 0.05 compared to untreated controls using a one-way ANOVA followed by a posthoc Tukey test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The thermodynamics of inhibitor binding, especially enthalpy of binding, has been identified as an important factor in identifying quality compounds.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Using isothermal calorimetry (ITC), we measured the thermodynamic signature of select analogues from the optimization process to determine what effect the optimization had on the thermodynamics of binding (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Table 1">Supporting Information Table 1</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Karlberg et al. determined that <b>1</b> binds with both favorable enthalpic and entropic contributions, although entropic contributions are more significant.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Compound <b>7</b>, despite having TNKS2 affinity lower than that of <b>1</b>, has a similar LipE, but binding is enthalpy-driven (Δ<i>H</i> = −10.3 kcal/mol) with a slight entropic penalty (TΔ<i>S</i> = −1.1 kcal/mol). Compound <b>20</b> was the first analogue that went beyond the ABC ring system of XAV939 and was only 3-fold less potent than <b>7</b>. The improved thermodynamic profile (Δ<i>H</i> = −18.3 kcal/mol) is likely due in part to the additional hydrogen bond gained to the amide carbonyl. <b>20</b> has a secondary amide bond in the linker, and therefore we hypothesize a portion of the large unfavorable entropic penalty (<i>T</i>Δ<i>S</i> = −9.9 kcal/mol) must be paid for the s-cis amide conformation to bind. Further optimization into the hybrid <b>34</b> benefits from an additional hydrogen bond (Δ<i>H</i> = −18.7 kcal/mol) while the entropic penalty is only slightly diminished. The potency gain with <b>42</b> is attributed to potency gained from desolvation of the hydrophobic cyclopropylmethyl moiety, while the terminal methoxy group of <b>43</b> again shifts to a more enthalpy-driven binding signature. The high enthalpy of binding is reflected in the high selectivity of this class of compounds against PARPs 1 and 2 as well as a panel of off-target activities (data not shown).</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Isothermal calorimetry data for select compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We previously reported the identification of novel inhibitors of TNKS which is a druggable node in the Wnt pathway. Beginning with compound <b>1</b>, we explored the previously untested approach of utilizing LipE to survey a diverse range of chemical structures to understand what portions of each molecule efficiently interacted with our target protein. With this information we undertook a LipE-driven optimization approach at several junctures. We consciously deprioritized modifications to achieve more potent compounds in favor of modifications to obtain less potent, but more lipophilic, efficient inhibitors. We went from compound <b>1</b> (cellular IC<sub>50</sub> of 0.078 μM) to compound <b>7</b> (cellular IC<sub>50</sub> of 2.7 μM) to compound <b>20</b> (cellular IC<sub>50</sub> of 1.9 μM) before finally optimizing to <b>43</b> (cellular IC<sub>50</sub> of 0.0035 μM) with demonstrated in vivo activity for proof of concept studies. The thermodynamic profile of key analogues generated during the optimization demonstrates that our optimization created inhibitors with enthalpy-driven binding. It is possible that a LipE-driven optimization approach may be a more general approach for yielding enthalpy-driven inhibitors, but further studies investigating this are warranted. For the case of TNKS, LipE was a valuable decision-making tool for the rapid generation of potent, selective, and in vivo active compounds for target validation and lead optimization.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Materials and Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44312" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44312" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Tankyrase AutoPARsylation Assay</h3><div class="NLM_p last">PARP catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of nicotinamide, as previously described.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The autoPARsylation reactions were performed at room temperature in 384-well Greiner flat-bottom plates. The final reaction mixture contained 2.5% DMSO and inhibitors with concentrations ranging from 0.0001 to 18.75 μM. GST-TNKS2P, GST-TNKS1P, PARP1, and PARP2 enzymes were used at final concentrations or 5, 5, 5, and 2 nM, respectively. The nicotinamide concentration in the resulting supernatants was measured by LC-MS. The % inhibition was calculated as follows: (control – sample)/(control – background) × 100. “Control” is the average value of eight wells without compound, and “background” is the average of eight wells mixed with 5× quenching solution measured prior to initiation of the reaction.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> SuperTop Flash (STF) Reporter Gene Assay</h3><div class="NLM_p last">Compound activity in inhibiting Wnt ligand-induced signaling was measured using a Wnt-responsive SuperTopFlash (STF) luciferase reporter gene assay in HEK293 cells. The % inhibition was calculated as follows: (maximum Wnt-induced signaling – sample)/(maximum Wnt-induced signaling – background) × 100. “Maximum Wnt-induced signaling” is the STF signal level induced by 20% Wnt3A CM without compound, and “background” is the STF signal level without the addition of Wnt3A CM or compound. To demonstrate the specific activity of inhibitors regulating Wnt signaling, counter screen was performed in HEK293T cells expressing a cAMP-response element (CRE) luciferase reporter gene. Compound activity on the CRE-reporter was measured in the presence of 10 μM forskolin, which is an activator of cAMP signaling.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Axin2 Protein ELISA</h3><div class="NLM_p last">Compound activity in stabilizing the Axin2 protein was measured by Sandwich enzyme-linked immunosorbent (ELISA) assay in the colorectal cell line SW480. Cell lysates were prepared from cells treated with compounds in six-point dilution starting at 10 μM for 24 h. For the ELISA assay, anti Axin-2 capture antibody was diluted to a concentration of 1 μg/mL (1:1000) in carbonate coating buffer, pH 9.2 (Sigma, C3041–50CAP). Then 100 μL of the diluted anti Axin-2 capture antibody per well was used to coat the 96-well plate overnight at 4 °C. Plates were then washed three times with wash solution, PBST20 (PBS + 0.05% Tween), and blocked with 1% BSA/PBS for 1.5 h at room temperature while shaking gently. After blocking, plates were then washed three times with wash solution. Then 100 μL of prepared SW480 cell lysate was added to each well and incubated at room temperature for 2 h while shaking gently. After washing, 100 μL of biotinylated anti-Axin2 antibody was added to each well and incubated at room temperature for 2 h. Signal was detected by chemiluminescence (Pierce SuperSignal ELISA Femto no. 3704) using streptavidin-HRP (R&D Systems, DY998) and measured on PerkinElmer Wallac 1420 plate reader.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> MMTV-Wnt1 Allograft Model</h3><div class="NLM_p last">Athymic female nude mice (Harlan Laboratories) weighing 19–22 g were implanted subcutaneously with a 3 × 3 × 3 mm<sup>3</sup> tumor fragment from an MMTV-Wnt1 tumor-bearing mouse. Tumors were grown to approximately 250–300 mm<sup>3</sup>. Individual mice were given a single oral dose of vehicle (<i>n</i> = 3) (4% HCl:10% propylene glycol:20% Solutol HS15:60.5% D5W:0.5% NaOH) or TNKS656 at 350 mg/kg (<i>n</i> = 18). At 0.5, 1, 2, 4, 8, 16, or 24 h following dosing (<i>n</i> = 3/time point), mice were euthanized, and blood was collected via cardiac puncture and processed for plasma. Tumors were excised from mice and frozen at −80 °C for PD analysis.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Protein Purification and Crystallization</h3><div class="NLM_p last">Human TNKS1 protein was expressed, purified, and crystallized as previously described.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> To obtain crystals containing either <b>19</b>, <b>33</b>, or <b>35</b>, TNKS1/PJ34 complex crystals were transferred into a soaking solution containing 100 mM Bis-Tris pH 5.8, 18% PEG 3350, 320 mM ammonium sulfate, and 200 μM of compound. Transfer of the crystals into fresh solution occurred once per hour over a 4 h period. Crystals were cryoprotected using the same soaking solution with the addition of 20% glycerol, followed by flash-freezing directly into liquid nitrogen.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Data Collection and Structure Determination</h3><div class="NLM_p">Diffraction data for the TNKS1/<b>19</b> complex were collected on a Saturn92 CCD Detector using Cu Kα radiation (λ = 1.5418 Å) from a Rigaku FR-E rotating anode X-ray generator operating at 45 mV and 45 mA. Diffraction data for the TNKS1/<b>33</b> complex were collected on a Quantum315R CCD Detector at the ALS beamline BL5.0.3 at a wavelength of 1 Å. Diffraction data for the TNKS1/<b>35</b> complex were collected on a Dectris Pilatus 6 M Detector at the Swiss Light Source beamline X06SA at a wavelength of 1 Å. The data were measured from a single crystal, and the reflections were indexed, integrated, and scaled using XDS and XSCALE<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> or HKL2000.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The space group of the complex was C2 with two molecules in the asymmetric unit. The structure was determined with Fourier methods, using the TNKS1/PJ34 structure (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UH2">3UH2</a>) with active site waters and inhibitors removed as the starting model.</div><div class="NLM_p last">Structure determination was achieved through iterative rounds of positional and simulated annealing refinement using CNX<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> or PHENIX<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> with model building using COOT<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Individual B-factors were refined, and a bulk solvent correction was applied. The solvent, sulfate ions, and inhibitor were built into the density in later rounds of the refinement. Data collection and refinement statistics are shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Table 2">Supporting Information Table 2</a>.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Isothermal Calorimetry</h3><div class="NLM_p last">Isothermal calorimetry was used to determine the thermodynamic properties of ligand binding. Data were collected at 25 °C on an Auto-iTC<sub>200</sub> (GE Healthcare) using a sample buffer of 25 mM HEPES pH 7.4, 150 mM NaCl, with a matched DMSO concentration between the titrant and cell. Direct titration of 200 μM compound into 20 μM TNKS1 over 16 injections of 2.5 μL was performed in the case of <b>34</b>, <b>42</b>, and <b>43</b>. Direct titration of 300 μM compound into 20 μM TNKS1 over 20 injections of 2 μL was performed in the case of <b>20</b>. Finally, a reverse titration using 200 μM TNKS1 into 20 μM <b>7</b> over 16 injections of 2.5 μL was performed. The individual heat values were plotted against the molar ratio, and the values for the number of binding sites (<i>n</i>), the enthalpy change (Δ<i>H</i>), and dissociation constant (<i>K</i><sub>D</sub> = 1/<i>K</i><sub>A</sub>) were obtained by nonlinear regression of the data.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemical Synthesis</h3><div class="NLM_p">The purity of all compounds was determined using high resolution HPLC/MS characterization and found to be >95% pure except as noted. High resolution LC/ESI-MS data were recorded using an Agilent 6220 mass spectrometer with electrospray ionization source and an Agilent 1200 liquid chromatograph with a gradient from 5% to 95% acetonitrile in water on a C18 reverse phase column with a diode array detection. The resolution of the MS system was approximately 11000 (fwhm definition). HPLC separation was performed using one of the methods (denoted in the header text) listed at end of report. Purine and hexakis(1<i>H</i>,1<i>H</i>,3<i>H</i>-tetrafluoropropoxy)phosphazine (protonated molecules <i>m</i>/<i>z</i> 121.05087 and 922.00979, respectively) were used as a reference. The mass accuracy of the system has been found to be <2 ppm.</div><div id="sec3_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Procedure A: Synthesis of Benzamidines</h4><div id="sec3_8_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 4-(Trifluoromethoxy)benzimidamide (<b>15a</b>)</h5><div class="NLM_p last">Trimethylaluminum (2 M in toluene, 2.4 mL, 4.8 mmol, 3 equiv) was added to a ca. 5 °C suspension of ammonium chloride (257 mg, 4.8 mmol, 3 equiv) in 8 mL of toluene. The reaction mixture was then stirred in the cold bath for 1.5 h and then at room temperature for 0.5 h. 4-(Trifluoromethoxy)benzonitrile (300 mg, 1.6 mmol, 1.0 equiv) was then added, and the reaction mixture was heated to reflux overnight. The reaction mixture was cooled to room temperature, quenched with MeOH (30 mL), and cooled in an ice bath, and 2 g of silica gel in DCM with 1% MeOH was added. The mixture was stirred for 15 min, and the solid was collected and then washed with excess MeOH. The filtrate was concentrated in vacuo to give a white solid (327 mg, 1.6 mmol, 100% yield) and used without further purification.</div></div></div><div id="sec3_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Procedure B: Synthesis of Pyrimidinones</h4><div id="sec3_8_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 2-(4-(Trifluoromethyl)phenyl)-7,8-dihydro-3<i>H</i>-thiopyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>1</b>)</h5><div class="NLM_p last">K<sub>2</sub>CO<sub>3</sub> (1.42 g, 10.2 mmol, 2.0 equiv) was added to a room temperature mixture of methyl 4-oxotetrahydro-2<i>H</i>-thiopyran-3-carboxylate<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (876 mg, 5.03 mmol) and 4-(trifluoromethyl)benzimidamide hydrochloride dihydrate (1.42 g, 5.46 mmol, 1.08 equiv) in methanol (25 mL). The reaction mixture was then refluxed overnight. The reaction mixture was then filtered with the aid of methanol and then concentrated to ca. 1/4 volume. The resulting material was dissolved in water and acidified to ca. pH 3 using 1 N aqueous HCl. The resulting precipitate was filtered and washed several times with water/MeOH (1:1) followed by several washes with ether. The resulting white solid was dried in a high vacuum oven (35 °C) for several hours, affording <b>1</b> (1.24 g, 79%) as a white solid. Exact mass calculated for C<sub>14</sub>H<sub>12</sub>F<sub>3</sub>N<sub>2</sub>OS 313.0622, found 313.0628 (ESI, M + H). 1H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.94 (br s, 1 H) 8.28 (d, <i>J</i> = 8.08 Hz, 2 H) 7.89 (d, <i>J</i> = 8.59 Hz, 2 H) 3.55 (s, 2 H) 2.91 (s, 4 H)</div></div></div><div id="sec3_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Ethyl 3-Oxotetrahydro-2<i>H</i>-thiopyran-2-carboxylate (<b>3a</b>)</h4><div class="NLM_p">One drop of MeOH was added to a room temperature suspension of NaH in Et<sub>2</sub>O (2 mL). A solution of ethyl 4-((2-ethoxy-2-oxoethyl)thio)butanoate in Et<sub>2</sub>O (4 mL) was then added, and the reaction mixture was heated at reflux for 5 h. The reaction mixture was cooled to room temperature and then quenched with 3 N aq AcOH. After separation, the aqueous layer was extracted with Et<sub>2</sub>O (2 × 80 mL). The combined organic layers were washed several times with sat. NaHCO<sub>3</sub> solution, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to dryness affording ethyl 3-oxotetrahydro-2<i>H</i>-thiopyran-2-carboxylate as a brown oil which was used without further purification. Mass calculated for C<sub>14</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>OS 312.1, found 313.0 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.94 (br s, 1H), 8.26 (d, <i>J</i> = 8.1 Hz, 2H), 7.87 (d, <i>J</i> = 8.6 Hz, 2H), 2.99 (td, <i>J</i> = 2.9, 5.3 Hz, 2H), 2.76 (t, <i>J</i> = 6.1 Hz, 2H), 2.14–2.01 (m, 2H).</div><div id="sec3_8_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 2-(4-(Trifluoromethyl)phenyl)-7,8-dihydro-3<i>H</i>-thiopyrano[3,2-<i>d</i>]pyrimidin-4(6<i>H</i>)-one (<b>3</b>)</h5><div class="NLM_p last">Following general procedure B, the title compound (64 mg, 0.21 mmol, 29% yield) was prepared from ethyl 3-oxotetrahydro-2<i>H</i>-thiopyran-2-carboxylate (142 mg, 0.72 mmol, 1.0 equiv) and 4-(trifluoromethyl)benzimidamide (200 mg, 0.77 mmol, 1.1 equiv). Mass calculated for C<sub>14</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>OS 312.1, found 313.0 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.94 (br s, 1H), 8.26 (d, <i>J</i> = 8.1 Hz, 2H), 7.87 (d, <i>J</i> = 8.6 Hz, 2H), 2.99 (td, <i>J</i> = 2.9, 5.3 Hz, 2H), 2.76 (t, <i>J</i> = 6.1 Hz, 2H), 2.14–2.01 (m, 2H).</div></div><div id="sec3_8_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 2-(4-(Trifluoromethyl)phenyl)-4a,5,7,7a-tetrahydrothieno[3,4-<i>d</i>]pyrimidin-4(3<i>H</i>)-one (<b>4</b>)</h5><div class="NLM_p last">Following general procedure B, the title compound (14.7 mg, 0.05 mmol, 9% yield) was prepared from methyl 4-oxotetrahydrothiophene-3-carboxylate (95 mg, 0.56 mmol, 1.0 equiv) and 4-(trifluoromethyl)benzimidamide hydrochloride dihydrate (200 mg, 0.62 mmol, 1.1 equiv). Mass calculated for C<sub>13</sub>H<sub>9</sub>F<sub>3</sub>N<sub>2</sub>OS 298.04, found 299.0 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 13.02 (br s, 1H), 8.29 (d, <i>J</i> = 7.6 Hz, 2H), 7.90 (d, <i>J</i> = 8.6 Hz, 2H), 4.23 (d, <i>J</i> = 3.0 Hz, 2H), 4.05 (d, <i>J</i> = 3.0 Hz, 2H).</div></div><div id="sec3_8_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 2-(4-(Trifluoromethyl)phenyl)-5,6,7,8-tetrahydroquinazolin-4(3<i>H</i>)-one (<b>5</b>)</h5><div class="NLM_p last">Following general procedure B, the title compound (53 mg, 0.18 mmol, 62% yield) was prepared from ethyl 2-oxocyclohexanecarboxylate (52 mg, 0.29 mmol, 1.0 equiv) and 4-(trifluoromethyl)benzimidamide hydrochloride dihydrate (100 mg, 0.38 mmol, 1.3 equiv). Exact mass calculated for C<sub>15</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>O 294.1, found 295.1 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 12.73 (br s, 1H), 8.28 (d, <i>J</i> = 7.6 Hz, 2H), 7.87 (d, <i>J</i> = 8.1 Hz, 2H), 2.70–2.57 (m, 2H), 2.42 (br s, 2H), 1.83–1.63 (m, 4H).</div></div><div id="sec3_8_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> <i>N</i>-(2-Carbamoylphenyl)-4-(trifluoromethyl)benzamide (<b>6a</b>)</h5><div class="NLM_p last">In a 20 mL vial, 4-(trifluoromethyl)benzoyl chloride (184 mg, 0.88 mmol, 1.2 equiv) was added to 2-aminobenzamide (100 mg, 0.73 mmol, 1.0 equiv) and DIEA (192 uL, 1.1 mmol, 1.5 equiv) in THF, and the reaction was stirred for 2 h resulting in a white precipitate. The reaction mixture was diluted with heptane, and the solid was collected, triturated with water, collected again, and then air-dried to give a white solid. The title compound (226 mg, 0.733 mmol, 100% yield) was used without further purification. Mass calculated for C<sub>15</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> 308.1, found 309.1 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.13 (s, 1H), 8.68 (d, <i>J</i> = 8.59 Hz, 1H), 8.44 (br s, 1H), 8.13 (d, <i>J</i> = 8.08 Hz, 2H), 7.98 (d, <i>J</i> = 8.59 Hz, 2H), 7.92 (dd, <i>J</i> = 1.26, 7.83 Hz, 1H), 7.82–7.89 (m, 1H), 7.55–7.63 (m, 1H), 7.17–7.25 (m, 1H).</div></div><div id="sec3_8_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 2-(4-(Trifluoromethyl)phenyl)quinazolin-4(3<i>H</i>)-one (<b>6</b>)</h5><div class="NLM_p last">In a 5 mL microwave vial, <i>N</i>-(2-carbamoylphenyl)-4-(trifluoromethyl)benzamide (226 mg, 0.73 mmol, 1.0 equiv) and KOEt (123 mg, 1.46 mmol, 2.0 equiv) were heated in the microwave at 140 °C for 20 min. The mixture was poured into 1 N HCl, and the resulting white solid was collected, washed with heptane, and air-dried to provide the title compound (202 mg, 0.696 mmol, 95% yield). Mass calculated for C<sub>15</sub>H<sub>9</sub>F<sub>3</sub>N<sub>2</sub>O 290.1, found 291.2 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.73 (br s, 1H), 8.38 (d, <i>J</i> = 8.08 Hz, 2H), 8.18 (dd, <i>J</i> = 1.52, 8.08 Hz, 1H), 7.93 (d, <i>J</i> = 8.59 Hz, 2H), 7.84–7.90 (m, 1H), 7.77–7.81 (m, 1H), 7.54–7.60 (m, 1H).</div></div><div id="sec3_8_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 2-(4-(Trifluoromethyl)phenyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>7</b>)</h5><div class="NLM_p last">Following general procedure B, the title compound (190 mg, 35% yield) was prepared from methyl 4-oxotetrahydro-2<i>H</i>-pyran-3-carboxylate (290 mg, 1.83 mmol) and 4-(trifluoromethyl)benzimidamide hydrochloride dihydrate hydrochloride dihydrate (526 mg, 2.02 mmol). Mass calculated for C<sub>14</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> 296.08, found 297.0 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.93 (br s, 1H), 8.29 (d, <i>J</i> = 8.08 Hz, 2H), 7.89 (d, <i>J</i> = 8.08 Hz, 2H), 4.46 (s, 2H), 3.91 (t, <i>J</i> = 5.56 Hz, 2H), 2.70 (br s, 2H).</div></div><div id="sec3_8_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 2-(4-(Trifluoromethyl)phenyl)-5,6-dihydro-3<i>H</i>-pyrano[3,4-<i>d</i>]pyrimidin-4(8<i>H</i>)-one (<b>8</b>)</h5><div class="NLM_p last">Following general procedure B, ethyl 3-oxotetrahydro-2<i>H</i>-pyran-4-carboxylate (100 mg, 0.436 mmol, 75% pure) and 4-(trifluoromethyl)benzimidamide (117 mg, 0.523 mmol) were converted to the title compound (82 mg, 0.277 mmol, 64% yield) as an off-white solid. MS <i>m</i>/<i>z</i> 297.2 (M + H), Ret time: 1.23 min; HRMS <i>m</i>/<i>z</i> (M + H) calculated for C<sub>14</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>: 297.0851, found: 297.0846. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.20–13.39 (m, 1H), 8.26 (d, <i>J</i> = 8.03 Hz, 2H), 7.90 (d, <i>J</i> = 8.03 Hz, 2H), 4.47 (s, 2H), 3.87 (t, <i>J</i> = 5.52 Hz, 2H), 2.50 (br s, 2H)</div></div><div id="sec3_8_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 2-(Thiophen-3-yl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>9</b>)</h5><div class="NLM_p last">Following general procedure B, methyl 4-oxotetrahydro-2<i>H</i>-pyran-3-carboxylate (100 mg, 0.474 mmol, 75% pure) and thiophene-3-carboximidamide (93 mg, 0.599 mmol) were converted to the title compound (73 mg, 0.296 mmol, 62% yield) as a yellow solid. MS <i>m</i>/<i>z</i> 235.2 (M + H), Ret time: 0.78 min; HRMS <i>m</i>/<i>z</i> (M + H) calculated for C<sub>11</sub>H<sub>10</sub>N<sub>2</sub>O<sub>2</sub>S: 235.0541, found: 235.0549. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.64 (br s 1H), 8.50 (s, 1H), 7.76 (d, <i>J</i> = 4.96 Hz, 1H), 7.66–7.70 (m, 1H), 4.41 (s, 2H), 3.88 (t, <i>J</i> = 5.51 Hz, 2H), 2.60–2.66 (m, 2H)</div></div><div id="sec3_8_3_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 2-(<i>p</i>-Tolyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>10</b>)</h5><div class="NLM_p last">Following general procedure B, methyl 4-oxotetrahydro-2<i>H</i>-pyran-3-carboxylate (100 mg, 0.474 mmol, 75% pure) and 4-methylbenzimidamide (76 mg, 0.569 mmol) were converted to the title compound (40 mg, 0.165 mmol, 35% yield) as an off-white solid. MS <i>m</i>/<i>z</i> 243.3 (M + H), Ret time: 1.03 min; HRMS <i>m</i>/<i>z</i> (M + H) calculated for C<sub>14</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>: 243.1134, found: 243.1138. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.65 (br s, 1H), 8.00 (d, <i>J</i> = 8.08 Hz, 2H), 7.33 (d, <i>J</i> = 8.08 Hz, 2H), 4.43 (s, 2H), 3.89 (t, <i>J</i> = 5.56 Hz, 2H), 2.66 (t, <i>J</i> = 5.31 Hz, 2H), 2.38 (s, 3H).</div></div><div id="sec3_8_3_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 2-(4-Chlorophenyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>11</b>)</h5><div class="NLM_p last">Following general procedure B, methyl 4-oxotetrahydro-2<i>H</i>-pyran-3-carboxylate (100 mg, 0.474 mmol, 75% pure) and 4-chlorobenzimidamide (161 mg, 0.569 mmol) were converted to the title compound (80 mg, 0.283 mmol, 60% yield) as a yellow solid. MS <i>m</i>/<i>z</i> 263.2 (M + H), Ret time: 0.98 min; HRMS <i>m</i>/<i>z</i> (M + H) calculated for C<sub>13</sub>H<sub>11</sub>ClN<sub>2</sub>O<sub>2</sub>: 263.0587, found: 263.0587. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.61 (br s 1H), 8.11 (d, <i>J</i> = 8.82 Hz, 2H), 7.58 (d, <i>J</i> = 7.71 Hz, 2H), 4.42 (s, 2H), 3.89 (t, <i>J</i> = 5.51 Hz, 2H), 2.69–2.62 (m, 2H).</div></div><div id="sec3_8_3_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 2-(4-Bromophenyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>12</b>)</h5><div class="NLM_p last">Following general procedure B, methyl 4-oxotetrahydro-2<i>H</i>-pyran-3-carboxylate (300 mg, 2.53 mmol, 75% pure) and 4-bromobenzimidamide (536 mg, 2.28 mmol) were converted to the title compound (183 mg, 0.554 mmol, 29% yield) as a white solid. MS <i>m</i>/<i>z</i> 307.1 (M + H), Ret time: 1.11 min; HRMS <i>m</i>/<i>z</i> (M + H) calculated for C<sub>13</sub>H<sub>11</sub>BrN<sub>2</sub>O<sub>2</sub>: 307.0082, found: 307.0070. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.03 (d, <i>J</i> = 8.46 Hz, 2H), 7.74 (d, <i>J</i> = 8.72 Hz, 2H), 7.25 (br s, 1H), 4.43 (s, 2H), 3.90 (t, <i>J</i> = 5.62 Hz, 2H), 2.67 (t, <i>J</i> = 5.31 Hz, 2H).</div></div><div id="sec3_8_3_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 2-(4-(Dimethylamino)phenyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>13</b>)</h5><div class="NLM_p last">Following general procedure B, ethyl 3-oxotetrahydro-2<i>H</i>-pyran-4-carboxylate (100 mg, 0.290 mmol, 50% pure) and 4-(dimethylamino)benzimidamide (76 mg, 0.348 mmol) were converted to the title compound (10 mg, 0.038 mmol, 13% yield) as a yellow solid. MS <i>m</i>/<i>z</i> 272.4 (M + H), Ret time: 1.05 min; HRMS <i>m</i>/<i>z</i> (M + H) calculated for C<sub>15</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>: 272.1399, found: 272.1406. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.32 (br s, 1H), 8.00 (d, <i>J</i> = 9.03 Hz, 2H), 6.75 (d, <i>J</i> = 9.03 Hz, 2H), 4.40 (s, 2H), 3.79–3.92 (m, 2H), 3.00 (s, 6H), 2.61 (t, <i>J</i> = 5.27 Hz, 2H).</div></div><div id="sec3_8_3_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 2-(4-Methoxyphenyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>14</b>)</h5><div class="NLM_p last">Following general procedure B, methyl 4-oxotetrahydro-2<i>H</i>-pyran-3-carboxylate (100 mg, 0.474 mmol, 75% pure) and 4-methoxybenzimidamide (85 mg, 0.569 mmol) were converted to the title compound (28 mg, 0.108 mmol, 23% yield) as an off-white solid. MS <i>m</i>/<i>z</i> 259.3 (M + H), Ret time: 0.97 min; HRMS <i>m</i>/<i>z</i> (M + H) calculated for C<sub>14</sub>H<sub>14</sub>N<sub>2</sub>O<sub>3</sub>: 259.1083, found: 259.1077. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.09 (d, <i>J</i> = 8.97 Hz, 2H), 7.0 (d, <i>J</i> = 8.97 Hz, 2H), 4.42 (s, 2H), 3.89 (t, <i>J</i> = 5.56 Hz, 2H), 3.84 (s, 3H), 2.62–2.67 (m, 2H).</div></div><div id="sec3_8_3_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 2-(4-(Trifluoromethoxy)phenyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>15</b>)</h5><div class="NLM_p last">Following general procedure B, the title compound (24 mg, 0.075 mmol, 16% yield) was prepared from <b>15a</b> (75 mg, 0.47 mmol, 1.0 equiv) and 4-(trifluoromethoxy)benzimidamide (145 mg, 0.711 mmol, 1.5 equiv). Mass calculated for C<sub>14</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>O<sub>3</sub> 312.2, found 313.1 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.82 (br s, 1H), 8.21 (d, <i>J</i> = 7.58 Hz, 2H), 7.51 (d, <i>J</i> = 8.59 Hz, 2H), 4.44 (s, 2H), 3.90 (t, <i>J</i> = 5.56 Hz, 2H), 2.67 (br s, 2H).</div></div><div id="sec3_8_3_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> Methyl 4-(4-Oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)benzoate (<b>16</b>)</h5><div class="NLM_p last">Following general procedure B, the title compound (601 mg, 80% yield) was prepared from methyl 4-oxotetrahydro-2<i>H</i>-pyran-3-carboxylate (402 mg, 2.63 mmol) and methyl 4-carbamimidoylbenzoate hydrochloride (0.672 g, 3.13 mmol). Mass calculated for C<sub>15</sub>H<sub>14</sub>N<sub>2</sub>O<sub>4</sub> 286.29, found 287.2 (ESI, M + H). 1H NMR (400 MHz, DMSO-d6) δ ppm 12.86 (br s, 1H), 8.22 (d, <i>J</i> = 8.08 Hz, 2H), 8.07 (d, <i>J</i> = 8.59 Hz, 2H), 4.45 (s, 2H), 3.87–3.93 (m, 5H), 2.69 (br s, 2H).</div></div><div id="sec3_8_3_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 2-(4-(Methylsulfonyl)phenyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>17</b>)</h5><div class="NLM_p last">Following general procedure B, methyl 4-oxotetrahydro-2<i>H</i>-pyran-3-carboxylate (50 mg, 0.316 mmol) and 4-(methylsulfonyl)benzimidamide (89 mg, 0.379 mmol) were converted to the title compound (9 mg, 0.029 mmol, 9% yield) as white solid. MS <i>m</i>/<i>z</i> 307.3 (M + H), Ret time: 0.72 min; HRMS <i>m</i>/<i>z</i> (M + H) calculated for C<sub>14</sub>H<sub>14</sub>N<sub>2</sub>O<sub>4</sub>S: 307.0753, found: 307.0751. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.01 (br s, 1H), 8.30 (br s, 2H), 8.07 (d, <i>J</i> = 8.53 Hz, 2H), 4.46 (br s, 2H), 3.91 (t, <i>J</i> = 5.27 Hz, 2H), 3.30 (s, 3H), 2.70 (br s, 2H).</div></div><div id="sec3_8_3_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 2-(4-(2-Hydroxypropan-2-yl)phenyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>18</b>)</h5><div class="NLM_p last">MeMgBr (3 M in Et2O, 780 μL, 2.34 mmol) was added to a ca. −78 °C mixture of compound <b>16</b> (0.99 mg, 0.346 mmol) in THF (3 mL). After complete addition, the reaction mixture was removed from the cold bath, stirred, and allowed to warm to room temperature over 1 h. The reaction mixture was cooled in an ice bath and slowly quenched with 1 N HCl (ca. 5 mL). The reaction mixture was then diluted with water and extracted with EtOAc (5 × 10 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to dryness, affording the title compound as an off-white solid (83 mg, 84% yield). Mass calculated for C<sub>16</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub> 286.33, found 287.2 (ESI, M + H). 1H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.63 (br s, 1H), 8.02 (d, <i>J</i> = 8.59 Hz, 2H), 7.59 (d, <i>J</i> = 8.59 Hz, 2H), 5.13 (s, 1H), 4.43 (s, 2H), 3.89 (t, <i>J</i> = 5.56 Hz, 2H), 2.66 (t, <i>J</i> = 5.05 Hz, 2H), 1.45 (s, 6H).</div></div><div id="sec3_8_3_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 2-Chloromethyl-3,5,7,8-tetrahydropyrano[4,3-<i>d</i>]pyrimidin-4-one (<b>45</b>)</h5><div class="NLM_p last">A mixture of 4-oxo-tetrahydropyran-3-carboxylic acid methyl ester (1780 g, 11 mol) and NEt<sub>3</sub> (830 g, 8.2 mol) in MeOH (3560 mL) was cooled to 0 °C under N<sub>2</sub>. A solution of 2-chloroacetamidine (567 g, 4.4 mol) in 890 mL of MeOH was added dropwise over 50 min. The reaction mixture was stirred at 0 °C for 30 min and then at about 20 °C for 16 h. LCMS at 215 nm and TLC (DCM:MeOH = 10:1) analysis showed that most of 4-oxotetrahydropyran-3-carboxylic acid methyl ester was consumed. The mixture was then filtered and concentrated to give a black oil, which was subsequently purified by flash column chromatography on silica gel and eluted with DCM to give a yellow solid/oil mixture, which was further triturated with MTBE (∼1200 mL) and H<sub>2</sub>O:CH<sub>3</sub>CN:EA = 1:1:2 (∼600 mL) to give the title compound as a white solid (318 g, 1.59 mol, 36% yield). MS <i>m</i>/<i>z</i> 201.2 (M + H). CHN analysis: calculated (results). C 47.89 (47.95), H 4.52 (4.401), N 13.96 (13.76).</div></div><div id="sec3_8_3_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 2-(Azidomethyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>46</b>)</h5><div class="NLM_p last">To a solution of <b>45</b> (20.6 g, 103 mmol) in acetone (513 mL) was added an aqueous solution of sodium azide (7.01 g, 108 mmol in 32 mL of water). The reaction was stirred at room temperature for 36 h. Mixture was split into three equal volumes and each was diluted with dichloromethane (500 mL) and brine was added (100 mL) and the layers were separated. The aqueous fractions were combined and extracted with dichloromethane (5 × 100 mL). The combined organic layers were concentrated in vacuo. The resulting residue was taken up in dichloromethane (200 mL) and evaporated to dryness three times to yield 19.25 g (92 mmol, 90% yield) of a yellow-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.58 (br s, 1H), 4.36 (s, 2H), 4.28 (s, 2H), 3.85 (t, <i>J</i> = 5.56 Hz, 2H), 2.59 (t, <i>J</i> = 5.56 Hz, 2H).</div></div><div id="sec3_8_3_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 2-(Aminomethyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>47</b>)</h5><div class="NLM_p last">To a solution of 2-(azidomethyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (19 g, 92 mmol) in THF (945 mL) at 35 °C was added triphenylphosphine (26.5 g, 101 mmol). Gas evolution was noted immediately and after approximately 40 min a fine precipitate formed. The reaction was allowed to stir for 1.5 h then 18.17 mL water was added. After an addition 2 h the reaction mixture was cooled to room temperature, filtered twice, concentrated to approximately 1/3 of the original volume and filtered once more. The solid material was washed with THF to yield a total of 15.82 g (87 mmol, 95% yield) of the title compound. <sup>1</sup>H NMR (400 MHz, MeOD): δ 4.49 (s, 2H), 3.94 (t, <i>J</i> = 5.56 Hz, 2H), 3.76 (s, 2H), 2.66 (t, <i>J</i> = 5.56 Hz, 2H).</div></div><div id="sec3_8_3_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> <i>N</i>-((4-Oxo-3,4-dihydroquinazolin-2-yl)methyl)-3-phenyl-<i>N</i>-(thiophen-2-ylmethyl)propanamide (<b>19</b>)</h5><div class="NLM_p last">To a solution of 2-(((thiophen-2-ylmethyl)amino)methyl)quinazolin-4(3<i>H</i>)-one (100 mg, 0.369 mmol) in methylene chloride (4 mL) were added triethylamine (113 μL, 0.811 mmol, 2.2 equiv) and 3-phenylpropanoyl chloride (75 mg, 0.442 mmol, 1.2 equiv), and the solution was stirred 4 h. The reaction mixture was concentrated in vacuo, taken up in EtOAc, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give a white solid. The crude product was absorbed onto silica gel and added to an Analogix SF15-12g column, and compound was eluted with 1% to 10% MeOH in DCM over 12 column volumes on a Biotage SP1. This product was absorbed onto silica gel and added to an Biotage SNAP-10g column, and the compound was eluted with 5% to 80% EtOAc in dichloromethane over 12 column volumes on a Biotage SP1. The concentrated fractions were recrystallized from diethyl ether, washed with hepatne, and dried under vacuum to give the title compound (30 mg, 0.074 mmol, 20% yield). Mass calculated for C<sub>23</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>S 403.1, found 404.3 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 10.13 (br s, 1H), 8.28 (d, <i>J</i> = 7.58 Hz, 1H), 7.71–7.78 (m, 1H), 7.64 (d, <i>J</i> = 8.08 Hz, 1H), 7.45–7.53 (m, 1H), 7.14–7.25 (m, 6H), 6.88–6.95 (m, 2H), 4.66 (s, 2H), 4.51 (s, 2H), 3.03–3.10 (m, 2H), 2.80–2.87 (m, 2H).</div></div></div><div id="sec3_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> General Procedure C</h4><div id="sec3_8_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 2-(((Thiophen-2-ylmethyl)amino)methyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>23</b>)</h5><div class="NLM_p last">A mixture of thiophene-2-carbaldehyde (0.021 mL, 0.22 mmol), <b>47</b> (40 mg, 0.22 mmol), and siliabond cyanoborohydride (240 mg, 0.24 mmol, 1 mmol/g) in ethanol (1 mL) was stirred at ambient temperature for 10 min. Acetic acid (0.013 mL, 0.22 mmol) was then added, and the mixture was stirred at ambient temperature for another 5 min. The reaction mixture was concentrated in vacuo and purified via flash column chromatography (ethyl acetate/hexane, 10:90 to 100:0, then methanol/dichloromethane, 1:99 to 10:90) to provide the title compound (30 mg, 49% yield). <i>m</i>/<i>z</i> 278.1 (M + H), retention time =  0.89 min. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.58 (d, <i>J</i>   = 5.05 Hz, 1H), 7.33 (d, <i>J</i> = 3.03 Hz, 1H), 7.07–7.16 (m, 1H), 4.63 (s, 2H), 4.47 (s, 2H), 4.24 (s, 2H), 3.94 (t, <i>J</i> = 5.56 Hz, 2H), 2.73 (t, <i>J</i> = 5.56 Hz, 2H).</div></div></div><div id="sec3_8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> General Procedure D</h4><div id="sec3_8_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> <i>N</i>-((4-Oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-3-phenyl-<i>N</i>-(thiophen-2-ylmethyl)propanamide (<b>20</b>)</h5><div class="NLM_p last">To a solution of compound <b>23</b> (95 mg, 0.34 mmol) in methylene chloride (3 mL) were added triethylamine (143 μL, 1.028 mmol) and 3-phenylpropanoyl chloride (58 mg, 0.34 mmol), and the solution was stirred 4 h. Purification was accomplished on an Isco 12 g column with 1% to 10% methanol in methylene chloride over 12 column volumes. The resulting partial purified product was taken up in DMSO and purified on a Sunfire C18 5 μm (19 × 100 mm) column. The mobile phase was 10% to 90% acetonitrile in water (0.1% TFA) to give title compound (39 mg, 0.095 mmol, 28% yield). Mass calculated for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>S 409.5, found 410.6 (ESI, M + H); <sup>1</sup>H NMR (400 MHz, MeOD) δ ppm 7.09–7.39 (m, 5H), 6.79–7.00 (m, 2H), 4.77 (s, 1H), 4.35–4.49 (m, 4H), 3.79–3.98 (m, 2H), 3.35 (s, 1H), 2.81–3.01 (m, 3H), 2.73 (t, <i>J</i> = 7.33 Hz, 1H), 2.49–2.68 (m, 2H).</div></div><div id="sec3_8_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> 2-((Ethylamino)methyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>21a</b>)</h5><div class="NLM_p last">The title compound (20 mg, 35% yield) was prepared using general procedure C from acetaldehyde (0.015 mL, 0.28 mmol) and <b>47</b> (50 mg, 0.28 mmol). Mass calculated for C<sub>10</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub> 209.2, found 210.3 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 4.49 (s, 2H) 3.94 (t, <i>J</i> = 5.52 Hz, 2H) 3.79 (s, 2H) 2.85 (q, <i>J</i> = 7.36 Hz, 2H) 2.65 (t, <i>J</i> = 5.52 Hz, 2H) 1.22 (t, <i>J</i> = 7.28 Hz, 3H).</div></div><div id="sec3_8_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> <i>N</i>-Ethyl-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-3-phenylpropanamide (<b>21</b>)</h5><div class="NLM_p last">The title compound (11 mg, 4% yield) was prepared using general procedure D from <b>21a</b> (20 mg, 0.096 mmol) and 3-phenylpropanoyl chloride (14 μL, 0.096 mmol). HRMS calculated for C<sub>19</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub> 342.1818, found (ESI, [M + H]<sup>+</sup>), 342.1811. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.55–6.78 (m, 5H), 4.02 (s, 2H), 3.82 (s, 2H), 3.40 (t, <i>J</i> = 5.3 Hz, 2H), 2.82 (q, <i>J</i> = 6.5 Hz, 2H), 2.37–2.56 (m, 2H), 2.01–2.22 (m, 4H), 0.71 (s, 1H), 0.45–0.64 (m, 3H).</div></div><div id="sec3_8_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> <i>N</i>-((4-Oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-3-phenylpropanamide (<b>22</b>)</h5><div class="NLM_p last">To a solution of <b>47</b> (24 mg, 0.130 mmol) in dichloromethane (1 mL) were added triethylamine (0.054 mL, 0.39 mmol, 3.0 equiv) and 3-phenylpropanoyl chloride (0.02 mL, 0.130 mmol, 1.0 equiv). The mixture was stirred at room temperature overnight. The solvent was removed, silica gel was added with methanol, and the mixture was concentrated in vacuo. The residue was purified using flash column chromatography (10g Isco column, 0 to 10% methanol/methylene chloride) to give the title compound (25 mg, 0.077 mmol, 59% yield). Mass calculated for C<sub>17</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub> 313.1, found 314.3 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, MeOH-d<sub>4</sub>) δ 7.12–7.26 (m, 5H), 4.47 (s, 2H), 4.22 (s, 2H), 3.93 (t, <i>J</i> = 5.56 Hz, 2H), 2.87–2.96 (m, 2H), 2.62–2.67 (m, 2H), 2.54–2.61 (m, 2H).</div></div><div id="sec3_8_5_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> <i>N</i>-((4-Oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-3-phenyl-<i>N</i>-(thiophen-3-ylmethyl)propanamide (<b>24</b>)</h5><div class="NLM_p last">Following the general procedure D, the title compound was prepared. Mass calculated for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>S 409.5, found 410.6 (ESI, M + H). <sup>1</sup>H NMR (MeOD) δ ppm 7.43 (dd, <i>J</i> = 5.05, 3.03 Hz, 1H), 7.11–7.39 (m, 6H), 6.88–7.02 (m, 1H), 4.74 (s, 1H), 4.67 (s, 1H), 4.44 −4.56 (m, 3H), 4.41 (s, 1H), 3.95 (q, <i>J</i> = 5.56 Hz, 2H), 2.95–3.09 (m, 2 H), 2.77–2.95 (m, 2 H), 2.58–2.74 (m, 2 H).</div></div><div id="sec3_8_5_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> <i>N</i>-((4-Oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-3-(pyridin-4-yl)-<i>N</i>-(thiophen-2-ylmethyl)propanamide (<b>25</b>)</h5><div class="NLM_p last">To a solution of <b>23</b> (100 mg, 0.369 mmol, 1.0 equiv) and 3-(pyridin-4-yl)propanoic acid (26 mg, 0.173 mmol, 1.0 equiv) in methylene chloride (1 mL) were added triethylamine (51 μL, 0.346 mmol, 2.0 equiv) and 2-chloro-1,3-dimethylimidazolidinium chloride (35 mg, 0.2 mmol, 1.2 equiv), and the solution was stirred overnight at room temperature. The reaction mixture was diluted with dichloromethane, washed with water (2×), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was dissolved in 1 mL of DMSO and purified on a Xterra C8 5 μm (19 × 100 mm) column, eluting with 10% to 70% MeCN in water (0.1% TFA) over 15 min. The fractions were combined and concentrated in vacuo. The product was dissolved MeOH, added to a SCX column (1 g), and washed with MeOH (100 mL), and then the product was eluted with 1 N NH<sub>3</sub> in MeOH (50 mL) and concentrated to provide the title compound (15 mg, 0.034 mmol, 23% yield). HRMS calculated for C<sub>21</sub>H<sub>22</sub>N<sub>4</sub>O<sub>3</sub>S 411.1491 (M + H), found 411.1507 (ESI, [M + H]<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.73 (d, <i>J</i> = 5.56 Hz, 2H), 7.96–8.12 (m, 2H), 7.20–7.45 (m, 1H), 6.77–7.16 (m, 2H), 4.95–5.14 (m, 2H), 4.56–4.81 (m, 4H), 3.91–4.19 (m, 3H), 3.34 (d, <i>J</i> = 6.06 Hz, 1H), 2.78–3.28 (m, 4H).</div></div><div id="sec3_8_5_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> <i>N</i>-((4-Oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-3-(pyridin-3-yl)-<i>N</i>-(thiophen-2-ylmethyl)propanamide (<b>26</b>)</h5><div class="NLM_p last">The title compound (10 mg, 0.022 mmol, 15% yield) was prepared following the same procedure as that for compound <b>25</b> from <b>23</b> (40 mg, 0.144 mmol, 1.0 equiv) and 3-(pyridin-3-yl)propanoic acid (26 mg, 0.173 mmol, 1.0 equiv). HRMS calculated for C<sub>21</sub>H<sub>22</sub>N<sub>4</sub>O<sub>3</sub>S 411.1491 (M + H), found 411.1492 (ESI, [M + H]<sup>+</sup>). 1H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.54–8.92 (m, 3H), 7.98–8.07 (m, 1H), 7.20–7.44 (m, 1H), 6.76–7.13 (m, 2H), 4.93–5.11 (m, 1H), 4.49–4.79 (m, 5H), 3.95–4.15 (m, 3H), 2.76–3.28 (m, 6H).</div></div><div id="sec3_8_5_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 3-(2-Fluorophenyl)-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-<i>N</i>-(thiophen-2-ylmethyl)propanamide (<b>27</b>)</h5><div class="NLM_p last">To a solution of <b>47</b> (45 mg, 0.16 mmol) and 3-(2-fluorophenyl)propionic acid (27 mg, 0.16 mmol) in dichloromethane (1 mL) were added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (37 mg, 0.20 mmol), 1-hydroxybenzotriazole (25 mg, 0.16 mmol), and triethylamine (68 μL, 0.49 mmol). The mixture was stirred at ambient temperature for 24 h. The mixture was added water and then extracted with dichloromethane two times. The combined organic layer was concentrated in vacuo and purified via flash column chromatography (ethyl acetate:hexane, 10:90 to 100:0) to give a residue. The residue was further purified via HPLC to provide the title compound (12 mg, 17% yield). HRMS calculated for C<sub>22</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>3</sub>S 428.1444, found (ESI, [M + H]<sup>+</sup>), 428.1439. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.49 (br s, 1H), 7.15–7.34 (m, 3H), 6.86–7.15 (m, 4H), 4.72 (s, 2H), 4.58 (s, 2H), 4.38–4.48 (m, 2H), 3.95 (t, <i>J</i> = 5.5 Hz, 2H), 3.09 (t, <i>J</i> = 7.8 Hz, 2H), 2.86 (t, <i>J</i> = 7.5 Hz, 2H), 2.57–2.72 (m, 2H).</div></div><div id="sec3_8_5_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> 3-(3-Fluorophenyl)-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-<i>N</i>-(thiophen-2-ylmethyl)propanamide (<b>28</b>)</h5><div class="NLM_p last">The title compound (8 mg, 11% yield) was prepared according to same procedure as that for compound <b>27</b> from 3-(3-fluorophenyl)propanoic acid. HRMS calculated for C<sub>22</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>3</sub>S 428.1444, found (ESI, [M + H]<sup>+</sup>), 428.1454. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.66 (br s, 1H), 7.20–7.38 (m, 2H), 6.84–7.07 (m, 5H), 4.72 (s, 2H), 4.57 (s, 2H), 4.44 (s, 2H), 3.95 (t, <i>J</i> = 5.5 Hz, 2H), 3.05 (t, <i>J</i> = 7.5 Hz, 2H), 2.85 (t, <i>J</i> = 7.5 Hz, 2H), 2.54–2.76 (m, 2H).</div></div><div id="sec3_8_5_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 3-(4-Fluorophenyl)-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-<i>N</i>-(thiophen-2-ylmethyl)propanamide (<b>29</b>)</h5><div class="NLM_p last">The title compound (20 mg, 43% yield) was prepared according to same procedure as that for compound <b>27</b> from 2-((thiophen-2-ylmethylamino)methyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (30 mg, 0.11 mmol) and 3-(4-fluorophenyl)propanoic acid (18 mg, 0.11 mmol). HRMS calculated for C<sub>22</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>3</sub>S 428.1444, found (ESI, [M + H]<sup>+</sup>), 428.1454. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.55 (br s 1H), 7.23–7.33 (m, 1H), 7.11–7.22 (m, 2H), 6.92–7.05 (m, 3H), 6.88 (d, <i>J</i> = 3.0 Hz, 1H), 4.70 (s, 2H), 4.58 (s, 2H), 4.42 (s, 2H), 3.95 (t, <i>J</i> = 5.5 Hz, 2H), 3.03 (t, <i>J</i> = 7.3 Hz, 2H), 2.82 (t, <i>J</i> = 7.5 Hz, 2H), 2.65 (t, <i>J</i> = 5.5 Hz, 2H).</div></div><div id="sec3_8_5_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 3-(2-Hydroxyphenyl)-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-<i>N</i>-(thiophen-2-ylmethyl)propanamide (<b>30</b>)</h5><div class="NLM_p last">The title compound (6 mg, 8% yield) was prepared according to same procedure as that for compound <b>27</b> from 3-(2-hydroxyphenyl)propionic acid. HRMS calculated for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>S 426.1488, found (ESI, [M + H]<sup>+</sup>), 426.1481. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.91 (br s, 1H), 8.21 (br s, 1H), 7.08–7.33 (m, 1H), 6.93–7.08 (m, 2H), 6.63–6.93 (m, 4H), 4.54 (s, 2H), 4.48 (s, 2H), 4.37 (s, 2H), 3.86 (t, <i>J</i> = 5.5 Hz, 2H), 2.94–3.07 (m, 2H), 2.78–2.94 (m, 2H), 2.52–2.63 (m, 2H).</div></div><div id="sec3_8_5_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> 3-(3-Hydroxyphenyl)-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-<i>N</i>-(thiophen-2-ylmethyl)propanamide (<b>31</b>)</h5><div class="NLM_p last">The title compound (7 mg, 10% yield) was prepared according to same procedure as that for compound <b>27</b> from 3-(3-hydroxyphenyl)propionic acid. HRMS calculated for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>S 426.1488, found (ESI, [M + H]<sup>+</sup>), 426.1494. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.78 (br s, 1H), 7.23 (d, <i>J</i> = 5.0 Hz, 1H), 7.17 (t, <i>J</i> = 7.8 Hz, 1H), 7.10 (br s, 1H), 6.86–6.98 (m, 1H), 6.74 (t, <i>J</i> = 6.8 Hz, 4H), 4.56 (d, <i>J</i> = 18.1 Hz, 4H), 4.46 (s, 2H), 3.94 (t, <i>J</i> = 5.5 Hz, 2H), 2.96–3.15 (m, 2H), 2.79–2.91 (m, 2H), 2.63 (t, <i>J</i> = 5.5 Hz, 2H).</div></div><div id="sec3_8_5_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> 3-(4-Hydroxyphenyl)-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-<i>N</i>-(thiophen-2-ylmethyl)propanamide (<b>32</b>)</h5><div class="NLM_p last">The title compound (7 mg, 9% yield) was prepared according to same procedure as that for compound <b>27</b> from 3-(4-hydroxyphenyl)propionic acid. HRMS calculated for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>S 426.1488, found (ESI, [M + H]<sup>+</sup>), 426.1493. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 11.17 (br s, 1H), 7.27–7.29 (m, 1H), 7.04 (m, <i>J</i> = 7.5 Hz, 2H), 6.93–7.00 (m, 1H), 6.89 (d, <i>J</i> = 3.0 Hz, 1H), 6.72 (m, <i>J</i> = 8.0 Hz, 2H), 4.71 (br s, 2H), 4.54 (br s, 2H), 4.44 (s, 2H), 3.95 (t, <i>J</i> = 5.3 Hz, 2H), 2.97 (t, <i>J</i> = 7.0 Hz, 2H), 2.83 (t, <i>J</i> = 7.0 Hz, 2H), 2.67 (br s, 2H).</div></div><div id="sec3_8_5_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> Ethyl 2-(4-(4-Fluorobenzoyl)piperidin-1-yl)acetate (<b>48</b>)</h5><div class="NLM_p last">To a solution of (4-fluorophenyl)(piperidin-4-yl)methanone hydrochloride (51.8 g, 213 mmol) in acetonitrile (400 mL) were added ethyl 2-bromoacetate (38.2 mL, 345 mmol) and triethylamine (70 mL, 506 mmol). The mixture was heated at reflux for 5 h. The solvent was evaporated under reduced pressure and purified via flash column chromatography (ethyl acetate/hexane, 10:90 to 100:0) to provide the title compound (52.7 g, 85% yield). MS <i>m</i>/<i>z</i> 294.4 (M + 1), retention time = 1.94 min. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.98 (dd, <i>J</i>  = 8.5, 5.5 Hz, 2 H), 7.16 (t, <i>J</i> = 8.5 Hz, 2 H), 4.22 (q, <i>J</i> = 7.2 Hz, 2 H), 3.16–3.27 (m, 1 H), 3.03 (d, <i>J</i>  = 11.5 Hz, 2 H), 2.43 (td, <i>J</i> = 11.2, 3.3 Hz, 2 H), 1.81–2.09 (m, 4 H), 1.51–1.73 (m, 2 H), 1.30 (t, <i>J</i>  = 7.3 Hz, 3 H).</div></div><div id="sec3_8_5_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> 2-(4-(4-Fluorobenzoyl)piperidin-1-yl)acetic Acid (<b>50</b>)</h5><div class="NLM_p last">To a solution of <b>48</b> (52.7 g, 180 mmol) in ethanol (300 mL) was added sodium hydroxide solution in water (1.8 M, 300 mL). The mixture was stirred at ambient temperature for 24 h and then neutralized with HCl (37%) until pH 5–7. The solvent was evaporated under reduced pressure, dissolved with methanol and methylene chloride, and filtered. The resulting solution was evaporated to give the title compound as a white solid (47.7 g, >99% yield). MS <i>m</i>/<i>z</i> 266.3 (M + H), retention time = 0.87 min. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.11 (dd, <i>J</i>  = 8.8, 5.3 Hz, 2H), 7.26 (t, <i>J</i> = 8.8 Hz, 2H), 3.57–3.85 (m, 5H), 3.21 (t, <i>J</i>  = 11.0 Hz, 2H), 1.96–2.18 (m, 4H).</div></div><div id="sec3_8_5_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> 2-(4-(4-Fluorobenzoyl)piperidin-1-yl)-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)acetamide (<b>34</b>)</h5><div class="NLM_p last">To a solution of <b>47</b> (1.7 g, 9.6 mmol) and <b>50</b> (2.7 g, 10 mmol) in dichloromethane (50 mL) were added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.2 g, 11 mmol), 1-hydroxybenzotriazole (1.5 g, 9.6 mmol), and triethylamine (4.0 mL, 29 mmol). The mixture was stirred at ambient temperature for 24 h. The reaction mixture was washed with ammonium chloride solution, concentrated in vacuo, and purified via flash column chromatography (ethyl acetate/hexane, 10:90 to 100:0, then methanol/dichloromethane, 1:99 to 10:90) to provide the title compound (2.2 g, 54% yield). HRMS calculated for C<sub>22</sub>H<sub>25</sub>N<sub>4</sub>O<sub>4</sub> 429.1938, found (ESI, [M + H]<sup>+</sup>), 429.1925. MS <i>m</i>/<i>z</i> 429.3 (M + 1), retention time = 1.28 min. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.12 (s, 1H), 8.07 (s, 1H), 7.99 (dd, <i>J</i> = 9.0, 5.5 Hz, 2H), 7.18 (t, <i>J</i> = 8.5 Hz, 2H), 4.58 (s, 2H), 4.41 (d, <i>J</i> = 6.0 Hz, 2H), 3.97 (t, <i>J</i>  = 5.5 Hz, 2H), 3.28 (m, 1H), 3.17 (m, 2H), 3.10 (m, 2H), 2.71 (m, 2H), 2.39 (m, 2H), 1.89 (m, 4H).</div></div><div id="sec3_8_5_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> 2-(4-(4-Fluorobenzoyl)piperidin-1-yl)-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-<i>N</i>-(thiophen-2-ylmethyl)acetamide (<b>35</b>)</h5><div class="NLM_p last">The title compound (296 mg, 0.56 mmol, 25% yield) was prepared similar to that for compound <b>34</b> from 2-((thiophen-2-ylmethylamino)methyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (710 mg, 2.3 mmol) and <b>50</b> (720 mg, 2.7 mmol). HRMS calculated for C<sub>27</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>4</sub>S 525.1972, found (ESI, [M + H]<sup>+</sup>), 525.1968. MS <i>m</i>/<i>z</i> 525.2 (M + 1), retention time = 3.08 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.93 (s, 1H), 8.00 (d, <i>J</i> = 8.8, 575 Hz, 2H), 7.38 (d, <i>J</i> = 4.4 Hz, 1H), 7.28 (t, <i>J</i> = 8.8 Hz, 2H), 7.00 (s, 1H), 6.95 (s, 1H), 4.85 (s, 2H), 4.47 (s, 2H), 4.38 (s, 2H), 3.85 (t, <i>J</i> = 5.7 Hz, 2H), 3.29 (m, 2H), 2.90 (m, 3H), 2.53 (t, <i>J</i> = 5.4 Hz, 2H), 2.29 (t, <i>J</i> = 10.7 Hz, 2H), 1.76 (m, 2H), 1.63 (m, 2H).</div></div><div id="sec3_8_5_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> 2-((Benzylamino)methyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>36a</b>)</h5><div class="NLM_p last">Following general procedure E, the title compound (30 mg, 0.11 mmol, 11% yield) was prepared from phenylmethanamine (107 mg, 0.996 mmol). Mass calculated for C<sub>15</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub> 271.3, found 272.4 (ESI, M + H).</div></div><div id="sec3_8_5_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> <i>N</i>-Benzyl-2-(4-(4-fluorobenzoyl)piperidin-1-yl)-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)acetamide (<b>36</b>)</h5><div class="NLM_p last">Following the procedure for compound <b>34</b>, the title compound (17.7 mg, 0.034 mmol, 18% yield) was prepared from <b>36a</b> (46 mg, 0.170 mmol) and <b>50</b> (50 mg, 0.19 mmol). Mass calculated for C<sub>29</sub>H<sub>31</sub>FN<sub>4</sub>O<sub>4</sub> 518.6, found 519.4 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, dichloromethane-<i>d</i><sub>2</sub>) δ 7.98 (br s, 2H) 7.28–7.52 (m, 1H) 7.21 (d, <i>J</i> = 7.58 Hz, 4H) 4.66 (d, <i>J</i> = 8.08 Hz, 2H) 4.60 (br s, 1H) 4.48 (br s, 2H) 3.85–4.08 (m, 5H) 3.81 (br s, 2H) 3.42 (d, <i>J</i> = 7.07 Hz, 2H) 3.28 (br s, 2H) 2.70 (d, <i>J</i> = 15.66 Hz, 2H) 2.06–2.36 (m, 3H) 1.17–1.41 (m, 2H).</div></div><div id="sec3_8_5_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> 2-(((Pyridin-2-ylmethyl)amino)methyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>37a</b>)</h5><div class="NLM_p last">A mixture of <b>47</b> (150 mg, 0.83 mmol) and 2-(bromomethyl)pyridine (168 mg, 0.66 mmol) was heated via microwave in ethanol (1.5 mL) at 120 °C for 5 min. The reaction mixture was concentrated in vacuo, and the residue was purified via flash column chromatography (ethyl acetate/hexane, 20:80 to 100:0 and then methanol/dichloromethane, 1:99 to 30:70) to provide the title compound (225 mg, 100% yield). MS <i>m</i>/<i>z</i> 273.2 (M + 1), retention time = 0.78 min.</div></div><div id="sec3_8_5_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> 2-(4-(4-Fluorobenzoyl)piperidin-1-yl)-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-<i>N</i>-(pyridin-2-ylmethyl)acetamide (<b>37</b>)</h5><div class="NLM_p last">Following the procedure for compound <b>34</b>, the title compound (20 mg, 0.038 mmol, 8% yield) was prepared from <b>37a</b> (130 mg, 0.477 mmol) and <b>50</b> (149 mg, 0.477 mmol). HRMS calculated for C<sub>28</sub>H<sub>30</sub>FN<sub>5</sub>O<sub>5</sub> 520.2360, found (ESI, [M + H]<sup>+</sup>), 520.2367. Retention time = 4.44 min. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 16.14 (br s, 0.5H), 14.65 (br s, 0.5H), 8.81–8.97 (m, 1H), 7.99–8.08 (m, 2H), 7.82–7.98 (m, 1H), 7.46–7.53 (m, 1H), 7.35–7.43 (m, 1H), 7.19–7.29 (m, 2H), 5.20 (s, 1H), 4.84 (s, 2H), 4.69 (s, 1H), 4.58 (s, 1H), 4.02–4.23 (m, 2H), 3.15–3.28 (m, 2H), 2.86–2.97 (m, 2H), 2.75–2.85 (m, 2H), 2.17–2.40 (m, 2H), 1.85 (d, <i>J</i> = 10.54 Hz, 4H), 1.54–1.73 (m, 2H).</div></div></div><div id="sec3_8_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> General Procedure E</h4><div id="sec3_8_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> 2-((Isobutylamino)methyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>38a</b>)</h5><div class="NLM_p last">To a solution of <b>45</b> (50 mg, 0.25 mmol) in 3 mL of EtOH was added 2-methylpropan-1-amine (40 mg, 0.54 mmol, 2.2 equiv). The resulting mixture was heated at 65 <i>°</i>C overnight. After 18 h, the reaction mixture was concentrated in vacuo to give an oil that was dissolved in MeOH and added to a SCX column. The SCX column was washed with MeOH, and the product was eluted with 1 N NH<sub>3</sub> in MeOH and concentrated in vacuo. The crude product was absorbed onto silica gel and added to an Biotage SNAP-10g column, and compound was eluted with 1% to 10% MeOH in dichloromethane over 12 column volumes to provide the title compound (13.7 mg, 0.058 mmol, 23% yield). Mass calculated for C<sub>12</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub> 237.30, found 238.4 (ESI, M + H).</div></div><div id="sec3_8_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> 2-(4-(4-Fluorobenzoyl)piperidin-1-yl)-<i>N</i>-isobutyl-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)acetamide (<b>38</b>)</h5><div class="NLM_p last">To a solution of <b>50</b> (50 mg, 0.188 mmol) and diisopropylethylamine (0.082 mL, 0.47 mmol) in DMF (1 mL) was added HATU (107 mg, 0.283 mmol, 1.5 equiv), and the mixture was stirred for 30 min. Then <b>38a</b> (40 mg, 0.170 mmol) in DMP (1 mL) was added, and mixture was stirred at ambient temperature overnight. The crude reaction was purified directly by prep-HPLC on a Sunfire C18–5 μm (19 × 100 mm) column, eluting with 10% to 90% MeCN in water (0.1% TFA) over 10 min to provide the title compound (36.4 mg, 0.058 mmol, 31% yield). Exact mass calculated for C<sub>26</sub>H<sub>33</sub>FN<sub>4</sub>O<sub>4</sub> 485.2564, found 485.2588 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, dichloromethane-<i>d</i><sub>2</sub>) δ ppm 7.98 (dd, <i>J</i> = 8.84, 5.31 Hz, 2H), 7.20 (t, <i>J</i> = 8.59 Hz, 2H), 4.48–4.67 (m, 4H), 4.21 (br s, 2H), 3.89–4.01 (m, 2H), 3.82 (br s, 3H), 3.23 (br s, 4H), 2.62–2.83 (m, 2H), 2.19 (br s, 3H), 2.13 (s, 1H), 2.07 (d, <i>J</i> = 6.57 Hz, 1H), 0.98 (d, <i>J</i> = 6.57 Hz, 4H), 0.88 (d, <i>J</i> = 5.56 Hz, 2H).</div></div><div id="sec3_8_6_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> 2-((Propylamino)methyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>39a</b>)</h5><div class="NLM_p last">Following general procedure E, the title compound (41 mg, 0.173 mmol, 69% yield) was prepared from <b>45</b> (50 mg, 0.25 mmol) and propylamine (59 mg, 0.997 mmol). Mass calculated for C<sub>11</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub> 223.2, found 224.3 (ESI, M + H).</div></div><div id="sec3_8_6_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> 2-(4-(4-Fluorobenzoyl)piperidin-1-yl)-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)-<i>N</i>-propylacetamide (<b>39</b>)</h5><div class="NLM_p last">Following the procedure for compound <b>38</b>, the title compound (37.3 mg, 0.064 mmol, 34% yield) was prepared from <b>39a</b> (38 mg, 0.170 mmol) and <b>50</b> (50 mg, 0.188 mmol). Exact mass calculated for C<sub>25</sub>H<sub>31</sub>FN<sub>4</sub>O<sub>4</sub> 471.2408, found 471.2400 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, dichloromethane-<i>d</i><sub>2</sub>) δ ppm 7.89 (dd, <i>J</i> = 2.78, 5.81 Hz, 2H), 7.10 (t, <i>J</i> = 8.34 Hz, 2H), 4.37–4.56 (m, 4H), 4.19 (br s, 2H), 3.38–3.91 (m, 6H), 2.97–3.37 (m, 4H), 2.55–2.96 (m, 2H), 1.83–2.37 (m, 3H), 0.97–1.68 (m, 2H), 0.65–0.93 (m, 3H).</div></div><div id="sec3_8_6_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> <i>N</i>-Ethyl-2-(4-(4-fluorobenzoyl)piperidin-1-yl)-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)acetamide (<b>40</b>)</h5><div class="NLM_p last">To a solution of <b>45</b> (100 mg, 0.498 mmol) in EtOH (2 mL) was added ethylamine (128 mg, 1.99 mmol, 70% in water). The mixture was then heated at 65 °C for 16 h and concentrated to give 2-((ethylamino)methyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>40a</b>) as a crude yellow solid. This solid (103 mg, 0.493 mmol) was reacted with <b>50</b> (131 mg, 0.493 mmol) and <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate (281 mg, 0.740 mmol) in DMF (2.5 mL) using diisopropylethylamine (159 mg, 1.23 mmol). The resulting mixture was stirred at ambient temperature for 16 h, and the crude product was concentrated to dryness. The solid was partitioned between ethyl acetate and aqueous sodium bicarbonate, and the layers were separated. The organic layer was washed with brine and aqueous citric acid, dried (magnesium sulfate), and concentrated to give a crude oil that was purified by flash column chromatography (0–10% methanol in dichloromethane) to give the title compound as a yellow solid (34 mg, 0.074 mmol, 15% yield). MS <i>m</i>/<i>z</i> 457.4 (M + H), Ret time: 1.25 min; HRMS <i>m</i>/<i>z</i> (M + H) calculated for C<sub>24</sub>H<sub>29</sub>N<sub>4</sub>O<sub>4</sub>F: 457.2248, found: 457.2251. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.00–8.14 (m, 2H), 7.27 (dt, <i>J</i> = 1.76, 8.66 Hz, 2H), 4.40–4.55 (m, 4H), 4.35 (br s, 1.3 H), 4.27 (br s, 0.7H), 3.87–3.98 (m, 2H), 3.72 (br s, 3H), 3.43–3.55 (m, 3H), 3.15–3.27 (m, 1H), 2.55–2.70 (m, 2H), 1.91–2.21 (m, 4H), 1.24–1.32 (m, 2H), 1.12 (t, <i>J</i> = 7.03 Hz, 1H) [individual rotamers could not be assigned].</div></div><div id="sec3_8_6_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> 2-((Methylamino)methyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>41a</b>)</h5><div class="NLM_p last">Following general procedure E, the title compound (30.7 mg, 0.157 mmol) was prepared from <b>45</b> (50 mg, 0.25 mmol) and 30% methanamine (57 mg, 0.548 mmol) in water. Mass calculated for C<sub>9</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub> 195.2, found 196.3 (ESI, M + H).</div></div><div id="sec3_8_6_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> 2-(4-(4-Fluorobenzoyl)piperidin-1-yl)-<i>N</i>-methyl-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)acetamide (<b>41</b>)</h5><div class="NLM_p last">Following the procedure for compound <b>38</b>, the title compound (22.5 mg, 0.50 mmol, 26% yield) was prepared from <b>41a</b> (33 mg, 0.169 mmol) and <b>50</b> (50 mg, 0.188 mmol). Exact mass calculated for C<sub>23</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>4</sub> 443.2095, found 443.2099 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, dichloromethane-<i>d</i><sub>2</sub>) δ ppm 7.95–8.01 (m, 2H), 7.14–7.20 (m, 2H), 4.23–4.56 (m, 4H), 3.89–3.95 (m, 2H), 3.05–3.56 (m, 5H), 2.89 (s, 2H), 2.58–2.69 (m, 2H), 2.45–2.57 (m, 2H), 2.14–2.29 (m, 1H), 1.85–2.03 (m, 2H), 1.46 (t, <i>J</i> = 7.58 Hz, 2H).</div></div><div id="sec3_8_6_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> 2-((Cyclopropylmethylamino)methyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (<b>42a</b>)</h5><div class="NLM_p last">To a solution of <b>45</b> (1 g, 5 mmol, 1 equiv) and DIEA (4.35 mL, 24.9 mmol, 5 equiv) in 7 mL of EtOH was added cyclopropylmethylamine (1.4 g, 20 mmol, 4 equiv). The resulting mixture was heated at 65 <i>°</i>C overnight. After 18 h, the reaction mixture was concentrated in vacuo to give an oil that was purified by silica gel column chromatography (100% CH<sub>2</sub>Cl<sub>2</sub>) to give the title compound as a white solid (0.23 g, 20%). Mass calculated for C<sub>12</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub> 236.1; MS (ESI) <i>m</i>/<i>z</i> 236.9 (M + H)<sup>+</sup>. Retention time: 0.56 min (5–95% CH<sub>3</sub>CN/H<sub>2</sub>O over 2 min with 0.1% formic acid, Inertsil 3 × 3 mm C-8-3 column with flow rate of 2 mL/min). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 4.37–4.42 (m, 2H), 3.95 (s, 1H), 3.80–3.88 (m, 3H), 2.63–2.72 (m, 1H), 2.54–2.63 (m, 3H), 0.89–1.05 (m, 1H), 0.42–0.54 (m, 2H), 0.14–0.26 (m, 2H).</div></div><div id="sec3_8_6_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> <i>N</i>-(Cyclopropylmethyl)-2-(4-(4-fluorobenzoyl)piperidin-1-yl)-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)acetamide (<b>42</b>)</h5><div class="NLM_p last">Following the procedure for compound <b>38</b>, the title compound (14.4 mg, 0.030 mmol, 16% yield) was prepared from 2-((cyclopropylmethylamino)methyl)-7,8-dihydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-4(5<i>H</i>)-one (44 mg, 0.188 mmol) and <b>50</b> (50 mg, 0.188 mmol). Exact mass calculated for C<sub>26</sub>H<sub>31</sub>FN<sub>4</sub>O<sub>4</sub> 483.2408, found 483.2416 (ESI, M + H). <sup>1</sup>H NMR (400 MHz, dichloromethane-<i>d</i><sub>2</sub>) δ ppm 7.98 (dd, <i>J</i> = 5.56, 8.59 Hz, 2H), 7.19 (t, <i>J</i> = 8.59 Hz, 2H), 4.42–4.75 (m, 5H), 4.12–4.31 (m, 2H), 3.86–3.98 (m, 2H), 3.36–3.76 (m, 2H), 3.06–3.33 (m, 2H), 2.56–2.76 (m, 2H), 2.22 (br s, 4H), 0.79–1.04 (m, 1H), 0.61 (d, <i>J</i> = 7.58 Hz, 2H), 0.35–0.54 (m, 1H), 0.12–0.33 (m, 3H).</div></div><div id="sec3_8_6_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> [4-(4-Methoxybenzoyl)piperidin-1-yl]acetic Acid Ethyl Ester (<b>49</b>)</h5><div class="NLM_p last">To a solution of (4-methoxyphenyl)(piperidin-4-yl)methanone (20 g, 78 mmol, 1 equiv) in acetonitrile (313 mL) was added triethylamine (22 mL, 156 mmol, 2 equiv), followed by ethyl 2-bromoacetate (9.5 mL, 86 mmol, 1.1 equiv) dropwise. The resulting mixture was heated at 85<i> °</i>C overnight. After 18 h, the reaction mixture was diluted with saturated NaHCO<sub>3</sub> (150 mL) and extracted with ethyl acetate (3 × 500 mL). The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give an oil. This oil was purified by silica gel column chromatography (10–20% acetone/heptane) to give the title compound as a white solid (11.7 g, 49% yield). Mass calculated for C<sub>17</sub>H<sub>24</sub>N<sub>1</sub>O<sub>4</sub> 306.2. MS (ESI) <i>m</i>/<i>z</i> 306.4 (M + H)<sup>+</sup>.</div></div><div id="sec3_8_6_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> [4-(4-Methoxybenzoyl)piperidin-1-yl]acetic Acid (<b>51</b>)</h5><div class="NLM_p last">To a solution of <b>49</b> (11.7 g, 38 mmol, 1 equiv) in 154 mL of EtOH was added a solution of NaOH (3.07 g, 77 mmol, 2 equiv) in 154 mL of H<sub>2</sub>O. The resulting mixture was stirred at room temperature overnight. After 18 h, the reaction mixture was concentrated and treated with 1 N HCl to pH 5. The resulting mixture was freeze-dried using a lyophilizer to remove H<sub>2</sub>O. The resulting yellow solid was washed with dichloromethane/methanol, and NaCl was filtered off. The filtrate was concentrated to give the title compound as a white solid (11 g, 38 mmol). Mass calculated for C<sub>15</sub>H<sub>20</sub>NO<sub>4</sub> 278.1. MS (ESI) <i>m</i>/<i>z</i> 278.8 (M + H)<sup>+</sup>.</div></div><div id="sec3_8_6_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> <i>N</i>-(Cyclopropylmethyl)-2-(4-(4-methoxybenzoyl)piperidin-1-yl)-<i>N</i>-((4-oxo-4,5,7,8-tetrahydro-3<i>H</i>-pyrano[4,3-<i>d</i>]pyrimidin-2-yl)methyl)acetamide (<b>43</b>)</h5><div class="NLM_p last">To a solution of <b>51</b> (0.071 g, 0.26 mmol, 1 equiv) and DIEA (0.089 mL, 0.51 mmol, 2 equiv) in 2 mL of DMF was added HATU (0.107 g, 0.281 mmol, 1.1 equiv). The resulting mixture was stirred at room temperature for 30 min. <b>42a</b> (0.06 g, 0.26 mmol, 1 equiv) in 1 mL of DMF was added, and the mixture was stirred at room temperature overnight. The reaction mixture was diluted with H<sub>2</sub>O (10 mL) and extracted with dichloromethane (3 × 50 mL). The combined organic layers were concentrated in vacuo and purified by preparative HPLC (20–100% CH<sub>3</sub>CN/H<sub>2</sub>O over 10 min with 0.1% TFA on a Sunfire C18 OBD 50 × 50 mm column with flow rate of 60 mL/min) to give the title compound as a white solid (0.03 g, 0.06 mmol, 24% yield). HRMS calculated for C<sub>27</sub>H<sub>35</sub>N<sub>4</sub>O<sub>5</sub> 495.2607, found (ESI, [M + H]<sup>+</sup>) 495.2606. MS (ESI) <i>m</i>/<i>z</i> 495.3 (M + H)<sup>+</sup>. Retention time: 2.89 min (5–95% CH<sub>3</sub>CN/H<sub>2</sub>O over 7.75 min with 0.1% formic acid, Inertsil ODS3 100 × 3 mm C18 column with flow rate of 1.0 mL/min). <sup>1</sup>H NMR (400 MHz, MeOD) δ ppm 12.20–12.62 (m, 1H), 7.88–7.97 (m, 2H), 7.03 (dd, <i>J</i> = 5.56, 8.59 Hz, 2H), 4.58 (s, 1H), 4.30–4.44 (m, 3H), 3.77–3.86 (m, 5H), 3.44 (d, <i>J</i> = 7.07 Hz, 1H), 3.32–3.39 (m, 1H), 3.13–3.27 (m, 4H), 2.76–3.00 (m, 2H), 2.44 (br s, 1H), 2.04–2.21 (m, 2H), 1.50–1.77 (m, 3H), 1.31–1.46 (m, 1H), 0.86–1.11 (m, 1H), 0.33–0.48 (m, 2H), 0.13–0.27 (m, 2H).</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87"><a href="/doi/suppl/10.1021/jm400807n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17146" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17146" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Graphs of calculated versus measured log <i>P</i> as well as thermodynamic data. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400807n/suppl_file/jm400807n_si_001.pdf">jm400807n_si_001.pdf (191.75 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes for the TNKS1 structures in complex with <b>19</b>, <b>33</b>, and <b>35</b> are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI6">4LI6</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI7">4LI7</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI8">4LI8</a>, respectively.</p><div class="testing" data-doi="10.1021/jm400807n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52313" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52313" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael D. Shultz</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#660b0f050e07030a48150e130a121c260809100714120f154805090b"><span class="__cf_email__" data-cfemail="e5888c868d848089cb968d9089919fa58b8a938497918c96cb868a88">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Atwood K. Cheung</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christina A. Kirby</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brant Firestone</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianmei Fan</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Hiu-Tung Chen</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhouliang Chen</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donovan N. Chin</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lucian DiPietro</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aleem Fazal</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yun Feng</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascal D. Fortin</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ty Gould</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bharat Lagu</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huangshu Lei</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francois Lenoir</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dyuti Majumdar</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Etienne Ochala</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">M. G. Palermo</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ly Pham</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minying Pu</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Troy Smith</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Travis Stams</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald C. Tomlinson</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">B. Barry Touré</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Visser</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Run Ming Wang</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nigel J. Waters</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenlin Shao</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for Biomedical Research,
Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts
02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d929e4936-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13214" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13214" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Tim Ramsey for many helpful suggestions during the preparation of this manuscript. We would like to acknowledge the work of James Groarke and Guoping Xiao for protein purification of TNKS1. The TNKS1/33 data collection was performed on the 5.0.3 beamline at the Advanced Light Source at Berkeley Lab. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The TNKS1/35 data collection was performed on the X06SA beamline at the Swiss Light Source, Paul Scherrer Institut, Villigen, Switzerland.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i96" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i96"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i97" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i97"> Abbreviations Used</h2><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly(ADP-ribose) polymerase</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic efficiency</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">molecular matched pair</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SER</td><td class="NLM_def"><p class="first last">structure–efficiency relationship</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i98">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Schreiber, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dantzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ame, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose): nNovel functions for an old molecule</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1038%2Fnrm1963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=16829982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1Ohsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=517-528&author=V.+Schreiberauthor=F.+Dantzerauthor=J.+C.+Ameauthor=G.+de+Murcia&title=Poly%28ADP-ribose%29%3A+nNovel+functions+for+an+old+molecule"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose): novel functions for an old molecule</span></div><div class="casAuthors">Schreiber, Valerie; Dantzer, Francoise; Ame, Jean-Christophe; de Murcia, Gilbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">517-528</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The addn. to proteins of the neg. charged polymer of ADP-ribose, which is synthesized by poly(ADP-ribose) polymerase (PARPs) from NAD, is a unique post-translational modification.  It regulates not only cell survival and cell-death programs, but also an increasing no. of other biol. functions with which novel members of the PARP family have been assocd.  These functions include transcriptional regulation, telomere cohesion and mitotic spindle formation during cell division, intracellular trafficking, and energy metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLsI4_BKfjdrVg90H21EOLACvtfcHk0lhIuep4S7iUig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1Ohsb4%253D&md5=676e83755491500f3bf2137f348dfa1b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm1963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1963%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DV.%26aulast%3DDantzer%26aufirst%3DF.%26aulast%3DAme%26aufirst%3DJ.%2BC.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26atitle%3DPoly%2528ADP-ribose%2529%253A%2520nNovel%2520functions%2520for%2520an%2520old%2520molecule%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D517%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hsiao, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span> </span><span class="NLM_article-title">Tankyrase function at telomeres, spindle poles, and beyond</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2008&pages=83-92&author=S.+J.+Hsiaoauthor=S.+Smith&title=Tankyrase+function+at+telomeres%2C+spindle+poles%2C+and+beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DS.%2BJ.%26aulast%3DSmith%26aufirst%3DS.%26atitle%3DTankyrase%2520function%2520at%2520telomeres%252C%2520spindle%2520poles%252C%2520and%2520beyond%26jtitle%3DBiochimie%26date%3D2008%26volume%3D90%26spage%3D83%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Seimiya, H.</span><span> </span><span class="NLM_article-title">The telomeric PARP, tankyrases, as targets for cancer therapy</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1038%2Fsj.bjc.6602951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=16421589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFGqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=341-345&author=H.+Seimiya&title=The+telomeric+PARP%2C+tankyrases%2C+as+targets+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The telomeric PARP, tankyrases, as targets for cancer therapy</span></div><div class="casAuthors">Seimiya, H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">341-345</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The requirement for the maintenance of telomeres by telomerase by most cancer cells for continued proliferation is a target in anticancer strategies.  Tankyrases are poly(ADP-ribose) polymerases that enhance telomerase access to telomeres.  Tankyrase 1 modulates telomerase inhibition in human cancer cells and is reviewed in this report as a potential telomere-directed anticancer target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr10pYfhlLTiLVg90H21EOLACvtfcHk0liXOwo52_dqrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFGqsL4%253D&md5=06d25a6a317ba92dc1137ea1c1417d8a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6602951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6602951%26sid%3Dliteratum%253Aachs%26aulast%3DSeimiya%26aufirst%3DH.%26atitle%3DThe%2520telomeric%2520PARP%252C%2520tankyrases%252C%2520as%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26spage%3D341%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Levaot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voytyuk, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitriou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sircoulomb, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrakumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krzyzanowski, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scotter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janmohamed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cong, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoncic, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottapel, R.</span><span> </span><span class="NLM_article-title">Loss of tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">1324</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2011&pages=1324-1339&author=N.+Levaotauthor=O.+Voytyukauthor=I.+Dimitriouauthor=F.+Sircoulombauthor=A.+Chandrakumarauthor=M.+Deckertauthor=P.+M.+Krzyzanowskiauthor=A.+Scotterauthor=S.+Guauthor=S.+Janmohamedauthor=F.+Congauthor=P.+D.+Simoncicauthor=Y.+Uekiauthor=R.+J.+Laauthor=R.+Rottapel&title=Loss+of+tankyrase-mediated+destruction+of+3BP2+is+the+underlying+pathogenic+mechanism+of+cherubism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevaot%26aufirst%3DN.%26aulast%3DVoytyuk%26aufirst%3DO.%26aulast%3DDimitriou%26aufirst%3DI.%26aulast%3DSircoulomb%26aufirst%3DF.%26aulast%3DChandrakumar%26aufirst%3DA.%26aulast%3DDeckert%26aufirst%3DM.%26aulast%3DKrzyzanowski%26aufirst%3DP.%2BM.%26aulast%3DScotter%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DS.%26aulast%3DJanmohamed%26aufirst%3DS.%26aulast%3DCong%26aufirst%3DF.%26aulast%3DSimoncic%26aufirst%3DP.%2BD.%26aulast%3DUeki%26aufirst%3DY.%26aulast%3DLa%26aufirst%3DR.%2BJ.%26aulast%3DRottapel%26aufirst%3DR.%26atitle%3DLoss%2520of%2520tankyrase-mediated%2520destruction%2520of%25203BP2%2520is%2520the%2520underlying%2520pathogenic%2520mechanism%2520of%2520cherubism%26jtitle%3DCell%26date%3D2011%26volume%3D147%26spage%3D1324%26epage%3D1339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Huang, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishina, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegmeier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaud, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlat, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiellette, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiessner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hild, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mickanin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serluca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shultz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghidelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschner, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallarico, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouwmeester, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cong, F.</span><span> </span><span class="NLM_article-title">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">461</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1038%2Fnature08356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=19759537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=614-620&author=S.+M.+Huangauthor=Y.+M.+Mishinaauthor=S.+Liuauthor=A.+Cheungauthor=F.+Stegmeierauthor=G.+A.+Michaudauthor=O.+Charlatauthor=E.+Wielletteauthor=Y.+Zhangauthor=S.+Wiessnerauthor=M.+Hildauthor=X.+Shiauthor=C.+J.+Wilsonauthor=C.+Mickaninauthor=V.+Myerauthor=A.+Fazalauthor=R.+Tomlinsonauthor=F.+Serlucaauthor=W.+Shaoauthor=H.+Chengauthor=M.+Shultzauthor=C.+Rauauthor=M.+Schirleauthor=J.+Schleglauthor=S.+Ghidelliauthor=S.+Fawellauthor=C.+Luauthor=D.+Curtisauthor=M.+W.+Kirschnerauthor=C.+Lengauerauthor=P.+M.+Finanauthor=J.+A.+Tallaricoauthor=T.+Bouwmeesterauthor=J.+A.+Porterauthor=A.+Bauerauthor=F.+Cong&title=Tankyrase+inhibition+stabilizes+axin+and+antagonizes+Wnt+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span></div><div class="casAuthors">Huang, Shih-Min A.; Mishina, Yuji M.; Liu, Shanming; Cheung, Atwood; Stegmeier, Frank; Michaud, Gregory A.; Charlat, Olga; Wiellette, Elizabeth; Zhang, Yue; Wiessner, Stephanie; Hild, Marc; Shi, Xiaoying; Wilson, Christopher J.; Mickanin, Craig; Myer, Vic; Fazal, Aleem; Tomlinson, Ronald; Serluca, Fabrizio; Shao, Wenlin; Cheng, Hong; Shultz, Michael; Rau, Christina; Schirle, Markus; Schlegl, Judith; Ghidelli, Sonja; Fawell, Stephen; Lu, Chris; Curtis, Daniel; Kirschner, Marc W.; Lengauer, Christoph; Finan, Peter M.; Tallarico, John A.; Bouwmeester, Tewis; Porter, Jeffery A.; Bauer, Andreas; Cong, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7264</span>),
    <span class="NLM_cas:pages">614-620</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The stability of the Wnt pathway transcription factor β-catenin is tightly regulated by the multi-subunit destruction complex.  Deregulated Wnt pathway activity has been implicated in many cancers, making this pathway an attractive target for anticancer therapies.  However, the development of targeted Wnt pathway inhibitors has been hampered by the limited no. of pathway components that are amenable to small mol. inhibition.  Here, we used a chem. genetic screen to identify a small mol., XAV939, which selectively inhibits β-catenin-mediated transcription.  XAV939 stimulates β-catenin degrdn. by stabilizing axin, the concn.-limiting component of the destruction complex.  Using a quant. chem. proteomic approach, we discovered that XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2.  Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degrdn. through the ubiquitin-proteasome pathway.  Thus, our study provides new mechanistic insights into the regulation of axin protein homeostasis and presents new avenues for targeted Wnt pathway therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom3c1M4OoOarVg90H21EOLACvtfcHk0liXOwo52_dqrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP&md5=6a76dfa7ed2a57b29e0c1ee367bd652c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature08356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08356%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BM.%26aulast%3DMishina%26aufirst%3DY.%2BM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DMichaud%26aufirst%3DG.%2BA.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DWiellette%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWiessner%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWilson%26aufirst%3DC.%2BJ.%26aulast%3DMickanin%26aufirst%3DC.%26aulast%3DMyer%26aufirst%3DV.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DTomlinson%26aufirst%3DR.%26aulast%3DSerluca%26aufirst%3DF.%26aulast%3DShao%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DShultz%26aufirst%3DM.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DGhidelli%26aufirst%3DS.%26aulast%3DFawell%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DCurtis%26aufirst%3DD.%26aulast%3DKirschner%26aufirst%3DM.%2BW.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DCong%26aufirst%3DF.%26atitle%3DTankyrase%2520inhibition%2520stabilizes%2520axin%2520and%2520antagonizes%2520Wnt%2520signalling%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D614%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Guettler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRose, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petsalaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scotter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottapel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicheri, F.</span><span> </span><span class="NLM_article-title">Structural basis and sequence rules for substrate recognition by tankyrase explain the basis for cherubism disease</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">1340</span><span class="NLM_x">–</span> <span class="NLM_lpage">1354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2011&pages=1340-1354&author=S.+Guettlerauthor=J.+LaRoseauthor=E.+Petsalakiauthor=G.+Gishauthor=A.+Scotterauthor=T.+Pawsonauthor=R.+Rottapelauthor=F.+Sicheri&title=Structural+basis+and+sequence+rules+for+substrate+recognition+by+tankyrase+explain+the+basis+for+cherubism+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuettler%26aufirst%3DS.%26aulast%3DLaRose%26aufirst%3DJ.%26aulast%3DPetsalaki%26aufirst%3DE.%26aulast%3DGish%26aufirst%3DG.%26aulast%3DScotter%26aufirst%3DA.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DRottapel%26aufirst%3DR.%26aulast%3DSicheri%26aufirst%3DF.%26atitle%3DStructural%2520basis%2520and%2520sequence%2520rules%2520for%2520substrate%2520recognition%2520by%2520tankyrase%2520explain%2520the%2520basis%2520for%2520cherubism%2520disease%26jtitle%3DCell%26date%3D2011%26volume%3D147%26spage%3D1340%26epage%3D1354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="ref7_1"><span><span class="NLM_contrib-group">Cheung, A. K.; Chin, D. N.; Fan, J.; Shultz, M. D.; Tomlinson, R. C.</span><span> </span><span class="NLM_article-title">4-Oxo-3,5,7,8-Tetrahydro-4h-Pyrano {4,3-D} Pyrminidinyl Compounds For Use As Tankyrase Inhibitors</span>. WO 2013010092, US 2011-507313P,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+K.+Cheung&author=D.+N.+Chin&author=J.+Fan&author=M.+D.+Shultz&author=R.+C.+Tomlinson&title=4-Oxo-3%2C5%2C7%2C8-Tetrahydro-4h-Pyrano+%7B4%2C3-D%7D+Pyrminidinyl+Compounds+For+Use+As+Tankyrase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref7_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DA.%2BK.%26atitle%3D4-Oxo-3%252C5%252C7%252C8-Tetrahydro-4h-Pyrano%2520%257B4%252C3-D%257D%2520Pyrminidinyl%2520Compounds%2520For%2520Use%2520As%2520Tankyrase%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span> </span><span class="NLM_article-title">Novel binding mode of a potent and selective tankyrase inhibitor</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e33740</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1371%2Fjournal.pone.0033740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=22438990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVaht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e33740&author=H.+Gunaydinauthor=Y.+Guauthor=X.+Huang&title=Novel+binding+mode+of+a+potent+and+selective+tankyrase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel binding mode of a potent and selective tankyrase inhibitor</span></div><div class="casAuthors">Gunaydin, Hakan; Gu, Yan; Huang, Xin</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e33740</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Tankyrases (TNKS1 and TNKS2) are key regulators of cellular processes such as telomere pathway and Wnt signaling.  IWRs (inhibitors of Wnt response) have recently been identified as potent and selective inhibitors of tankyrases.  However, it is not clear how these IWRs interact with tankyrases.  Here we report the crystal structure of the catalytic domain of human TNKS1 in complex with IWR2, which reveals a novel binding site for tankyrase inhibitors.  The TNKS1/IWR2 complex provides a mol. basis for their strong and specific interactions and suggests clues for further development of tankyrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqidLqR8KN4obVg90H21EOLACvtfcHk0lhtfu72gxIMqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVaht70%253D&md5=7ab7c96221b170534538c51605e76e85</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0033740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0033740%26sid%3Dliteratum%253Aachs%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DNovel%2520binding%2520mode%2520of%2520a%2520potent%2520and%2520selective%2520tankyrase%2520inhibitor%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De33740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Shultz, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blank, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlat, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cong, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, W.</span><span> </span><span class="NLM_article-title">[1,2,4]Triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: Antagonists of the Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1127</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2011222" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1127-1136&author=M.+D.+Shultzauthor=C.+A.+Kirbyauthor=T.+Stamsauthor=D.+N.+Chinauthor=J.+Blankauthor=O.+Charlatauthor=H.+Chengauthor=A.+Cheungauthor=F.+Congauthor=Y.+Fengauthor=P.+D.+Fortinauthor=T.+Hoodauthor=V.+Tyagiauthor=M.+Xuauthor=B.+Zhangauthor=W.+Shao&title=%5B1%2C2%2C4%5DTriazol-3-ylsulfanylmethyl%29-3-phenyl-%5B1%2C2%2C4%5Doxadiazoles%3A+Antagonists+of+the+Wnt+pathway+that+inhibit+tankyrases+1+and+2+via+novel+adenosine+pocket+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm2011222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2011222%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DKirby%26aufirst%3DC.%2BA.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DChin%26aufirst%3DD.%2BN.%26aulast%3DBlank%26aufirst%3DJ.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DCong%26aufirst%3DF.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DHood%26aufirst%3DT.%26aulast%3DTyagi%26aufirst%3DV.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DShao%26aufirst%3DW.%26atitle%3D%255B1%252C2%252C4%255DTriazol-3-ylsulfanylmethyl%2529-3-phenyl-%255B1%252C2%252C4%255Doxadiazoles%253A%2520Antagonists%2520of%2520the%2520Wnt%2520pathway%2520that%2520inhibit%2520tankyrases%25201%2520and%25202%2520via%2520novel%2520adenosine%2520pocket%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1127%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Waaler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korinek, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulsen, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eide, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machonova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voronkov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kries, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, S.</span><span> </span><span class="NLM_article-title">A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">2822</span><span class="NLM_x">–</span> <span class="NLM_lpage">2832</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1158%2F0008-5472.CAN-11-3336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=22440753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2822-2832&author=J.+Waalerauthor=O.+Machonauthor=L.+Tumovaauthor=H.+Dinhauthor=V.+Korinekauthor=S.+R.+Wilsonauthor=J.+E.+Paulsenauthor=N.+M.+Pedersenauthor=T.+J.+Eideauthor=O.+Machonovaauthor=D.+Gradlauthor=A.+Voronkovauthor=J.+P.+von+Kriesauthor=S.+Krauss&title=A+novel+tankyrase+inhibitor+decreases+canonical+Wnt+signaling+in+colon+carcinoma+cells+and+reduces+tumor+growth+in+conditional+APC+mutant+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice</span></div><div class="casAuthors">Waaler, Jo; Machon, Ondrej; Tumova, Lucie; Dinh, Huyen; Korinek, Vladimir; Wilson, Steven Ray; Paulsen, Jan Erik; Pedersen, Nina Marie; Eide, Tor J.; Machonova, Olga; Gradl, Dietmar; Voronkov, Andrey; von Kries, Jens Peter; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2822-2832</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This preclin. proof-of-concept study suggests a new strategy to treat colon cancer by increasing the degrdn. of β-catenin, which drives this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokQ3hrnF8gMLVg90H21EOLACvtfcHk0lhUnGAcmnUS6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D&md5=9814ad25dc1d5da6d9babaff8df19327</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-3336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-3336%26sid%3Dliteratum%253Aachs%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DTumova%26aufirst%3DL.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DPaulsen%26aufirst%3DJ.%2BE.%26aulast%3DPedersen%26aufirst%3DN.%2BM.%26aulast%3DEide%26aufirst%3DT.%2BJ.%26aulast%3DMachonova%26aufirst%3DO.%26aulast%3DGradl%26aufirst%3DD.%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DA%2520novel%2520tankyrase%2520inhibitor%2520decreases%2520canonical%2520Wnt%2520signaling%2520in%2520colon%2520carcinoma%2520cells%2520and%2520reduces%2520tumor%2520growth%2520in%2520conditional%2520APC%2520mutant%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2822%26epage%3D2832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Distler, A.; Deloch, L.; Huang, J.; Dees, C.; Lin, N. Y.; Palumbo-Zerr, K.;  Beyer, C.; Weidemann, A.; Distler, O.; Schett, G.; Distler, J. H.</span><span> </span><span class="NLM_article-title"> Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span>doi: <span class="refDoi"> DOI: 10.1136/annrheumdis-2012-202275</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1136%2Fannrheumdis-2012-202275" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+Distler&author=L.+Deloch&author=J.+Huang&author=C.+Dees&author=N.+Y.+Lin&author=K.+Palumbo-Zerr&author=C.++Beyer&author=A.+Weidemann&author=O.+Distler&author=G.+Schett&author=J.+H.+Distler&title=+Inactivation+of+tankyrases+reduces+experimental+fibrosis+by+inhibiting+canonical+Wnt+signalling&doi=10.1136%2Fannrheumdis-2012-202275"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2012-202275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2012-202275%26sid%3Dliteratum%253Aachs%26aulast%3DDistler%26aufirst%3DA.%26atitle%3D%2520Inactivation%2520of%2520tankyrases%2520reduces%2520experimental%2520fibrosis%2520by%2520inhibiting%2520canonical%2520Wnt%2520signalling%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2012%26doi%3D10.1136%2Fannrheumdis-2012-202275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamauchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamakura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goshima, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, Y.</span><span> </span><span class="NLM_article-title">Herpes simplex virus requires poly(ADP-ribose) polymerase activity for efficient replication and induces extracellular signal-related kinase-dependent phosphorylation and ICP0-dependent nuclear localization of tankyrase 1</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1128%2FJVI.05897-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=22013039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVKksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2012&pages=492-503&author=Z.+Liauthor=Y.+Yamauchiauthor=M.+Kamakuraauthor=T.+Murayamaauthor=F.+Goshimaauthor=H.+Kimuraauthor=Y.+Nishiyama&title=Herpes+simplex+virus+requires+poly%28ADP-ribose%29+polymerase+activity+for+efficient+replication+and+induces+extracellular+signal-related+kinase-dependent+phosphorylation+and+ICP0-dependent+nuclear+localization+of+tankyrase+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Herpes simplex virus requires poly(ADP-ribose) polymerase activity for efficient replication and induces extracellular signal-related kinase-dependent phosphorylation and ICP0-dependent nuclear localization of tankyrase 1</span></div><div class="casAuthors">Li, Zhuan; Yamauchi, Yohei; Kamakura, Maki; Murayama, Tsugiya; Goshima, Fumi; Kimura, Hiroshi; Nishiyama, Yukihiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">492-503</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Tankyrase 1 is a poly(ADP-ribose) polymerase (PARP) which localizes to multiple subcellular sites, including telomeres and mitotic centrosomes.  Poly(ADP-ribosyl)ation of the nuclear mitotic app. (NuMA) protein by tankyrase 1 during mitosis is essential for sister telomere resoln. and mitotic spindle pole formation.  In interphase cells, tankyrase 1 resides in the cytoplasm, and its role therein is not well understood.  In this study, we found that herpes simplex virus (HSV) infection induced extensive modification of tankyrase 1 but not tankyrase 2.  This modification was dependent on extracellular signal-regulated kinase (ERK) activity triggered by HSV infection.  Following HSV-1 infection, tankyrase 1 was recruited to the nucleus.  In the early phase of infection, tankyrase 1 colocalized with ICP0 and thereafter localized within the HSV replication compartment, which was blocked in cells infected with the HSV-1 ICP0-null mutant R7910.  In the absence of infection, ICP0 interacted with tankyrase 1 and efficiently promoted its nuclear localization.  HSV did not replicate efficiently in cells depleted of both tankyrases 1 and 2.  Moreover, XAV939, an inhibitor of tankyrase PARP activity, decreased viral titers to 2 to 5% of control values.  We concluded that HSV targets tankyrase 1 in an ICP0- and ERK-dependent manner to facilitate its replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLtDPmy0QelrVg90H21EOLACvtfcHk0lhUnGAcmnUS6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVKksLo%253D&md5=84fa225605d6aa39b181d2484ae06447</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FJVI.05897-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.05897-11%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYamauchi%26aufirst%3DY.%26aulast%3DKamakura%26aufirst%3DM.%26aulast%3DMurayama%26aufirst%3DT.%26aulast%3DGoshima%26aufirst%3DF.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DNishiyama%26aufirst%3DY.%26atitle%3DHerpes%2520simplex%2520virus%2520requires%2520poly%2528ADP-ribose%2529%2520polymerase%2520activity%2520for%2520efficient%2520replication%2520and%2520induces%2520extracellular%2520signal-related%2520kinase-dependent%2520phosphorylation%2520and%2520ICP0-dependent%2520nuclear%2520localization%2520of%2520tankyrase%25201%26jtitle%3DJ.%2520Virol.%26date%3D2012%26volume%3D86%26spage%3D492%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Tenbaum, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ordonez-Moran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puig, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chicote, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arques, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landolfi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herance, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gispert, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendizabal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cajal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivancos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabernero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, H. G.</span><span> </span><span class="NLM_article-title">Beta-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1038%2Fnm.2772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=22610277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC38XntF2hsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=892-901&author=S.+P.+Tenbaumauthor=P.+Ordonez-Moranauthor=I.+Puigauthor=I.+Chicoteauthor=O.+Arquesauthor=S.+Landolfiauthor=Y.+Fernandezauthor=J.+R.+Heranceauthor=J.+D.+Gispertauthor=L.+Mendizabalauthor=S.+Aguilarauthor=S.+Cajalauthor=S.+Schwartzauthor=A.+Vivancosauthor=E.+Espinauthor=S.+Rojasauthor=J.+Baselgaauthor=J.+Taberneroauthor=A.+Munozauthor=H.+G.+Palmer&title=Beta-catenin+confers+resistance+to+PI3K+and+AKT+inhibitors+and+subverts+FOXO3a+to+promote+metastasis+in+colon+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer</span></div><div class="casAuthors">Tenbaum, Stephan P.; Ordonez-Moran, Paloma; Puig, Isabel; Chicote, Irene; Arques, Oriol; Landolfi, Stefania; Fernandez, Yolanda; Herance, Jose Raul; Gispert, Juan D.; Mendizabal, Leire; Aguilar, Susana; Cajal, Santiago Ramon y; Schwartz, Simo; Vivancos, Ana; Espin, Eloy; Rojas, Santiago; Baselga, Jose; Tabernero, Josep; Munoz, Alberto; Palmer, Hector G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">892-901</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Wnt-β-catenin and PI3K-AKT-FOXO3a pathways have a central role in cancer.  AKT phosporylates FOXO3a, relocating it from the cell nucleus to the cytoplasm, an effect that is reversed by PI3K and AKT inhibitors.  Simultaneous hyperactivation of the Wnt-β-catenin pathway and inhibition of PI3K-AKT signaling promote nuclear accumulation of β-catenin and FOXO3a, resp., promoting cell scattering and metastasis by regulating a defined set of target genes.  Indeed, the anti-tumoral AKT inhibitor API-2 promotes nuclear FOXO3a accumulation and metastasis of cells with high nuclear β-catenin content.  Nuclear β-catenin confers resistance to the FOXO3a-mediated apoptosis induced by PI3K and AKT inhibitors in patient-derived primary cultures and in corresponding xenograft tumors in mice.  This resistance is reversed by XAV-939, an inhibitor of Wnt-β-catenin signaling.  In the presence of high nuclear β-catenin content, activation of FOXO3a by PI3K or AKT inhibitors makes it behave as a metastasis inductor rather than a proapoptotic tumor suppressor.  We show that it is possible to evaluate the β-catenin status of patients' carcinomas and the response of patient-derived cells to target-directed drugs that accumulate FOXO3a in the nucleus before deciding on a course of treatment.  We propose that this evaluation could be essential to the provision of a safer and more effective personalized treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfghc13e9HzbVg90H21EOLACvtfcHk0lhf3hdVC7KOWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntF2hsr4%253D&md5=06a507a1f35f4ee380f36d10c9112c1b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnm.2772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2772%26sid%3Dliteratum%253Aachs%26aulast%3DTenbaum%26aufirst%3DS.%2BP.%26aulast%3DOrdonez-Moran%26aufirst%3DP.%26aulast%3DPuig%26aufirst%3DI.%26aulast%3DChicote%26aufirst%3DI.%26aulast%3DArques%26aufirst%3DO.%26aulast%3DLandolfi%26aufirst%3DS.%26aulast%3DFernandez%26aufirst%3DY.%26aulast%3DHerance%26aufirst%3DJ.%2BR.%26aulast%3DGispert%26aufirst%3DJ.%2BD.%26aulast%3DMendizabal%26aufirst%3DL.%26aulast%3DAguilar%26aufirst%3DS.%26aulast%3DCajal%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DS.%26aulast%3DVivancos%26aufirst%3DA.%26aulast%3DEspin%26aufirst%3DE.%26aulast%3DRojas%26aufirst%3DS.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DMunoz%26aufirst%3DA.%26aulast%3DPalmer%26aufirst%3DH.%2BG.%26atitle%3DBeta-catenin%2520confers%2520resistance%2520to%2520PI3K%2520and%2520AKT%2520inhibitors%2520and%2520subverts%2520FOXO3a%2520to%2520promote%2520metastasis%2520in%2520colon%2520cancer%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D892%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Ulsamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, H. A.</span><span> </span><span class="NLM_article-title">Axin pathway activity regulates in vivo pY654-beta-catenin accumulation and pulmonary fibrosis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">5164</span><span class="NLM_x">–</span> <span class="NLM_lpage">5172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=5164-5172&author=A.+Ulsamerauthor=Y.+Weiauthor=K.+K.+Kimauthor=K.+Tanauthor=S.+Wheelerauthor=Y.+Xiauthor=R.+S.+Thiesauthor=H.+A.+Chapman&title=Axin+pathway+activity+regulates+in+vivo+pY654-beta-catenin+accumulation+and+pulmonary+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUlsamer%26aufirst%3DA.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DK.%2BK.%26aulast%3DTan%26aufirst%3DK.%26aulast%3DWheeler%26aufirst%3DS.%26aulast%3DXi%26aufirst%3DY.%26aulast%3DThies%26aufirst%3DR.%2BS.%26aulast%3DChapman%26aufirst%3DH.%2BA.%26atitle%3DAxin%2520pathway%2520activity%2520regulates%2520in%2520vivo%2520pY654-beta-catenin%2520accumulation%2520and%2520pulmonary%2520fibrosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D5164%26epage%3D5172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Fancy, S. P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silbereis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baranzini, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otero, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nusse, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, R. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowitch, D. H.</span><span> </span><span class="NLM_article-title">Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1U99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1038%2Fnn.2855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=21706018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotV2hsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=1009-1U99&author=S.+P.+J.+Fancyauthor=E.+P.+Harringtonauthor=T.+J.+Yuenauthor=J.+C.+Silbereisauthor=C.+Zhaoauthor=S.+E.+Baranziniauthor=C.+C.+Bruceauthor=J.+J.+Oteroauthor=E.+J.+Huangauthor=R.+Nusseauthor=R.+J.+M.+Franklinauthor=D.+H.+Rowitch&title=Axin2+as+regulatory+and+therapeutic+target+in+newborn+brain+injury+and+remyelination"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination</span></div><div class="casAuthors">Fancy, Stephen P. J.; Harrington, Emily P.; Yuen, Tracy J.; Silbereis, John C.; Zhao, Chao; Baranzini, Sergio E.; Bruce, Charlotte C.; Otero, Jose J.; Huang, Eric J.; Nusse, Roel; Franklin, Robin J. M.; Rowitch, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1009-1016</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Permanent damage to white matter tracts, comprising axons and myelinating oligodendrocytes, is an important component of brain injuries of the newborn that cause cerebral palsy and cognitive disabilities, as well as multiple sclerosis in adults.  However, regulatory factors relevant in human developmental myelin disorders and in myelin regeneration are unclear.  We found that AXIN2 was expressed in immature oligodendrocyte progenitor cells (OLPs) in white matter lesions of human newborns with neonatal hypoxic-ischemic and gliotic brain damage, as well as in active multiple sclerosis lesions in adults.  Axin2 is a target of Wnt transcriptional activation that neg. feeds back on the pathway, promoting β-catenin degrdn.  We found that Axin2 function was essential for normal kinetics of remyelination.  The small mol. inhibitor XAV939, which targets the enzymic activity of tankyrase, acted to stabilize Axin2 levels in OLPs from brain and spinal cord and accelerated their differentiation and myelination after hypoxic and demyelinating injury.  Together, these findings indicate that Axin2 is an essential regulator of remyelination and that it might serve as a pharmacol. checkpoint in this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbvJsaEtdCN7Vg90H21EOLACvtfcHk0lhf3hdVC7KOWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotV2hsb4%253D&md5=204d38465ca799604b20e8df173b498c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnn.2855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2855%26sid%3Dliteratum%253Aachs%26aulast%3DFancy%26aufirst%3DS.%2BP.%2BJ.%26aulast%3DHarrington%26aufirst%3DE.%2BP.%26aulast%3DYuen%26aufirst%3DT.%2BJ.%26aulast%3DSilbereis%26aufirst%3DJ.%2BC.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DBaranzini%26aufirst%3DS.%2BE.%26aulast%3DBruce%26aufirst%3DC.%2BC.%26aulast%3DOtero%26aufirst%3DJ.%2BJ.%26aulast%3DHuang%26aufirst%3DE.%2BJ.%26aulast%3DNusse%26aufirst%3DR.%26aulast%3DFranklin%26aufirst%3DR.%2BJ.%2BM.%26aulast%3DRowitch%26aufirst%3DD.%2BH.%26atitle%3DAxin2%2520as%2520regulatory%2520and%2520therapeutic%2520target%2520in%2520newborn%2520brain%2520injury%2520and%2520remyelination%26jtitle%3DNat.%2520Neurosci.%26date%3D2011%26volume%3D14%26spage%3D1009%26epage%3D1U99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Bregman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span> </span><span class="NLM_article-title">Discovery of a class of novel tankyrase inhibitors that bind to both the nicotinamide pocket and the induced pocket</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1341</span><span class="NLM_x">–</span> <span class="NLM_lpage">1345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301607v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1341-1345&author=H.+Bregmanauthor=H.+Gunaydinauthor=Y.+Guauthor=S.+Schneiderauthor=C.+Wilsonauthor=E.+F.+DiMauroauthor=X.+Huang&title=Discovery+of+a+class+of+novel+tankyrase+inhibitors+that+bind+to+both+the+nicotinamide+pocket+and+the+induced+pocket"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm301607v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301607v%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520a%2520class%2520of%2520novel%2520tankyrase%2520inhibitors%2520that%2520bind%2520to%2520both%2520the%2520nicotinamide%2520pocket%2520and%2520the%2520induced%2520pocket%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1341%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lau, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waaler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambrone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korinek, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polakis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, M.</span><span> </span><span class="NLM_article-title">A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">3132</span><span class="NLM_x">–</span> <span class="NLM_lpage">3144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1158%2F0008-5472.CAN-12-4562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=23539443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=3132-3144&author=T.+Lauauthor=E.+Chanauthor=M.+Callowauthor=J.+Waalerauthor=J.+Boggsauthor=R.+A.+Blakeauthor=S.+Magnusonauthor=A.+Sambroneauthor=M.+Schuttenauthor=R.+Firesteinauthor=O.+Machonauthor=V.+Korinekauthor=E.+Chooauthor=D.+Diazauthor=M.+Merchantauthor=P.+Polakisauthor=D.+D.+Holsworthauthor=S.+Kraussauthor=M.+Costa&title=A+novel+tankyrase+small-molecule+inhibitor+suppresses+APC+mutation-driven+colorectal+tumor+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation-Driven Colorectal Tumor Growth</span></div><div class="casAuthors">Lau, Ted; Chan, Emily; Callow, Marinella; Waaler, Jo; Boggs, Jason; Blake, Robert A.; Magnuson, Steven; Sambrone, Amy; Schutten, Melissa; Firestein, Ron; Machon, Ondrej; Korinek, Vladimir; Choo, Edna; Diaz, Dolores; Merchant, Mark; Polakis, Paul; Holsworth, Daniel D.; Krauss, Stefan; Costa, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3132-3144</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Most colorectal cancers (CRC) are initiated by mutations of APC, leading to increased β-catenin-mediated signaling.  However, continued requirement of Wnt/P-catenin signaling for tumor progression in the context of acquired KRAS and other mutations is less well-established.  To attenuate Wnt/β-catenin signaling in tumors, we have developed potent and specific small-mol. tankyrase inhibitors, G007-LK and G244-LM, that reduce Wnt./p-catenin signaling by preventing poly(ADP-ribosyl)ation-dependent AXIN degrdn., thereby promoting β-catenin destabilization.  We show that novel tankyrase inhibitors completely block ligand-driven Wnt/β-catenin signaling in cell culture and display approx. 50% inhibition of APC mutation-driven signaling in most CRC cell lines.  It was previously unknown whether the level of AXIN protein stabilization by tankyrase inhibition is sufficient to impact tumor growth in the absence of normal APC activity.  Compd. G007-LK displays favorable pharmacokinetic properties and inhibits in vivo tumor growth in a subset of APC-mutant CRC xenograft models.  In the xenograft model most sensitive to tankyrase inhibitor, COLO-320DM, G007-LK inhibits cell-cycle progression, reduces colony formation, and induces differentiation, suggesting that β-catenin-dependent maintenance of an undifferentiated state may be blocked by tankyrase inhibition.  The full potential of the antitumor activity of G007-LK may be limited by intestinal toxicity assocd. with inhibition of Wnt/β-catenin signaling and cell proliferation in intestinal crypts.  These results establish proof-of-concept antitumor efficacy for tankyrase inhibitors in APC-mutant CRC models and uncover potential diagnostic and safety concerns to be overcome as tankyrase inhibitors are advanced into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbDZ01XGjOaLVg90H21EOLACvtfcHk0lhQUFJs8_FS4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D&md5=9f1d7b05b92ba8df593ccca9e7ea2cdf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-4562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-4562%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DCallow%26aufirst%3DM.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DSchutten%26aufirst%3DM.%26aulast%3DFirestein%26aufirst%3DR.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DChoo%26aufirst%3DE.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DM.%26atitle%3DA%2520novel%2520tankyrase%2520small-molecule%2520inhibitor%2520suppresses%2520APC%2520mutation-driven%2520colorectal%2520tumor%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D3132%26epage%3D3144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Voronkov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waaler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perdreau-Dahl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morth, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, S.</span><span> </span><span class="NLM_article-title">Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3012</span><span class="NLM_x">–</span> <span class="NLM_lpage">3023</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4000566" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3012-3023&author=A.+Voronkovauthor=D.+D.+Holsworthauthor=J.+Waalerauthor=S.+R.+Wilsonauthor=B.+Ekbladauthor=H.+Perdreau-Dahlauthor=H.+Dinhauthor=G.+Drewesauthor=C.+Hopfauthor=J.+P.+Morthauthor=S.+Krauss&title=Structural+basis+and+SAR+for+G007-LK%2C+a+lead+stage+1%2C2%2C4-triazole+based+specific+tankyrase+1%2F2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis and SAR for G007-LK, a Lead Stage 1,2,4-Triazole Based Specific Tankyrase 1/2 Inhibitor</span></div><div class="casAuthors">Voronkov, Andrew; Holsworth, Daniel D.; Waaler, Jo; Wilson, Steven R.; Ekblad, Bie; Perdreau-Dahl, Harmonie; Dinh, Huyen; Drewes, Gerard; Hopf, Carsten; Morth, Jens P.; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3012-3023</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 (TNKS1/2) are promising pharmacol. biotargets with possible applications for the development of novel anticancer therapeutics.  A focused structure-activity relationship study was conducted based on the tankyrase inhibitor JW74 (1).  Chem. analoging of 1 improved the 1,2,4-triazole based core and led to 4-{5-[(E)-2-{4-(2-chlorophenyl)-5-[5-(methylsulfonyl)pyridin-2-yl]-4H-1,2,4-triazol-3-yl}ethenyl]-1,3,4-oxadiazol-2-yl}benzonitrile (G007-LK), a potent, "rule of 5" compliant and a metabolically stable TNKS1/2 inhibitor.  G007-LK (66) displayed high selectivity toward tankyrases 1 and 2 with biochem. IC50 values of 46 nM and 25 nM, resp., and a cellular IC50 value of 50 nM combined with an excellent pharmacokinetic profile in mice.  The PARP domain of TNKS2 was cocrystd. with 66, and the X-ray structure was detd. at 2.8 Å resoln. in the space group P3221.  The structure revealed that 66 binds to unique structural features in the extended adenosine binding pocket which forms the structural basis for the compd.'s high target selectivity and specificity.  Our study provides a significantly optimized compd. for targeting TNKS1/2 in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvUxhCxkLuYbVg90H21EOLACvtfcHk0lhQUFJs8_FS4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D&md5=f2bee61f0fdc326e3e798b3705072e9d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm4000566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000566%26sid%3Dliteratum%253Aachs%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DEkblad%26aufirst%3DB.%26aulast%3DPerdreau-Dahl%26aufirst%3DH.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DMorth%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DStructural%2520basis%2520and%2520SAR%2520for%2520G007-LK%252C%2520a%2520lead%2520stage%25201%252C2%252C4-triazole%2520based%2520specific%2520tankyrase%25201%252F2%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3012%26epage%3D3023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lhQUFJs8_FS4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2ea2nUf923-i17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Arnott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planey, S. L.</span><span> </span><span class="NLM_article-title">The influence of lipophilicity in drug discovery and design</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1517%2F17460441.2012.714363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=22992175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=863-875&author=J.+A.+Arnottauthor=S.+L.+Planey&title=The+influence+of+lipophilicity+in+drug+discovery+and+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of lipophilicity in drug discovery and design</span></div><div class="casAuthors">Arnott, John A.; Planey, Sonia Lobo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">863-875</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The role of lipophilicity in drug discovery and design is a crit. one.  Lipophilicity is a key physicochem. property that plays a crucial role in detg. ADMET (absorption, distribution, metab., excretion, and toxicity) properties and the overall suitability of drug candidates.  There is increasing evidence to suggest that control of physicochem. properties such as lipophilicity, within a defined optimal range, can improve compd. quality and the likelihood of therapeutic success.Areas covered: This review focuses on understanding lipophilicity, techniques used to measure lipophilicity, and summarizes the importance of lipophilicity in drug discovery and development, including a discussion of its impact on individual ADMET parameters as well as its overall influence on the drug discovery and design process, specifically within the past 15 years.Expert opinion: A current review of the literature reveals a continued reliance on the synthesis of novel structures with increased potency, rather than a focus on maintaining optimal physicochem. properties assocd. with ADMET throughout drug optimization.  Particular attention to the optimum region of lipophilicity, as well as monitoring of lipophilic efficiency indexes, may contribute significantly to the overall quality of candidate drugs at different stages of discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolWJgvv9yK87Vg90H21EOLACvtfcHk0lgOOlEIJcCw4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsbvJ&md5=4dc5d7268216c9a59fcbd841fbf66735</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.714363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.714363%26sid%3Dliteratum%253Aachs%26aulast%3DArnott%26aufirst%3DJ.%2BA.%26aulast%3DPlaney%26aufirst%3DS.%2BL.%26atitle%3DThe%2520influence%2520of%2520lipophilicity%2520in%2520drug%2520discovery%2520and%2520design%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D863%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Griffen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. J.</span><span> </span><span class="NLM_article-title">Matched molecular pairs as a medicinal chemistry tool</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7739</span><span class="NLM_x">–</span> <span class="NLM_lpage">7750</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200452d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7739-7750&author=E.+Griffenauthor=A.+G.+Leachauthor=G.+R.+Robbauthor=D.+J.+Warner&title=Matched+molecular+pairs+as+a+medicinal+chemistry+tool"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Medicinal Chemistry Tool</span></div><div class="casAuthors">Griffen, Ed; Leach, Andrew G.; Robb, Graeme R.; Warner, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7739-7750</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">At the very heart of the role of a medicinal chemist or drug designer is the ability to link chem. structure to mol. properties.  This is the structure-activity relationship(SAR) or structure-property relationship(SPR).  Drug discovery projects often discover that a particular structural change causes a change to a property of interest.  The authors of this paper have been involved in developing and implementing some variations on the original theme of MMPA (matched mol. pairs anal.) and felt this to be the time to highlight some of these and to point toward future developments.  All of them are involved in the process of drug design, and it is within this context that they will set their comments.  In outline, they introduce matched mol. pair anal. and highlight why it fits so well with the kind of problem solving that is required in the process of drug design.  This will be followed by some comments concerning when the application of the methodol. is appropriate.  Then in a section intended for those with more computational interests, the authors describe the various ways that have been devised for identifying such matched pairs.  Throughout the paper, the authors have elected to use a publicly available data set to illustrate some of the comments: the ChEMBL database of inhibitors of the epidermal growth factor receptor tyrosine kinase (EGFR).  This consists of 2899 measurements of an IC50 annotated as a binding measurement on 2348 unique compds.  These measurements are drawn from a no. of sources, having been abstracted from the scientific literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMGFfO8Flm5bVg90H21EOLACvtfcHk0lgOOlEIJcCw4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK&md5=fab3344d790d1c0ae688ec65830d9143</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm200452d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200452d%26sid%3Dliteratum%253Aachs%26aulast%3DGriffen%26aufirst%3DE.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DWarner%26aufirst%3DD.%2BJ.%26atitle%3DMatched%2520molecular%2520pairs%2520as%2520a%2520medicinal%2520chemistry%2520tool%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7739%26epage%3D7750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Trunzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerlin, A.</span><span> </span><span class="NLM_article-title">Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8008663" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFChsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=329-335&author=M.+Trunzerauthor=B.+Fallerauthor=A.+Zimmerlin&title=Metabolic+soft+spot+identification+and+compound+optimization+in+early+discovery+phases+using+MetaSite+and+LC-MS%2FMS+validation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Soft Spot Identification and Compound Optimization in Early Discovery Phases Using MetaSite and LC-MS/MS Validation</span></div><div class="casAuthors">Trunzer, Markus; Faller, Bernard; Zimmerlin, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">329-335</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metabolic stability is a key property to enable drugs to reach therapeutic concns.  Microsomal clearance assays are used to dial out labile compds. in early discovery phases.  However, because they do not provide any information on soft spots, the rational design of more stable compds. remains challenging.  A robust soft spot identification procedure combining in silico prediction ranking using MetaSite and mass-spectrometric confirmation is described.  MetaSite's first rank order predictions were exptl. confirmed for only about 55% of the compds.  For another 29% of the compds., the second (20%) or the third (9%) rank order predictions were detected.  This automatic and high-throughput reprioritization of a likely soft-spot increases the likelihood of working on the right soft spot from about 50% to more than 80%.  With this information, the structure-metab. relationships are likely to be understood faster and earlier in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV4vzsZ7zQ_rVg90H21EOLACvtfcHk0liKjKxRog3yrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFChsLfJ&md5=8628722a0cd75b0c6497cc383bd4ec16</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm8008663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8008663%26sid%3Dliteratum%253Aachs%26aulast%3DTrunzer%26aufirst%3DM.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DZimmerlin%26aufirst%3DA.%26atitle%3DMetabolic%2520soft%2520spot%2520identification%2520and%2520compound%2520optimization%2520in%2520early%2520discovery%2520phases%2520using%2520MetaSite%2520and%2520LC-MS%252FMS%2520validation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D329%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Cruciani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosati, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethirajulu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, R.</span><span> </span><span class="NLM_article-title">MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6970</span><span class="NLM_x">–</span> <span class="NLM_lpage">6979</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050529c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6970-6979&author=G.+Crucianiauthor=E.+Carosatiauthor=B.+B.+Deauthor=K.+Ethirajuluauthor=C.+Mackieauthor=T.+Howeauthor=R.+Vianello&title=MetaSite%3A+understanding+metabolism+in+human+cytochromes+from+the+perspective+of+the+chemist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm050529c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050529c%26sid%3Dliteratum%253Aachs%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DCarosati%26aufirst%3DE.%26aulast%3DDe%26aufirst%3DB.%2BB.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DVianello%26aufirst%3DR.%26atitle%3DMetaSite%253A%2520understanding%2520metabolism%2520in%2520human%2520cytochromes%2520from%2520the%2520perspective%2520of%2520the%2520chemist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6970%26epage%3D6979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">T’jollyn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boussery, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortishire-Smith, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Bocxlaer, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannens, G.</span><span> </span><span class="NLM_article-title">Evaluation of three state-of-the-art metabolite prediction software packages (Meteor, MetaSite, and StarDrop) through independent and synergistic use</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2066</span><span class="NLM_x">–</span> <span class="NLM_lpage">2075</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=2066-2075&author=H.+T%E2%80%99jollynauthor=K.+Bousseryauthor=R.+J.+Mortishire-Smithauthor=K.+Coeauthor=B.+B.+Deauthor=J.+F.+Van+Bocxlaerauthor=G.+Mannens&title=Evaluation+of+three+state-of-the-art+metabolite+prediction+software+packages+%28Meteor%2C+MetaSite%2C+and+StarDrop%29+through+independent+and+synergistic+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DT%25E2%2580%2599jollyn%26aufirst%3DH.%26aulast%3DBoussery%26aufirst%3DK.%26aulast%3DMortishire-Smith%26aufirst%3DR.%2BJ.%26aulast%3DCoe%26aufirst%3DK.%26aulast%3DDe%26aufirst%3DB.%2BB.%26aulast%3DVan%2BBocxlaer%26aufirst%3DJ.%2BF.%26aulast%3DMannens%26aufirst%3DG.%26atitle%3DEvaluation%2520of%2520three%2520state-of-the-art%2520metabolite%2520prediction%2520software%2520packages%2520%2528Meteor%252C%2520MetaSite%252C%2520and%2520StarDrop%2529%2520through%2520independent%2520and%2520synergistic%2520use%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D2066%26epage%3D2075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Shin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E.</span><span> </span><span class="NLM_article-title">Comparison of metabolic soft spot predictions of CYP3A4, CYP2C9 and CYP2D6 substrates using MetaSite and StarDrop</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.2174%2F138620711796957170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=21605066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Cit7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=811-823&author=Y.+G.+Shinauthor=H.+Leauthor=C.+Khojastehauthor=C.+E.+Hop&title=Comparison+of+metabolic+soft+spot+predictions+of+CYP3A4%2C+CYP2C9+and+CYP2D6+substrates+using+MetaSite+and+StarDrop"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of metabolic soft spot predictions of CYP3A4, CYP2C9 and CYP2D6 substrates using MetaSite and StarDrop</span></div><div class="casAuthors">Shin, Young G.; Le, Hoa; Khojasteh, Cyrus; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">811-823</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Metabolite identification study plays an important role in detg. the sites of metabolic liability of new chem. entities (NCEs) in drug discovery for lead optimization.  Here we compare the two predictive software, MetaSite and StarDrop, available for this purpose.  They work very differently but are used to predict the site of oxidn. by major human cytochrome P 450 (CYP) isoforms.  Neither software can predict non-CYP catalyzed metab. nor the rates of metab.  For the purpose of comparing the two software packages, we tested known probe substrate for these enzymes, which included 12 substrates of CYP3A4 and 18 substrates of CYP2C9 and CYP2D6 were analyzed by each software and the results were compared.  It is possible that these known substrates were part of the training set but we are not aware of it.  To assess the performance of each software we assigned a point system for each correct prediction.  The total points assigned for each CYP isoform exptl. were compared as a percentage of the total points assigned theor. for the first choice prediction for all substrates for each isoform.  Our results show that MetaSite and StarDrop are similar in predicting the correct site of metab. by CYP3A4 (78% vs 83%, resp.).  StarDrop appears to do slightly better in predicting the correct site of metab. by CYP2C9 and CYP2D6 metab. (89% and 93%, resp.) compared to MetaSite (63% and 70%, resp.).  The sites of metab. (SOM) from 34 inhouse NCEs incubated in human liver microsomes or human hepatocytes were also evaluated using two prediction software packages and the results showed comparable SOM predictions.  What makes this comparison challenging is that the contribution of each isoform to the intrinsic clearance (Clint) is not known.  Overall the software were comparable except for MetaSite performing better for CYP2D6 and that MetaSite has a liver model that is absent in StarDrop that predicted with 82% accuracy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq00wGGTwAAibVg90H21EOLACvtfcHk0liKjKxRog3yrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Cit7nK&md5=af53cda11a6e67b832002fdada6af924</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F138620711796957170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620711796957170%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DY.%2BG.%26aulast%3DLe%26aufirst%3DH.%26aulast%3DKhojasteh%26aufirst%3DC.%26aulast%3DHop%26aufirst%3DC.%2BE.%26atitle%3DComparison%2520of%2520metabolic%2520soft%2520spot%2520predictions%2520of%2520CYP3A4%252C%2520CYP2C9%2520and%2520CYP2D6%2520substrates%2520using%2520MetaSite%2520and%2520StarDrop%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2011%26volume%3D14%26spage%3D811%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Storni, A.</span>Carboxamides. EP 124476, Nov 7,<span class="NLM_x"> </span><span class="NLM_year">1984</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&author=A.+Storni&title=Carboxamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DStorni%26aufirst%3DA.%26jtitle%3DCarboxamides%26date%3D1984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Bregman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egge, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullady, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strathdee, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span> </span><span class="NLM_article-title">Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4320</span><span class="NLM_x">–</span> <span class="NLM_lpage">4342</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4000038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4320-4342&author=H.+Bregmanauthor=N.+Chakkaauthor=A.+Guzman-Perezauthor=H.+Gunaydinauthor=Y.+Guauthor=X.+Huangauthor=V.+Berryauthor=J.+Liuauthor=Y.+Tefferaauthor=L.+Huangauthor=B.+Eggeauthor=E.+L.+Mulladyauthor=S.+Schneiderauthor=P.+S.+Andrewsauthor=A.+Mishraauthor=J.+Newcombauthor=R.+Serafinoauthor=C.+A.+Strathdeeauthor=S.+M.+Turciauthor=C.+Wilsonauthor=E.+F.+DiMauro&title=Discovery+of+novel%2C+induced-pocket+binding+oxazolidinones+as+potent%2C+selective%2C+and+orally+bioavailable+tankyrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel, Induced-Pocket Binding Oxazolidinones as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors</span></div><div class="casAuthors">Bregman, Howard; Chakka, Nagasree; Guzman-Perez, Angel; Gunaydin, Hakan; Gu, Yan; Huang, Xin; Berry, Virginia; Liu, Jingzhou; Teffera, Yohannes; Huang, Liyue; Egge, Bryan; Mullady, Erin L.; Schneider, Steve; Andrews, Paul S.; Mishra, Ankita; Newcomb, John; Serafino, Randy; Strathdee, Craig A.; Turci, Susan M.; Wilson, Cindy; DiMauro, Erin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4320-4342</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase (TNKS) is a poly-ADP-ribosylating protein (PARP) whose activity suppresses cellular axin protein levels and elevates β-catenin concns., resulting in increased oncogene expression.  The inhibition of tankyrase (TNKS1 and 2) may reduce the levels of β-catenin-mediated transcription and inhibit tumorigenesis.  Compd. I is a previously described moderately potent tankyrase inhibitor that suffers from poor pharmacokinetic properties.  Herein, we describe the utilization of structure-based design and mol. modeling toward novel, potent, and selective tankyrase inhibitors with improved pharmacokinetic properties (II, III).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNxO4sATmyjbVg90H21EOLACvtfcHk0lg1HwqFXcO-tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D&md5=c22d14a6a93ab185e3c13ccd04af9451</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm4000038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000038%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DEgge%26aufirst%3DB.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DStrathdee%26aufirst%3DC.%2BA.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26atitle%3DDiscovery%2520of%2520novel%252C%2520induced-pocket%2520binding%2520oxazolidinones%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4320%26epage%3D4342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Tsukamoto, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosschedl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parslow, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H. E.</span><span> </span><span class="NLM_article-title">Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1988&pages=619-625&author=A.+S.+Tsukamotoauthor=R.+Grosschedlauthor=R.+C.+Guzmanauthor=T.+Parslowauthor=H.+E.+Varmus&title=Expression+of+the+int-1+gene+in+transgenic+mice+is+associated+with+mammary+gland+hyperplasia+and+adenocarcinomas+in+male+and+female+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsukamoto%26aufirst%3DA.%2BS.%26aulast%3DGrosschedl%26aufirst%3DR.%26aulast%3DGuzman%26aufirst%3DR.%2BC.%26aulast%3DParslow%26aufirst%3DT.%26aulast%3DVarmus%26aufirst%3DH.%2BE.%26atitle%3DExpression%2520of%2520the%2520int-1%2520gene%2520in%2520transgenic%2520mice%2520is%2520associated%2520with%2520mammary%2520gland%2520hyperplasia%2520and%2520adenocarcinomas%2520in%2520male%2520and%2520female%2520mice%26jtitle%3DCell%26date%3D1988%26volume%3D55%26spage%3D619%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Freire, E.</span><span> </span><span class="NLM_article-title">Do enthalpy and entropy distinguish first in class from best in class?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1016%2Fj.drudis.2008.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=18703160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCgu7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=869-874&author=E.+Freire&title=Do+enthalpy+and+entropy+distinguish+first+in+class+from+best+in+class%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Do enthalpy and entropy distinguish first in class from best in class?</span></div><div class="casAuthors">Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19/20</span>),
    <span class="NLM_cas:pages">869-874</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A drug mol. should bind to its target with high affinity and selectivity.  Because the binding affinity is a combined function of the binding enthalpy and the binding entropy, extremely high affinity requires that both terms contribute favorably to binding.  The binding enthalpy, however, is notoriously more difficult to optimize than the binding entropy, a fact that has resulted in thermodynamically unbalanced mols. that do not achieve optimal potency.  In fact, with current technologies, the enthalpic optimization of drug candidates may take years and only appear in second-generation products.  Within that context, it is not surprising that structure/activity relationships (SARs) that explicitly incorporate the interplay between enthalpy and entropy and accelerate the optimization process are being developed and gaining popularity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5swEhu922BbVg90H21EOLACvtfcHk0lg1HwqFXcO-tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCgu7fN&md5=357358107c5686a1863a83291c1cdd92</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2008.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2008.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DDo%2520enthalpy%2520and%2520entropy%2520distinguish%2520first%2520in%2520class%2520from%2520best%2520in%2520class%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D869%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Conroy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C. T.</span><span> </span><span class="NLM_article-title">Using the electrostatic field effect to design a new class of inhibitors for cysteine proteases</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">4285</span><span class="NLM_x">–</span> <span class="NLM_lpage">4291</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9641867" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADyaK2sXivVWqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=4285-4291&author=J.+L.+Conroyauthor=T.+C.+Sandersauthor=C.+T.+Seto&title=Using+the+electrostatic+field+effect+to+design+a+new+class+of+inhibitors+for+cysteine+proteases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Using the Electrostatic Field Effect to Design a New Class of Inhibitors for Cysteine Proteases</span></div><div class="casAuthors">Conroy, Jeffrey L.; Sanders, Tanya C.; Seto, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4285-4291</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of competitive inhibitors for the cysteine protease papain is described.  These inhibitors are based upon a 4-heterocyclohexanone ring and are designed to react with the enzyme active site nucleophile to give a reversibly formed hemithioketal.  The electrophilicity of the ketone in these inhibitors is enhanced by ring strain and by through-space electrostatic repulsion with the heteroatom at the 1-position of the ring.  Equil. consts. for addn. of water and 3-mercaptopropionic acid to several 4-heterocyclohexanones were measured by 1H NMR spectroscopy.  These reactions model addn. of the active site nucleophile to the corresponding inhibitors.  The equil. consts. give a linear correlation with the field substituent const. F for the functional group at the 1-position of the heterocyclohexanone.  These equil. consts. also correlate well with the inhibition consts. for the 4-heterocyclohexanone-based inhibitors, which range from 11 to 120 μM.  Thus, the model system can be used to predict the potency of structurally related enzyme inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqvOC-4OuTB7Vg90H21EOLACvtfcHk0lg1HwqFXcO-tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivVWqtrk%253D&md5=d40497b24f57a94d5bb36e6491dec934</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja9641867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9641867%26sid%3Dliteratum%253Aachs%26aulast%3DConroy%26aufirst%3DJ.%2BL.%26aulast%3DSanders%26aufirst%3DT.%2BC.%26aulast%3DSeto%26aufirst%3DC.%2BT.%26atitle%3DUsing%2520the%2520electrostatic%2520field%2520effect%2520to%2520design%2520a%2520new%2520class%2520of%2520inhibitors%2520for%2520cysteine%2520proteases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D4285%26epage%3D4291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Karlberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, H.</span><span> </span><span class="NLM_article-title">Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5352</span><span class="NLM_x">–</span> <span class="NLM_lpage">5355</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100249w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVeht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5352-5355&author=T.+Karlbergauthor=N.+Markovaauthor=I.+Johanssonauthor=M.+Hammarstromauthor=P.+Schutzauthor=J.+Weigeltauthor=H.+Schuler&title=Structural+basis+for+the+interaction+between+tankyrase-2+and+a+potent+Wnt-signaling+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Interaction between Tankyrase-2 and a Potent Wnt-Signaling Inhibitor</span></div><div class="casAuthors">Karlberg, Tobias; Markova, Natalia; Johansson, Ida; Hammarstrom, Martin; Schutz, Patrick; Weigelt, Johan; Schuler, Herwig</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5352-5355</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report two crystal structures of the PARP domain of human tankyrase-2 (TNKS2).  Tankyrases are involved in fundamental cellular processes such as telomere homeostasis and Wnt signaling.  The complex of TNKS2 with the potent inhibitor XAV939 provides insights into the mol. basis of the strong interaction and suggests routes for further development of tankyrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB8HUahD927bVg90H21EOLACvtfcHk0ljQX0_0x4gPZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVeht7Y%253D&md5=3b037afbe6f4dc86a492855fa800fb44</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm100249w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100249w%26sid%3Dliteratum%253Aachs%26aulast%3DKarlberg%26aufirst%3DT.%26aulast%3DMarkova%26aufirst%3DN.%26aulast%3DJohansson%26aufirst%3DI.%26aulast%3DHammarstrom%26aufirst%3DM.%26aulast%3DSchutz%26aufirst%3DP.%26aulast%3DWeigelt%26aufirst%3DJ.%26aulast%3DSchuler%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520for%2520the%2520interaction%2520between%2520tankyrase-2%2520and%2520a%2520potent%2520Wnt-signaling%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5352%26epage%3D5355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['ref7_1'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 73 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Hans-Peter Buchstaller, Uwe Anlauf, Dieter Dorsch, Sarah Kögler, Daniel Kuhn, Martin Lehmann, Birgitta Leuthner, Sara Lodholz, Djordje Musil, Daniela Radtki, Corinna Rettig, Claudio Ritzert, Felix Rohdich, Richard Schneider, Ansgar Wegener, Stefan Weigt, Kai Wilkinson, <span class="NLM_string-name hlFld-ContribAuthor">Christina Esdar</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of a Screening Hit toward M2912, an Oral Tankyrase Inhibitor with Antitumor Activity in Colorectal Cancer Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 10371-10392. <a href="https://doi.org/10.1021/acs.jmedchem.1c00800" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00800</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00800%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252Ba%252BScreening%252BHit%252Btoward%252BM2912%25252C%252Ban%252BOral%252BTankyrase%252BInhibitor%252Bwith%252BAntitumor%252BActivity%252Bin%252BColorectal%252BCancer%252BModels%26aulast%3DBuchstaller%26aufirst%3DHans-Peter%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D03052021%26date%3D13072021%26volume%3D64%26issue%3D14%26spage%3D10371%26epage%3D10392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhiqing Liu, Pingyuan Wang, Eric A. Wold, Qiaoling Song, Chenyang Zhao, Changyun Wang, <span class="NLM_string-name hlFld-ContribAuthor">Jia Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4257-4288. <a href="https://doi.org/10.1021/acs.jmedchem.0c01799" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01799%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BInhibitors%252BTargeting%252Bthe%252BCanonical%252BWNT%252BSignaling%252BPathway%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DLiu%26aufirst%3DZhiqing%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14102020%26date%3D06042021%26volume%3D64%26issue%3D8%26spage%3D4257%26epage%3D4288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elliott D. Bayle, Fredrik Svensson, Benjamin N. Atkinson, David Steadman, Nicky J. Willis, Hannah L. Woodward, Paul Whiting, Jean-Paul Vincent, <span class="NLM_string-name hlFld-ContribAuthor">Paul V. Fish</span>. </span><span class="cited-content_cbyCitation_article-title">Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4289-4311. <a href="https://doi.org/10.1021/acs.jmedchem.0c01974" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01974</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01974%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCarboxylesterase%252BNotum%252BIs%252Ba%252BDruggable%252BTarget%252Bto%252BModulate%252BWnt%252BSignaling%26aulast%3DBayle%26aufirst%3DElliott%2BD.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14112020%26date%3D30032021%26volume%3D64%26issue%3D8%26spage%3D4289%26epage%3D4311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fumiyuki Shirai, Anna Mizutani, Yoko Yashiroda, Takeshi Tsumura, Yuko Kano, Yukiko Muramatsu, Tsubasa Chikada, Hitomi Yuki, Hideaki Niwa, Shin Sato, Kenichi Washizuka, Yasuko Koda, Yui Mazaki, Myung-Kyu Jang, Haruka Yoshida, Akiko Nagamori, Masayuki Okue, Takashi Watanabe, Kouichi Kitamura, Eiki Shitara, Teruki Honma, Takashi Umehara, Mikako Shirouzu, Takehiro Fukami, Hiroyuki Seimiya, Minoru Yoshida, <span class="NLM_string-name hlFld-ContribAuthor">Hiroo Koyama</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (8)
                                     , 4183-4204. <a href="https://doi.org/10.1021/acs.jmedchem.0c00045" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00045%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BDiscovery%252Bof%252Ban%252BOrally%252BEfficacious%252BSpiroindolinone-Based%252BTankyrase%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BColon%252BCancer%26aulast%3DShirai%26aufirst%3DFumiyuki%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10012020%26date%3D01042020%26date%3D23032020%26volume%3D63%26issue%3D8%26spage%3D4183%26epage%3D4204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wei Yang, Yingjun Li, Yong Ai, Obinna N. Obianom, Dong Guo, Hong Yang, Srilatha Sakamuru, Menghang Xia, Yan Shu, <span class="NLM_string-name hlFld-ContribAuthor">Fengtian Xue</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 11151-11164. <a href="https://doi.org/10.1021/acs.jmedchem.9b01252" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01252%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrazole-4-Carboxamide%252B%252528YW2065%252529%25253A%252BA%252BTherapeutic%252BCandidate%252Bfor%252BColorectal%252BCancer%252Bvia%252BDual%252BActivities%252Bof%252BWnt%25252F%2525CE%2525B2-Catenin%252BSignaling%252BInhibition%252Band%252BAMP-Activated%252BProtein%252BKinase%252B%252528AMPK%252529%252BActivation%26aulast%3DYang%26aufirst%3DWei%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D31072019%26date%3D10122019%26date%3D26112019%26volume%3D62%26issue%3D24%26spage%3D11151%26epage%3D11164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Recent Strategic Advances in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9375-9414. <a href="https://doi.org/10.1021/acs.jmedchem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252BRecent%252BStrategic%252BAdvances%252Bin%252BMedicinal%252BChemistry%26aulast%3DWu%26aufirst%3DGaochan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D28052019%26date%3D03052019%26volume%3D62%26issue%3D21%26spage%3D9375%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hans-Peter Buchstaller, Uwe Anlauf, Dieter Dorsch, Daniel Kuhn, Martin Lehmann, Birgitta Leuthner, Djordje Musil, Daniela Radtki, Claudio Ritzert, Felix Rohdich, Richard Schneider, <span class="NLM_string-name hlFld-ContribAuthor">Christina Esdar</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (17)
                                     , 7897-7909. <a href="https://doi.org/10.1021/acs.jmedchem.9b00656" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00656%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252B2-Arylquinazolin-4-ones%252Binto%252Ba%252BPotent%252Band%252BSelective%252BTankyrase%252BInhibitor%252BModulating%252BWnt%252BPathway%252BActivity%26aulast%3DBuchstaller%26aufirst%3DHans-Peter%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24042019%26date%3D20082019%26date%3D05082019%26volume%3D62%26issue%3D17%26spage%3D7897%26epage%3D7909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fumiyuki Shirai, Takeshi Tsumura, Yoko Yashiroda, Hitomi Yuki, Hideaki Niwa, Shin Sato, Tsubasa Chikada, Yasuko Koda, Kenichi Washizuka, Nobuko Yoshimoto, Masako Abe, Tetsuo Onuki, Yui Mazaki, Chizuko Hirama, Takehiro Fukami, Hirofumi Watanabe, Teruki Honma, Takashi Umehara, Mikako Shirouzu, Masayuki Okue, Yuko Kano, Takashi Watanabe, Kouichi Kitamura, Eiki Shitara, Yukiko Muramatsu, Haruka Yoshida, Anna Mizutani, Hiroyuki Seimiya, Minoru Yoshida, <span class="NLM_string-name hlFld-ContribAuthor">Hiroo Koyama</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3407-3427. <a href="https://doi.org/10.1021/acs.jmedchem.8b01888" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01888</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01888%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BSpiroindoline%252BDerivatives%252Bas%252BSelective%252BTankyrase%252BInhibitors%26aulast%3DShirai%26aufirst%3DFumiyuki%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D30112018%26date%3D01042019%26date%3D18032019%26volume%3D62%26issue%3D7%26spage%3D3407%26epage%3D3427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Noriaki Okimoto, Takao Otsuka, Yoshinori Hirano, <span class="NLM_string-name hlFld-ContribAuthor">Makoto Taiji</span>. </span><span class="cited-content_cbyCitation_article-title">Use of the Multilayer Fragment Molecular Orbital Method to Predict the Rank Order of Protein–Ligand Binding Affinities: A Case Study Using Tankyrase 2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (4)
                                     , 4475-4485. <a href="https://doi.org/10.1021/acsomega.8b00175" title="DOI URL">https://doi.org/10.1021/acsomega.8b00175</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b00175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b00175%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DUse%252Bof%252Bthe%252BMultilayer%252BFragment%252BMolecular%252BOrbital%252BMethod%252Bto%252BPredict%252Bthe%252BRank%252BOrder%252Bof%252BProtein%2525E2%252580%252593Ligand%252BBinding%252BAffinities%25253A%252BA%252BCase%252BStudy%252BUsing%252BTankyrase%252B2%252BInhibitors%26aulast%3DOkimoto%26aufirst%3DNoriaki%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D28012018%26date%3D23032018%26volume%3D3%26issue%3D4%26spage%3D4475%26epage%3D4485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Upendra
Rao Anumala, Jo Waaler, Yves Nkizinkiko, Alexander Ignatev, Katina Lazarow, Peter Lindemann, Petter Angell Olsen, Sudarshan Murthy, Ezeogo Obaji, Alexander G. Majouga, Sergey Leonov, Jens Peter von Kries, Lari Lehtiö, Stefan Krauss, <span class="NLM_string-name hlFld-ContribAuthor">Marc Nazaré</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Series of Tankyrase Inhibitors by a Hybridization Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (24)
                                     , 10013-10025. <a href="https://doi.org/10.1021/acs.jmedchem.7b00883" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00883</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00883%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BTankyrase%252BInhibitors%252Bby%252Ba%252BHybridization%252BApproach%26aulast%3DAnumala%26aufirst%3DUpendra%2BRao%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D29062017%26date%3D08122017%26date%3D20112017%26volume%3D60%26issue%3D24%26spage%3D10013%26epage%3D10025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas W.  Thomson</span>, <span class="hlFld-ContribAuthor ">Anne J.  Wagner</span>, <span class="hlFld-ContribAuthor ">Marcus  Bantscheff</span>, <span class="hlFld-ContribAuthor ">R. Edward  Benson</span>, <span class="hlFld-ContribAuthor ">Lars  Dittus</span>, <span class="hlFld-ContribAuthor ">Birgit  Duempelfeld</span>, <span class="hlFld-ContribAuthor ">Gerard  Drewes</span>, <span class="hlFld-ContribAuthor ">Jana  Krause</span>, <span class="hlFld-ContribAuthor ">John T.  Moore</span>, <span class="hlFld-ContribAuthor ">Katrin  Mueller</span>, <span class="hlFld-ContribAuthor ">Daniel  Poeckel</span>, <span class="hlFld-ContribAuthor ">Christina  Rau</span>, <span class="hlFld-ContribAuthor ">Elsa  Salzer</span>, <span class="hlFld-ContribAuthor ">Lisa  Shewchuk</span>, <span class="hlFld-ContribAuthor ">Carsten  Hopf</span>, <span class="hlFld-ContribAuthor ">John G.  Emery</span>, and <span class="hlFld-ContribAuthor ">Marcel  Muelbaier</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5455-5471. <a href="https://doi.org/10.1021/acs.jmedchem.7b00137" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00137%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BHighly%252BSelective%252BTankyrase%252BInhibitor%252BDisplaying%252BGrowth%252BInhibition%252BEffects%252Bagainst%252Ba%252BDiverse%252BRange%252Bof%252BTumor%252BDerived%252BCell%252BLines%26aulast%3DThomson%26aufirst%3DDouglas%2BW.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D26012017%26date%3D27062017%26date%3D13072017%26date%3D07062017%26volume%3D60%26issue%3D13%26spage%3D5455%26epage%3D5471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William G.  Devine</span>, <span class="hlFld-ContribAuthor ">Rosario  Diaz-Gonzalez</span>, <span class="hlFld-ContribAuthor ">Gloria  Ceballos-Perez</span>, <span class="hlFld-ContribAuthor ">Domingo  Rojas</span>, <span class="hlFld-ContribAuthor ">Takashi  Satoh</span>, <span class="hlFld-ContribAuthor ">Westley  Tear</span>, <span class="hlFld-ContribAuthor ">Ranae M.  Ranade</span>, <span class="hlFld-ContribAuthor ">Ximena  Barros-Álvarez</span>, <span class="hlFld-ContribAuthor ">Wim G. J.  Hol</span>, <span class="hlFld-ContribAuthor ">Frederick S.  Buckner</span>, <span class="hlFld-ContribAuthor ">Miguel  Navarro</span>, and <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>  . </span><span class="cited-content_cbyCitation_article-title">From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African Trypanosomiasis. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2017,</strong> <em>3 </em>
                                    (3)
                                     , 225-236. <a href="https://doi.org/10.1021/acsinfecdis.6b00202" title="DOI URL">https://doi.org/10.1021/acsinfecdis.6b00202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.6b00202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.6b00202%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DFrom%252BCells%252Bto%252BMice%252Bto%252BTarget%25253A%252BCharacterization%252Bof%252BNEU-1053%252B%252528SB-443342%252529%252Band%252BIts%252BAnalogues%252Bfor%252BTreatment%252Bof%252BHuman%252BAfrican%252BTrypanosomiasis%26aulast%3DDevine%26aufirst%3DWilliam%2BG.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D30112016%26date%3D08022017%26date%3D10032017%26date%3D22012017%26volume%3D3%26issue%3D3%26spage%3D225%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Devine</span>, <span class="hlFld-ContribAuthor ">Sarah M.  Thomas</span>, <span class="hlFld-ContribAuthor ">Jessey  Erath</span>, <span class="hlFld-ContribAuthor ">Kelly A.  Bachovchin</span>, <span class="hlFld-ContribAuthor ">Patricia J.  Lee</span>, <span class="hlFld-ContribAuthor ">Susan E.  Leed</span>, <span class="hlFld-ContribAuthor ">Ana  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Richard J.  Sciotti</span>, <span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>, and <span class="hlFld-ContribAuthor ">Michael P.  Pollastri</span>  . </span><span class="cited-content_cbyCitation_article-title">Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan Parasites. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 350-354. <a href="https://doi.org/10.1021/acsmedchemlett.7b00011" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00011%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAntiparasitic%252BLead%252BDiscovery%25253A%252BToward%252BOptimization%252Bof%252Ba%252BChemotype%252Bwith%252BActivity%252BAgainst%252BMultiple%252BProtozoan%252BParasites%26aulast%3DDevine%26aufirst%3DWilliam%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D09012017%26date%3D05022017%26date%3D20022017%26date%3D09032017%26date%3D05022017%26volume%3D8%26issue%3D3%26spage%3D350%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit  Nathubhai</span>, <span class="hlFld-ContribAuthor ">Teemu  Haikarainen</span>, <span class="hlFld-ContribAuthor ">Jarkko  Koivunen</span>, <span class="hlFld-ContribAuthor ">Sudarshan  Murthy</span>, <span class="hlFld-ContribAuthor ">Françoise  Koumanov</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Lloyd</span>, <span class="hlFld-ContribAuthor ">Geoffrey D.  Holman</span>, <span class="hlFld-ContribAuthor ">Taina  Pihlajaniemi</span>, <span class="hlFld-ContribAuthor ">David  Tosh</span>, <span class="hlFld-ContribAuthor ">Lari  Lehtiö</span>, and <span class="hlFld-ContribAuthor ">Michael D.  Threadgill</span>  . </span><span class="cited-content_cbyCitation_article-title">Highly Potent and Isoform Selective Dual Site Binding Tankyrase/Wnt Signaling Inhibitors That Increase Cellular Glucose Uptake and Have Antiproliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (2)
                                     , 814-820. <a href="https://doi.org/10.1021/acs.jmedchem.6b01574" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01574%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BPotent%252Band%252BIsoform%252BSelective%252BDual%252BSite%252BBinding%252BTankyrase%25252FWnt%252BSignaling%252BInhibitors%252BThat%252BIncrease%252BCellular%252BGlucose%252BUptake%252Band%252BHave%252BAntiproliferative%252BActivity%26aulast%3DNathubhai%26aufirst%3DAmit%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D28102016%26date%3D09012017%26date%3D26012017%26date%3D16122016%26volume%3D60%26issue%3D2%26spage%3D814%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raphael M.  Franzini</span> and <span class="hlFld-ContribAuthor ">Cassie  Randolph</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemical Space of DNA-Encoded Libraries. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (14)
                                     , 6629-6644. <a href="https://doi.org/10.1021/acs.jmedchem.5b01874" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01874</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01874%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemical%252BSpace%252Bof%252BDNA-Encoded%252BLibraries%26aulast%3DFranzini%26aufirst%3DRaphael%2BM.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D04122015%26date%3D25022016%26date%3D28072016%26volume%3D59%26issue%3D14%26spage%3D6629%26epage%3D6644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dennis  Schade</span> and <span class="hlFld-ContribAuthor ">Alleyn T.  Plowright</span>  . </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry Approaches to Heart Regeneration. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (24)
                                     , 9451-9479. <a href="https://doi.org/10.1021/acs.jmedchem.5b00446" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00446%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252BChemistry%252BApproaches%252Bto%252BHeart%252BRegeneration%26aulast%3DSchade%26aufirst%3DDennis%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D19032015%26date%3D03092015%26date%3D24122015%26date%3D19082015%26volume%3D58%26issue%3D24%26spage%3D9451%26epage%3D9479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Javier  de Vicente</span>, <span class="hlFld-ContribAuthor ">Parcharee  Tivitmahaisoon</span>, <span class="hlFld-ContribAuthor ">Pamela  Berry</span>, <span class="hlFld-ContribAuthor ">David R.  Bolin</span>, <span class="hlFld-ContribAuthor ">Daisy  Carvajal</span>, <span class="hlFld-ContribAuthor ">Wei  He</span>, <span class="hlFld-ContribAuthor ">Kuo-Sen  Huang</span>, <span class="hlFld-ContribAuthor ">Cheryl  Janson</span>, <span class="hlFld-ContribAuthor ">Lena  Liang</span>, <span class="hlFld-ContribAuthor ">Christine  Lukacs</span>, <span class="hlFld-ContribAuthor ">Ann  Petersen</span>, <span class="hlFld-ContribAuthor ">Hong  Qian</span>, <span class="hlFld-ContribAuthor ">Lin  Yi</span>, <span class="hlFld-ContribAuthor ">Yong  Zhuang</span>, and <span class="hlFld-ContribAuthor ">Johannes C.  Hermann</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Drug Design of Novel Pyranopyridones as Cell Active and Orally Bioavailable Tankyrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (9)
                                     , 1019-1024. <a href="https://doi.org/10.1021/acsmedchemlett.5b00251" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00251%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFragment-Based%252BDrug%252BDesign%252Bof%252BNovel%252BPyranopyridones%252Bas%252BCell%252BActive%252Band%252BOrally%252BBioavailable%252BTankyrase%252BInhibitors%26aulast%3Dde%2BVicente%26aufirst%3DJavier%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D23062015%26date%3D04082015%26date%3D06082015%26date%3D10092015%26date%3D04082015%26volume%3D6%26issue%3D9%26spage%3D1019%26epage%3D1024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florent  Samain</span>, <span class="hlFld-ContribAuthor ">Torun  Ekblad</span>, <span class="hlFld-ContribAuthor ">Gediminas  Mikutis</span>, <span class="hlFld-ContribAuthor ">Nan  Zhong</span>, <span class="hlFld-ContribAuthor ">Mauro  Zimmermann</span>, <span class="hlFld-ContribAuthor ">Angela  Nauer</span>, <span class="hlFld-ContribAuthor ">Davor  Bajic</span>, <span class="hlFld-ContribAuthor ">Willy  Decurtins</span>, <span class="hlFld-ContribAuthor ">Jörg  Scheuermann</span>, <span class="hlFld-ContribAuthor ">Peter J.  Brown</span>, <span class="hlFld-ContribAuthor ">Jonathan  Hall</span>, <span class="hlFld-ContribAuthor ">Susanne  Gräslund</span>, <span class="hlFld-ContribAuthor ">Herwig  Schüler</span>, <span class="hlFld-ContribAuthor ">Dario  Neri</span>, and <span class="hlFld-ContribAuthor ">Raphael M.  Franzini</span>  . </span><span class="cited-content_cbyCitation_article-title">Tankyrase 1 Inhibitors with Drug-like Properties Identified by Screening a DNA-Encoded Chemical Library. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (12)
                                     , 5143-5149. <a href="https://doi.org/10.1021/acs.jmedchem.5b00432" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00432</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00432%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTankyrase%252B1%252BInhibitors%252Bwith%252BDrug-like%252BProperties%252BIdentified%252Bby%252BScreening%252Ba%252BDNA-Encoded%252BChemical%252BLibrary%26aulast%3DSamain%26aufirst%3DFlorent%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D18032015%26date%3D10062015%26date%3D25062015%26volume%3D58%26issue%3D12%26spage%3D5143%26epage%3D5149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aurélie  Mallinger</span>, <span class="hlFld-ContribAuthor ">Simon  Crumpler</span>, <span class="hlFld-ContribAuthor ">Mark  Pichowicz</span>, <span class="hlFld-ContribAuthor ">Dennis  Waalboer</span>, <span class="hlFld-ContribAuthor ">Mark  Stubbs</span>, <span class="hlFld-ContribAuthor ">Olajumoke  Adeniji-Popoola</span>, <span class="hlFld-ContribAuthor ">Bozena  Wood</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Smith</span>, <span class="hlFld-ContribAuthor ">Ching  Thai</span>, <span class="hlFld-ContribAuthor ">Alan T.  Henley</span>, <span class="hlFld-ContribAuthor ">Katrin  Georgi</span>, <span class="hlFld-ContribAuthor ">William  Court</span>, <span class="hlFld-ContribAuthor ">Steve  Hobbs</span>, <span class="hlFld-ContribAuthor ">Gary  Box</span>, <span class="hlFld-ContribAuthor ">Maria-Jesus  Ortiz-Ruiz</span>, <span class="hlFld-ContribAuthor ">Melanie  Valenti</span>, <span class="hlFld-ContribAuthor ">Alexis  De Haven Brandon</span>, <span class="hlFld-ContribAuthor ">Robert  TePoele</span>, <span class="hlFld-ContribAuthor ">Birgitta  Leuthner</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>, <span class="hlFld-ContribAuthor ">Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">Oliver  Poeschke</span>, <span class="hlFld-ContribAuthor ">Trevor  Dale</span>, <span class="hlFld-ContribAuthor ">Dirk  Wienke</span>, <span class="hlFld-ContribAuthor ">Christina  Esdar</span>, <span class="hlFld-ContribAuthor ">Felix  Rohdich</span>, <span class="hlFld-ContribAuthor ">Florence  Raynaud</span>, <span class="hlFld-ContribAuthor ">Paul A.  Clarke</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Frank  Stieber</span>, <span class="hlFld-ContribAuthor ">Kai  Schiemann</span>, and <span class="hlFld-ContribAuthor ">Julian  Blagg</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent, Orally Bioavailable, Small-Molecule Inhibitors of WNT Signaling from a Cell-Based Pathway Screen. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (4)
                                     , 1717-1735. <a href="https://doi.org/10.1021/jm501436m" title="DOI URL">https://doi.org/10.1021/jm501436m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501436m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501436m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%25252C%252BOrally%252BBioavailable%25252C%252BSmall-Molecule%252BInhibitors%252Bof%252BWNT%252BSignaling%252Bfrom%252Ba%252BCell-Based%252BPathway%252BScreen%26aulast%3DMallinger%26aufirst%3DAur%25C3%25A9lie%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D18092014%26date%3D13022015%26date%3D26022015%26volume%3D58%26issue%3D4%26spage%3D1717%26epage%3D1735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zihao  Hua</span>, <span class="hlFld-ContribAuthor ">Howard  Bregman</span>, <span class="hlFld-ContribAuthor ">John L.  Buchanan</span>, <span class="hlFld-ContribAuthor ">Nagasree  Chakka</span>, <span class="hlFld-ContribAuthor ">Angel  Guzman-Perez</span>, <span class="hlFld-ContribAuthor ">Hakan  Gunaydin</span>, <span class="hlFld-ContribAuthor ">Xin  Huang</span>, <span class="hlFld-ContribAuthor ">Yan  Gu</span>, <span class="hlFld-ContribAuthor ">Virginia  Berry</span>, <span class="hlFld-ContribAuthor ">Jingzhou  Liu</span>, <span class="hlFld-ContribAuthor ">Yohannes  Teffera</span>, <span class="hlFld-ContribAuthor ">Liyue  Huang</span>, <span class="hlFld-ContribAuthor ">Bryan  Egge</span>, <span class="hlFld-ContribAuthor ">Renee  Emkey</span>, <span class="hlFld-ContribAuthor ">Erin L.  Mullady</span>, <span class="hlFld-ContribAuthor ">Steve  Schneider</span>, <span class="hlFld-ContribAuthor ">Paul S.  Andrews</span>, <span class="hlFld-ContribAuthor ">Lisa  Acquaviva</span>, <span class="hlFld-ContribAuthor ">Jennifer  Dovey</span>, <span class="hlFld-ContribAuthor ">Ankita  Mishra</span>, <span class="hlFld-ContribAuthor ">John  Newcomb</span>, <span class="hlFld-ContribAuthor ">Douglas  Saffran</span>, <span class="hlFld-ContribAuthor ">Randy  Serafino</span>, <span class="hlFld-ContribAuthor ">Craig A.  Strathdee</span>, <span class="hlFld-ContribAuthor ">Susan M.  Turci</span>, <span class="hlFld-ContribAuthor ">Mary  Stanton</span>, <span class="hlFld-ContribAuthor ">Cindy  Wilson</span>, and <span class="hlFld-ContribAuthor ">Erin F.  DiMauro</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Novel Dual Binders as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (24)
                                     , 10003-10015. <a href="https://doi.org/10.1021/jm401317z" title="DOI URL">https://doi.org/10.1021/jm401317z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401317z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401317z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BNovel%252BDual%252BBinders%252Bas%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BTankyrase%252BInhibitors%26aulast%3DHua%26aufirst%3DZihao%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D26082013%26date%3D11122013%26date%3D27122013%26date%3D02122013%26volume%3D56%26issue%3D24%26spage%3D10003%26epage%3D10015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anders E. G.  Lindgren</span>, <span class="hlFld-ContribAuthor ">Tobias  Karlberg</span>, <span class="hlFld-ContribAuthor ">Torun  Ekblad</span>, <span class="hlFld-ContribAuthor ">Sara  Spjut</span>, <span class="hlFld-ContribAuthor ">Ann-Gerd  Thorsell</span>, <span class="hlFld-ContribAuthor ">C. David  Andersson</span>, <span class="hlFld-ContribAuthor ">Ton Tong  Nhan</span>, <span class="hlFld-ContribAuthor ">Victor  Hellsten</span>, <span class="hlFld-ContribAuthor ">Johan  Weigelt</span>, <span class="hlFld-ContribAuthor ">Anna  Linusson</span>, <span class="hlFld-ContribAuthor ">Herwig  Schüler</span>, and <span class="hlFld-ContribAuthor ">Mikael  Elofsson</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemical Probes to Study ADP-Ribosylation: Synthesis and Biochemical Evaluation of Inhibitors of the Human ADP-Ribosyltransferase ARTD3/PARP3. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (23)
                                     , 9556-9568. <a href="https://doi.org/10.1021/jm401394u" title="DOI URL">https://doi.org/10.1021/jm401394u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401394u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401394u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemical%252BProbes%252Bto%252BStudy%252BADP-Ribosylation%25253A%252BSynthesis%252Band%252BBiochemical%252BEvaluation%252Bof%252BInhibitors%252Bof%252Bthe%252BHuman%252BADP-Ribosyltransferase%252BARTD3%25252FPARP3%26aulast%3DLindgren%26aufirst%3DAnders%2BE.%2BG.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D05072013%26date%3D22112013%26date%3D12122013%26date%3D04112013%26volume%3D56%26issue%3D23%26spage%3D9556%26epage%3D9568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael D.  Shultz</span>, <span class="hlFld-ContribAuthor ">Dyuti  Majumdar</span>, <span class="hlFld-ContribAuthor ">Donovan N.  Chin</span>, <span class="hlFld-ContribAuthor ">Pascal D.  Fortin</span>, <span class="hlFld-ContribAuthor ">Yun  Feng</span>, <span class="hlFld-ContribAuthor ">Ty  Gould</span>, <span class="hlFld-ContribAuthor ">Christina A.  Kirby</span>, <span class="hlFld-ContribAuthor ">Travis  Stams</span>, <span class="hlFld-ContribAuthor ">Nigel J.  Waters</span>, and <span class="hlFld-ContribAuthor ">Wenlin  Shao</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Efficiency Relationship of [1,2,4]Triazol-3-ylamines as Novel Nicotinamide Isosteres that Inhibit Tankyrases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (17)
                                     , 7049-7059. <a href="https://doi.org/10.1021/jm400826j" title="DOI URL">https://doi.org/10.1021/jm400826j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400826j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400826j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Efficiency%252BRelationship%252Bof%252B%25255B1%25252C2%25252C4%25255DTriazol-3-ylamines%252Bas%252BNovel%252BNicotinamide%252BIsosteres%252Bthat%252BInhibit%252BTankyrases%26aulast%3DShultz%26aufirst%3DMichael%2BD.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D03062013%26date%3D14082013%26date%3D12092013%26date%3D23072013%26volume%3D56%26issue%3D17%26spage%3D7049%26epage%3D7059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esteban  Zamudio-Martinez</span>, <span class="hlFld-ContribAuthor ">Ana Belén  Herrera-Campos</span>, <span class="hlFld-ContribAuthor ">Alberto  Muñoz</span>, <span class="hlFld-ContribAuthor ">José Manuel  Rodríguez-Vargas</span>, <span class="hlFld-ContribAuthor ">F. Javier  Oliver</span>. </span><span class="cited-content_cbyCitation_article-title">Tankyrases as modulators of pro-tumoral functions: molecular insights and therapeutic opportunities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2021,</strong> <em>40 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-021-01950-6" title="DOI URL">https://doi.org/10.1186/s13046-021-01950-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-021-01950-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-021-01950-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DTankyrases%252Bas%252Bmodulators%252Bof%252Bpro-tumoral%252Bfunctions%25253A%252Bmolecular%252Binsights%252Band%252Btherapeutic%252Bopportunities%26aulast%3DZamudio-Martinez%26aufirst%3DEsteban%26date%3D2021%26date%3D2021%26volume%3D40%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chirag C.  Mehta</span>, <span class="hlFld-ContribAuthor ">Hardik G.  Bhatt</span>. </span><span class="cited-content_cbyCitation_article-title">Tankyrase inhibitors as antitumor agents: a patent update (2013 – 2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (7)
                                     , 645-661. <a href="https://doi.org/10.1080/13543776.2021.1888929" title="DOI URL">https://doi.org/10.1080/13543776.2021.1888929</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1888929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1888929%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTankyrase%252Binhibitors%252Bas%252Bantitumor%252Bagents%25253A%252Ba%252Bpatent%252Bupdate%252B%2525282013%252B%2525E2%252580%252593%252B2020%252529%26aulast%3DMehta%26aufirst%3DChirag%2BC.%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D7%26spage%3D645%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hwani  Ryu</span>, <span class="hlFld-ContribAuthor ">Ky-Youb  Nam</span>, <span class="hlFld-ContribAuthor ">Hyo Jeong  Kim</span>, <span class="hlFld-ContribAuthor ">Jie-Young  Song</span>, <span class="hlFld-ContribAuthor ">Sang-Gu  Hwang</span>, <span class="hlFld-ContribAuthor ">Jae Sung  Kim</span>, <span class="hlFld-ContribAuthor ">Joon  Kim</span>, <span class="hlFld-ContribAuthor ">Jiyeon  Ahn</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Triazolopyridine Derivative as a Tankyrase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (14)
                                     , 7330. <a href="https://doi.org/10.3390/ijms22147330" title="DOI URL">https://doi.org/10.3390/ijms22147330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22147330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22147330%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BTriazolopyridine%252BDerivative%252Bas%252Ba%252BTankyrase%252BInhibitor%26aulast%3DRyu%26aufirst%3DHwani%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D14%26spage%3D7330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Line  Mygland</span>, <span class="hlFld-ContribAuthor ">Shoshy Alam  Brinch</span>, <span class="hlFld-ContribAuthor ">Martin Frank  Strand</span>, <span class="hlFld-ContribAuthor ">Petter Angell  Olsen</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Aizenshtadt</span>, <span class="hlFld-ContribAuthor ">Kaja  Lund</span>, <span class="hlFld-ContribAuthor ">Nina Therese  Solberg</span>, <span class="hlFld-ContribAuthor ">Max  Lycke</span>, <span class="hlFld-ContribAuthor ">Tor Espen  Thorvaldsen</span>, <span class="hlFld-ContribAuthor ">Sandra  Espada</span>, <span class="hlFld-ContribAuthor ">Dorna  Misaghian</span>, <span class="hlFld-ContribAuthor ">Christian M.  Page</span>, <span class="hlFld-ContribAuthor ">Oleg  Agafonov</span>, <span class="hlFld-ContribAuthor ">Ståle  Nygård</span>, <span class="hlFld-ContribAuthor ">Nai-Wen  Chi</span>, <span class="hlFld-ContribAuthor ">Eva  Lin</span>, <span class="hlFld-ContribAuthor ">Jenille  Tan</span>, <span class="hlFld-ContribAuthor ">Yihong  Yu</span>, <span class="hlFld-ContribAuthor ">Mike  Costa</span>, <span class="hlFld-ContribAuthor ">Stefan  Krauss</span>, <span class="hlFld-ContribAuthor ">Jo  Waaler</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines. </span><span class="cited-content_cbyCitation_journal-name">iScience</span><span> <strong>2021,</strong> <em>24 </em>
                                    (7)
                                     , 102807. <a href="https://doi.org/10.1016/j.isci.2021.102807" title="DOI URL">https://doi.org/10.1016/j.isci.2021.102807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.isci.2021.102807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.isci.2021.102807%26sid%3Dliteratum%253Aachs%26jtitle%3DiScience%26atitle%3DIdentification%252Bof%252Bresponse%252Bsignatures%252Bfor%252Btankyrase%252Binhibitor%252Btreatment%252Bin%252Btumor%252Bcell%252Blines%26aulast%3DMygland%26aufirst%3DLine%26date%3D2021%26volume%3D24%26issue%3D7%26spage%3D102807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anu  Verma</span>, <span class="hlFld-ContribAuthor ">Ashwani  Kumar</span>, <span class="hlFld-ContribAuthor ">Arshiya  Chugh</span>, <span class="hlFld-ContribAuthor ">Sunil  Kumar</span>, <span class="hlFld-ContribAuthor ">Parvin  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Tankyrase inhibitors: emerging and promising therapeutics for cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (1)
                                     , 50-73. <a href="https://doi.org/10.1007/s00044-020-02657-7" title="DOI URL">https://doi.org/10.1007/s00044-020-02657-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02657-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02657-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DTankyrase%252Binhibitors%25253A%252Bemerging%252Band%252Bpromising%252Btherapeutics%252Bfor%252Bcancer%252Btreatment%26aulast%3DVerma%26aufirst%3DAnu%26date%3D2021%26date%3D2020%26volume%3D30%26issue%3D1%26spage%3D50%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhumika  Patel</span>, <span class="hlFld-ContribAuthor ">Ankitkumar  Patel</span>, <span class="hlFld-ContribAuthor ">Abhishek  Patel</span>, <span class="hlFld-ContribAuthor ">Hardik  Bhatt</span>. </span><span class="cited-content_cbyCitation_article-title">CoMFA, CoMSIA, molecular docking and MOLCAD studies of pyrimidinone derivatives to design novel and selective tankyrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1221 </em>, 128783. <a href="https://doi.org/10.1016/j.molstruc.2020.128783" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.128783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.128783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.128783%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DCoMFA%25252C%252BCoMSIA%25252C%252Bmolecular%252Bdocking%252Band%252BMOLCAD%252Bstudies%252Bof%252Bpyrimidinone%252Bderivatives%252Bto%252Bdesign%252Bnovel%252Band%252Bselective%252Btankyrase%252Binhibitors%26aulast%3DPatel%26aufirst%3DBhumika%26date%3D2020%26volume%3D1221%26spage%3D128783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nuha  Almasoud</span>, <span class="hlFld-ContribAuthor ">Sarah  Binhamdan</span>, <span class="hlFld-ContribAuthor ">Ghaydaa  Younis</span>, <span class="hlFld-ContribAuthor ">Hanouf  Alaskar</span>, <span class="hlFld-ContribAuthor ">Amal  Alotaibi</span>, <span class="hlFld-ContribAuthor ">Muthurangan  Manikandan</span>, <span class="hlFld-ContribAuthor ">Musaad  Alfayez</span>, <span class="hlFld-ContribAuthor ">Moustapha  Kassem</span>, <span class="hlFld-ContribAuthor ">Nihal  AlMuraikhi</span>. </span><span class="cited-content_cbyCitation_article-title">Tankyrase inhibitor XAV-939 enhances osteoblastogenesis and mineralization of human skeletal (mesenchymal) stem cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-73439-9" title="DOI URL">https://doi.org/10.1038/s41598-020-73439-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-73439-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-73439-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DTankyrase%252Binhibitor%252BXAV-939%252Benhances%252Bosteoblastogenesis%252Band%252Bmineralization%252Bof%252Bhuman%252Bskeletal%252B%252528mesenchymal%252529%252Bstem%252Bcells%26aulast%3DAlmasoud%26aufirst%3DNuha%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiufang  Xu</span>, <span class="hlFld-ContribAuthor ">Miaofeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Faying  Xu</span>, <span class="hlFld-ContribAuthor ">Shaojie  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer</span><span> <strong>2020,</strong> <em>19 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12943-020-01276-5" title="DOI URL">https://doi.org/10.1186/s12943-020-01276-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12943-020-01276-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12943-020-01276-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%26atitle%3DWnt%252Bsignaling%252Bin%252Bbreast%252Bcancer%25253A%252Bbiological%252Bmechanisms%25252C%252Bchallenges%252Band%252Bopportunities%26aulast%3DXu%26aufirst%3DXiufang%26date%3D2020%26date%3D2020%26volume%3D19%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luned M.  Badder</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Hollins</span>, <span class="hlFld-ContribAuthor ">Bram  Herpers</span>, <span class="hlFld-ContribAuthor ">Kuan  Yan</span>, <span class="hlFld-ContribAuthor ">Kenneth B.  Ewan</span>, <span class="hlFld-ContribAuthor ">Mairian  Thomas</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Shone</span>, <span class="hlFld-ContribAuthor ">Delyth A.  Badder</span>, <span class="hlFld-ContribAuthor ">Marc  Naven</span>, <span class="hlFld-ContribAuthor ">Kevin E.  Ashelford</span>, <span class="hlFld-ContribAuthor ">Rachel  Hargest</span>, <span class="hlFld-ContribAuthor ">Alan R.  Clarke</span>, <span class="hlFld-ContribAuthor ">Christina  Esdar</span>, <span class="hlFld-ContribAuthor ">Hans-Peter  Buchstaller</span>, <span class="hlFld-ContribAuthor ">J. Mark  Treherne</span>, <span class="hlFld-ContribAuthor ">Sylvia  Boj</span>, <span class="hlFld-ContribAuthor ">Bahar  Ramezanpour</span>, <span class="hlFld-ContribAuthor ">Dirk  Wienke</span>, <span class="hlFld-ContribAuthor ">Leo S.  Price</span>, <span class="hlFld-ContribAuthor ">Paul H.  Shaw</span>, <span class="hlFld-ContribAuthor ">Trevor C.  Dale</span>, . </span><span class="cited-content_cbyCitation_article-title">3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2020,</strong> <em>15 </em>
                                    (8)
                                     , e0235319. <a href="https://doi.org/10.1371/journal.pone.0235319" title="DOI URL">https://doi.org/10.1371/journal.pone.0235319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0235319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0235319%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3D3D%252Bimaging%252Bof%252Bcolorectal%252Bcancer%252Borganoids%252Bidentifies%252Bresponses%252Bto%252BTankyrase%252Binhibitors%26aulast%3DBadder%26aufirst%3DLuned%2BM.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D8%26spage%3De0235319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Zhong</span>, <span class="hlFld-ContribAuthor ">David M.  Virshup</span>. </span><span class="cited-content_cbyCitation_article-title">Wnt Signaling and Drug Resistance in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2020,</strong> <em>97 </em>
                                    (2)
                                     , 72-89. <a href="https://doi.org/10.1124/mol.119.117978" title="DOI URL">https://doi.org/10.1124/mol.119.117978</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.119.117978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.119.117978%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DWnt%252BSignaling%252Band%252BDrug%252BResistance%252Bin%252BCancer%26aulast%3DZhong%26aufirst%3DZheng%26date%3D2020%26date%3D2019%26volume%3D97%26issue%3D2%26spage%3D72%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malini  Menon</span>, <span class="hlFld-ContribAuthor ">Richard  Elliott</span>, <span class="hlFld-ContribAuthor ">Leandra  Bowers</span>, <span class="hlFld-ContribAuthor ">Nicolae  Balan</span>, <span class="hlFld-ContribAuthor ">Rumana  Rafiq</span>, <span class="hlFld-ContribAuthor ">Sara  Costa-Cabral</span>, <span class="hlFld-ContribAuthor ">Felix  Munkonge</span>, <span class="hlFld-ContribAuthor ">Ines  Trinidade</span>, <span class="hlFld-ContribAuthor ">Roderick  Porter</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Campbell</span>, <span class="hlFld-ContribAuthor ">Emma R.  Johnson</span>, <span class="hlFld-ContribAuthor ">Christina  Esdar</span>, <span class="hlFld-ContribAuthor ">Hans-Peter  Buchstaller</span>, <span class="hlFld-ContribAuthor ">Birgitta  Leuthner</span>, <span class="hlFld-ContribAuthor ">Felix  Rohdich</span>, <span class="hlFld-ContribAuthor ">Richard  Schneider</span>, <span class="hlFld-ContribAuthor ">Owen  Sansom</span>, <span class="hlFld-ContribAuthor ">Dirk  Wienke</span>, <span class="hlFld-ContribAuthor ">Alan  Ashworth</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Lord</span>. </span><span class="cited-content_cbyCitation_article-title">A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-36447-4" title="DOI URL">https://doi.org/10.1038/s41598-018-36447-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-36447-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-36447-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252Bnovel%252Btankyrase%252Binhibitor%25252C%252BMSC2504877%25252C%252Benhances%252Bthe%252Beffects%252Bof%252Bclinical%252BCDK4%25252F6%252Binhibitors%26aulast%3DMenon%26aufirst%3DMalini%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarfaraz  Alam</span>, <span class="hlFld-ContribAuthor ">Feroz  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR, Docking, ADME/Tox studies on Flavone analogs reveal anticancer activity through Tankyrase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-41984-7" title="DOI URL">https://doi.org/10.1038/s41598-019-41984-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-41984-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-41984-7%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3D3D-QSAR%25252C%252BDocking%25252C%252BADME%25252FTox%252Bstudies%252Bon%252BFlavone%252Banalogs%252Breveal%252Banticancer%252Bactivity%252Bthrough%252BTankyrase%252Binhibition%26aulast%3DAlam%26aufirst%3DSarfaraz%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin  Dzobo</span>, <span class="hlFld-ContribAuthor ">Nicholas Ekow  Thomford</span>, <span class="hlFld-ContribAuthor ">Dimakatso A.  Senthebane</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy. </span><span class="cited-content_cbyCitation_journal-name">OMICS: A Journal of Integrative Biology</span><span> <strong>2019,</strong> <em>23 </em>
                                    (11)
                                     , 517-538. <a href="https://doi.org/10.1089/omi.2019.0147" title="DOI URL">https://doi.org/10.1089/omi.2019.0147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/omi.2019.0147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fomi.2019.0147%26sid%3Dliteratum%253Aachs%26jtitle%3DOMICS%253A%2520A%2520Journal%2520of%2520Integrative%2520Biology%26atitle%3DTargeting%252Bthe%252BVersatile%252BWnt%25252F%2525CE%2525B2-Catenin%252BPathway%252Bin%252BCancer%252BBiology%252Band%252BTherapeutics%25253A%252BFrom%252BConcept%252Bto%252BActionable%252BStrategy%26aulast%3DDzobo%26aufirst%3DKevin%26date%3D2019%26volume%3D23%26issue%3D11%26spage%3D517%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoyuki  Mukai</span>, <span class="hlFld-ContribAuthor ">Shunichi  Fujita</span>, <span class="hlFld-ContribAuthor ">Yoshitaka  Morita</span>. </span><span class="cited-content_cbyCitation_article-title">Tankyrase (PARP5) Inhibition Induces Bone Loss through Accumulation of Its Substrate SH3BP2. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2019,</strong> <em>8 </em>
                                    (2)
                                     , 195. <a href="https://doi.org/10.3390/cells8020195" title="DOI URL">https://doi.org/10.3390/cells8020195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells8020195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells8020195%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DTankyrase%252B%252528PARP5%252529%252BInhibition%252BInduces%252BBone%252BLoss%252Bthrough%252BAccumulation%252Bof%252BIts%252BSubstrate%252BSH3BP2%26aulast%3DMukai%26aufirst%3DTomoyuki%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D2%26spage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wendy A.  Loughlin</span>, <span class="hlFld-ContribAuthor ">Asmaa  Boufridi</span>. </span><span class="cited-content_cbyCitation_article-title">6-6 Bicyclic Systems: Three Heteroatoms 1:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14794-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14794-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14794-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14794-8%26sid%3Dliteratum%253Aachs%26atitle%3D6-6%252BBicyclic%252BSystems%25253A%252BThree%252BHeteroatoms%252B1%25253A2%26aulast%3DLoughlin%26aufirst%3DWendy%2BA.%26date%3D2019%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Palazzo</span>, <span class="hlFld-ContribAuthor ">Ivan  Ahel</span>. </span><span class="cited-content_cbyCitation_article-title">PARPs in genome stability and signal transduction: implications for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Society Transactions</span><span> <strong>2018,</strong> <em>46 </em>
                                    (6)
                                     , 1681-1695. <a href="https://doi.org/10.1042/BST20180418" title="DOI URL">https://doi.org/10.1042/BST20180418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BST20180418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBST20180418%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Society%2520Transactions%26atitle%3DPARPs%252Bin%252Bgenome%252Bstability%252Band%252Bsignal%252Btransduction%25253A%252Bimplications%252Bfor%252Bcancer%252Btherapy%26aulast%3DPalazzo%26aufirst%3DLuca%26date%3D2018%26date%3D2018%26volume%3D46%26issue%3D6%26spage%3D1681%26epage%3D1695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Mizutani</span>, <span class="hlFld-ContribAuthor ">Yoko  Yashiroda</span>, <span class="hlFld-ContribAuthor ">Yukiko  Muramatsu</span>, <span class="hlFld-ContribAuthor ">Haruka  Yoshida</span>, <span class="hlFld-ContribAuthor ">Tsubasa  Chikada</span>, <span class="hlFld-ContribAuthor ">Takeshi  Tsumura</span>, <span class="hlFld-ContribAuthor ">Masayuki  Okue</span>, <span class="hlFld-ContribAuthor ">Fumiyuki  Shirai</span>, <span class="hlFld-ContribAuthor ">Takehiro  Fukami</span>, <span class="hlFld-ContribAuthor ">Minoru  Yoshida</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Seimiya</span>. </span><span class="cited-content_cbyCitation_article-title">RK
              ‐287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2018,</strong> <em>109 </em>
                                    (12)
                                     , 4003-4014. <a href="https://doi.org/10.1111/cas.13805" title="DOI URL">https://doi.org/10.1111/cas.13805</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.13805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.13805%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DRK%252B%2525E2%252580%252590287107%25252C%252Ba%252Bpotent%252Band%252Bspecific%252Btankyrase%252Binhibitor%25252C%252Bblocks%252Bcolorectal%252Bcancer%252Bcell%252Bgrowth%252Bin%252Ba%252Bpreclinical%252Bmodel%26aulast%3DMizutani%26aufirst%3DAnna%26date%3D2018%26date%3D2018%26volume%3D109%26issue%3D12%26spage%3D4003%26epage%3D4014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keiji  Okamoto</span>, <span class="hlFld-ContribAuthor ">Tomokazu  Ohishi</span>, <span class="hlFld-ContribAuthor ">Mika  Kuroiwa</span>, <span class="hlFld-ContribAuthor ">Shun-ichiro  Iemura</span>, <span class="hlFld-ContribAuthor ">Tohru  Natsume</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Seimiya</span>. </span><span class="cited-content_cbyCitation_article-title">MERIT40-dependent recruitment of tankyrase to damaged DNA and its implication for cell sensitivity to DNA-damaging anticancer drugs. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (88)
                                     , 35844-35855. <a href="https://doi.org/10.18632/oncotarget.26312" title="DOI URL">https://doi.org/10.18632/oncotarget.26312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.26312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.26312%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DMERIT40-dependent%252Brecruitment%252Bof%252Btankyrase%252Bto%252Bdamaged%252BDNA%252Band%252Bits%252Bimplication%252Bfor%252Bcell%252Bsensitivity%252Bto%252BDNA-damaging%252Banticancer%252Bdrugs%26aulast%3DOkamoto%26aufirst%3DKeiji%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D88%26spage%3D35844%26epage%3D35855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masaru  Katoh</span>. </span><span class="cited-content_cbyCitation_article-title">Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review). </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Medicine</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.3892/ijmm.2018.3689" title="DOI URL">https://doi.org/10.3892/ijmm.2018.3689</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ijmm.2018.3689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fijmm.2018.3689%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Medicine%26atitle%3DMulti%2525E2%252580%252591layered%252Bprevention%252Band%252Btreatment%252Bof%252Bchronic%252Binflammation%25252C%252Borgan%252Bfibrosis%252Band%252Bcancer%252Bassociated%252Bwith%252Bcanonical%252BWNT%25252F%2525CE%2525B2%2525E2%252580%252591catenin%252Bsignaling%252Bactivation%252B%252528Review%252529%26aulast%3DKatoh%26aufirst%3DMasaru%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sébastien  Foulquier</span>, <span class="hlFld-ContribAuthor ">Evangelos P.  Daskalopoulos</span>, <span class="hlFld-ContribAuthor ">Gentian  Lluri</span>, <span class="hlFld-ContribAuthor ">Kevin C. M.  Hermans</span>, <span class="hlFld-ContribAuthor ">Arjun  Deb</span>, <span class="hlFld-ContribAuthor ">W. Matthijs  Blankesteijn</span>, . </span><span class="cited-content_cbyCitation_article-title">WNT Signaling in Cardiac and Vascular Disease. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2018,</strong> <em>70 </em>
                                    (1)
                                     , 68-141. <a href="https://doi.org/10.1124/pr.117.013896" title="DOI URL">https://doi.org/10.1124/pr.117.013896</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.117.013896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.117.013896%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DWNT%252BSignaling%252Bin%252BCardiac%252Band%252BVascular%252BDisease%26aulast%3DFoulquier%26aufirst%3DS%25C3%25A9bastien%26date%3D2018%26date%3D2017%26volume%3D70%26issue%3D1%26spage%3D68%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martina  Ferri</span>, <span class="hlFld-ContribAuthor ">Paride  Liscio</span>, <span class="hlFld-ContribAuthor ">Andrea  Carotti</span>, <span class="hlFld-ContribAuthor ">Stefania  Asciutti</span>, <span class="hlFld-ContribAuthor ">Roccaldo  Sardella</span>, <span class="hlFld-ContribAuthor ">Antonio  Macchiarulo</span>, <span class="hlFld-ContribAuthor ">Emidio  Camaioni</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>142 </em>, 506-522. <a href="https://doi.org/10.1016/j.ejmech.2017.09.030" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.09.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.09.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BWnt-driven%252Bcancers%25253A%252BDiscovery%252Bof%252Bnovel%252Btankyrase%252Binhibitors%26aulast%3DFerri%26aufirst%3DMartina%26date%3D2017%26volume%3D142%26spage%3D506%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Mariotti</span>, <span class="hlFld-ContribAuthor ">Katie  Pollock</span>, <span class="hlFld-ContribAuthor ">Sebastian  Guettler</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2017,</strong> <em>174 </em>
                                    (24)
                                     , 4611-4636. <a href="https://doi.org/10.1111/bph.14038" title="DOI URL">https://doi.org/10.1111/bph.14038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14038%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DRegulation%252Bof%252BWnt%25252F%2525CE%2525B2-catenin%252Bsignalling%252Bby%252Btankyrase-dependent%252Bpoly%252528ADP-ribosyl%252529ation%252Band%252Bscaffolding%26aulast%3DMariotti%26aufirst%3DLaura%26date%3D2017%26date%3D2017%26volume%3D174%26issue%3D24%26spage%3D4611%26epage%3D4636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Virginia  Murillo-Garzón</span>, <span class="hlFld-ContribAuthor ">Robert  Kypta</span>. </span><span class="cited-content_cbyCitation_article-title">WNT signalling in prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Urology</span><span> <strong>2017,</strong> <em>14 </em>
                                    (11)
                                     , 683-696. <a href="https://doi.org/10.1038/nrurol.2017.144" title="DOI URL">https://doi.org/10.1038/nrurol.2017.144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrurol.2017.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrurol.2017.144%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Urology%26atitle%3DWNT%252Bsignalling%252Bin%252Bprostate%252Bcancer%26aulast%3DMurillo-Garz%25C3%25B3n%26aufirst%3DVirginia%26date%3D2017%26date%3D2017%26volume%3D14%26issue%3D11%26spage%3D683%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tor Espen  Thorvaldsen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Tankyrase to Fight WNT-dependent Tumours. </span><span class="cited-content_cbyCitation_journal-name">Basic & Clinical Pharmacology & Toxicology</span><span> <strong>2017,</strong> <em>121 </em>
                                    (2)
                                     , 81-88. <a href="https://doi.org/10.1111/bcpt.12786" title="DOI URL">https://doi.org/10.1111/bcpt.12786</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bcpt.12786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbcpt.12786%26sid%3Dliteratum%253Aachs%26jtitle%3DBasic%2520%2526%2520Clinical%2520Pharmacology%2520%2526%2520Toxicology%26atitle%3DTargeting%252BTankyrase%252Bto%252BFight%252BWNT-dependent%252BTumours%26aulast%3DThorvaldsen%26aufirst%3DTor%2BEspen%26date%3D2017%26date%3D2017%26volume%3D121%26issue%3D2%26spage%3D81%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Ji</span>, <span class="hlFld-ContribAuthor ">Bo  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiaomo  Jiang</span>, <span class="hlFld-ContribAuthor ">Olga  Charlat</span>, <span class="hlFld-ContribAuthor ">Amy  Chen</span>, <span class="hlFld-ContribAuthor ">Craig  Mickanin</span>, <span class="hlFld-ContribAuthor ">Andreas  Bauer</span>, <span class="hlFld-ContribAuthor ">Wenqing  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoxue  Yan</span>, <span class="hlFld-ContribAuthor ">Feng  Cong</span>. </span><span class="cited-content_cbyCitation_article-title">The SIAH E3 ubiquitin ligases promote Wnt/β-catenin signaling through mediating Wnt-induced Axin degradation. </span><span class="cited-content_cbyCitation_journal-name">Genes & Development</span><span> <strong>2017,</strong> <em>31 </em>
                                    (9)
                                     , 904-915. <a href="https://doi.org/10.1101/gad.300053.117" title="DOI URL">https://doi.org/10.1101/gad.300053.117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/gad.300053.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fgad.300053.117%26sid%3Dliteratum%253Aachs%26jtitle%3DGenes%2520%2526%2520Development%26atitle%3DThe%252BSIAH%252BE3%252Bubiquitin%252Bligases%252Bpromote%252BWnt%25252F%2525CE%2525B2-catenin%252Bsignaling%252Bthrough%252Bmediating%252BWnt-induced%252BAxin%252Bdegradation%26aulast%3DJi%26aufirst%3DLei%26date%3D2017%26date%3D2017%26volume%3D31%26issue%3D9%26spage%3D904%26epage%3D915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tesshi  Yamada</span>, <span class="hlFld-ContribAuthor ">Mari  Masuda</span>. </span><span class="cited-content_cbyCitation_article-title">Emergence of TNIK inhibitors in cancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2017,</strong> <em>108 </em>
                                    (5)
                                     , 818-823. <a href="https://doi.org/10.1111/cas.13203" title="DOI URL">https://doi.org/10.1111/cas.13203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.13203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.13203%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DEmergence%252Bof%252BTNIK%252Binhibitors%252Bin%252Bcancer%252Btherapeutics%26aulast%3DYamada%26aufirst%3DTesshi%26date%3D2017%26date%3D2017%26volume%3D108%26issue%3D5%26spage%3D818%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lien-Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Tsung-Chih  Chen</span>, <span class="hlFld-ContribAuthor ">Shiag-Jiun  Chen</span>, <span class="hlFld-ContribAuthor ">Chun-Liang  Chen</span>, <span class="hlFld-ContribAuthor ">Chia-Chung  Lee</span>, <span class="hlFld-ContribAuthor ">Shih-Hsiung  Wu</span>, <span class="hlFld-ContribAuthor ">Yun  Yen</span>, <span class="hlFld-ContribAuthor ">Hsu-Shan  Huang</span>, <span class="hlFld-ContribAuthor ">Jing-Jer  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a new class of
              WNT1
              inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (42)
                                     , 67986-68001. <a href="https://doi.org/10.18632/oncotarget.6622" title="DOI URL">https://doi.org/10.18632/oncotarget.6622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.6622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.6622%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DIdentification%252Bof%252Ba%252Bnew%252Bclass%252Bof%252BWNT1%252Binhibitor%25253A%252BCancer%252Bcells%252Bmigration%25252C%252BG-quadruplex%252Bstabilization%252Band%252Btarget%252Bvalidation%26aulast%3DChang%26aufirst%3DLien-Cheng%26date%3D2016%26date%3D2015%26volume%3D7%26issue%3D42%26spage%3D67986%26epage%3D68001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit  Nathubhai</span>, <span class="hlFld-ContribAuthor ">Teemu  Haikarainen</span>, <span class="hlFld-ContribAuthor ">Penelope C.  Hayward</span>, <span class="hlFld-ContribAuthor ">Silvia  Muñoz-Descalzo</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Thompson</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Lloyd</span>, <span class="hlFld-ContribAuthor ">Lari  Lehtiö</span>, <span class="hlFld-ContribAuthor ">Michael D.  Threadgill</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>118 </em>, 316-327. <a href="https://doi.org/10.1016/j.ejmech.2016.04.041" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.04.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.04.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.04.041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationships%252Bof%252B2-arylquinazolin-4-ones%252Bas%252Bhighly%252Bselective%252Band%252Bpotent%252Binhibitors%252Bof%252Bthe%252Btankyrases%26aulast%3DNathubhai%26aufirst%3DAmit%26date%3D2016%26volume%3D118%26spage%3D316%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryoko  Okada-Iwasaki</span>, <span class="hlFld-ContribAuthor ">Yuichi  Takahashi</span>, <span class="hlFld-ContribAuthor ">Yasuo  Watanabe</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Ishida</span>, <span class="hlFld-ContribAuthor ">Jun-ichi  Saito</span>, <span class="hlFld-ContribAuthor ">Ryuichiro  Nakai</span>, <span class="hlFld-ContribAuthor ">Akira  Asai</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2016,</strong> <em>15 </em>
                                    (7)
                                     , 1525-1534. <a href="https://doi.org/10.1158/1535-7163.MCT-15-0938" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-15-0938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-15-0938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-15-0938%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DThe%252BDiscovery%252Band%252BCharacterization%252Bof%252BK-756%25252C%252Ba%252BNovel%252BWnt%25252F%2525CE%2525B2-Catenin%252BPathway%252BInhibitor%252BTargeting%252BTankyrase%26aulast%3DOkada-Iwasaki%26aufirst%3DRyoko%26date%3D2016%26date%3D2016%26volume%3D15%26issue%3D7%26spage%3D1525%26epage%3D1534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Bo  Lu</span>, <span class="hlFld-ContribAuthor ">Johnny  Castillo</span>, <span class="hlFld-ContribAuthor ">Yue  Zhang</span>, <span class="hlFld-ContribAuthor ">Zinger  Yang</span>, <span class="hlFld-ContribAuthor ">Gregory  McAllister</span>, <span class="hlFld-ContribAuthor ">Alicia  Lindeman</span>, <span class="hlFld-ContribAuthor ">John  Reece-Hoyes</span>, <span class="hlFld-ContribAuthor ">John  Tallarico</span>, <span class="hlFld-ContribAuthor ">Carsten  Russ</span>, <span class="hlFld-ContribAuthor ">Greg  Hoffman</span>, <span class="hlFld-ContribAuthor ">Wenqing  Xu</span>, <span class="hlFld-ContribAuthor ">Markus  Schirle</span>, <span class="hlFld-ContribAuthor ">Feng  Cong</span>. </span><span class="cited-content_cbyCitation_article-title">Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP Signaling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2016,</strong> <em>291 </em>
                                    (29)
                                     , 15256-15266. <a href="https://doi.org/10.1074/jbc.M116.722967" title="DOI URL">https://doi.org/10.1074/jbc.M116.722967</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M116.722967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M116.722967%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DTankyrase%252BInhibitor%252BSensitizes%252BLung%252BCancer%252BCells%252Bto%252BEndothelial%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BInhibition%252Bvia%252BStabilizing%252BAngiomotins%252Band%252BInhibiting%252BYAP%252BSignaling%26aulast%3DWang%26aufirst%3DHui%26date%3D2016%26volume%3D291%26issue%3D29%26spage%3D15256%26epage%3D15266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oriol  Arqués</span>, <span class="hlFld-ContribAuthor ">Irene  Chicote</span>, <span class="hlFld-ContribAuthor ">Isabel  Puig</span>, <span class="hlFld-ContribAuthor ">Stephan P.  Tenbaum</span>, <span class="hlFld-ContribAuthor ">Guillem  Argilés</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Dienstmann</span>, <span class="hlFld-ContribAuthor ">Natalia  Fernández</span>, <span class="hlFld-ContribAuthor ">Ginevra  Caratù</span>, <span class="hlFld-ContribAuthor ">Judit  Matito</span>, <span class="hlFld-ContribAuthor ">Daniel  Silberschmidt</span>, <span class="hlFld-ContribAuthor ">Jordi  Rodon</span>, <span class="hlFld-ContribAuthor ">Stefania  Landolfi</span>, <span class="hlFld-ContribAuthor ">Aleix  Prat</span>, <span class="hlFld-ContribAuthor ">Eloy  Espín</span>, <span class="hlFld-ContribAuthor ">Ramón  Charco</span>, <span class="hlFld-ContribAuthor ">Paolo  Nuciforo</span>, <span class="hlFld-ContribAuthor ">Ana  Vivancos</span>, <span class="hlFld-ContribAuthor ">Wenlin  Shao</span>, <span class="hlFld-ContribAuthor ">Josep  Tabernero</span>, <span class="hlFld-ContribAuthor ">Héctor G.  Palmer</span>. </span><span class="cited-content_cbyCitation_article-title">Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2016,</strong> <em>22 </em>
                                    (3)
                                     , 644-656. <a href="https://doi.org/10.1158/1078-0432.CCR-14-3081" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-14-3081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-14-3081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-14-3081%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DTankyrase%252BInhibition%252BBlocks%252BWnt%25252F%2525CE%2525B2-Catenin%252BPathway%252Band%252BReverts%252BResistance%252Bto%252BPI3K%252Band%252BAKT%252BInhibitors%252Bin%252Bthe%252BTreatment%252Bof%252BColorectal%252BCancer%26aulast%3DArqu%25C3%25A9s%26aufirst%3DOriol%26date%3D2016%26date%3D2015%26volume%3D22%26issue%3D3%26spage%3D644%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teemu  Haikarainen</span>, <span class="hlFld-ContribAuthor ">Jo  Waaler</span>, <span class="hlFld-ContribAuthor ">Alexander  Ignatev</span>, <span class="hlFld-ContribAuthor ">Yves  Nkizinkiko</span>, <span class="hlFld-ContribAuthor ">Harikanth  Venkannagari</span>, <span class="hlFld-ContribAuthor ">Ezeogo  Obaji</span>, <span class="hlFld-ContribAuthor ">Stefan  Krauss</span>, <span class="hlFld-ContribAuthor ">Lari  Lehtiö</span>. </span><span class="cited-content_cbyCitation_article-title">Development and structural analysis of adenosine site binding tankyrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (2)
                                     , 328-333. <a href="https://doi.org/10.1016/j.bmcl.2015.12.018" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.12.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.12.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Band%252Bstructural%252Banalysis%252Bof%252Badenosine%252Bsite%252Bbinding%252Btankyrase%252Binhibitors%26aulast%3DHaikarainen%26aufirst%3DTeemu%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D328%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shilong  Zheng</span>, <span class="hlFld-ContribAuthor ">Jiawang  Liu</span>, <span class="hlFld-ContribAuthor ">Yanyuan  Wu</span>, <span class="hlFld-ContribAuthor ">Tien L  Huang</span>, <span class="hlFld-ContribAuthor ">Guangdi  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (18)
                                     , 2485-2505. <a href="https://doi.org/10.4155/fmc.15.159" title="DOI URL">https://doi.org/10.4155/fmc.15.159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.15.159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.15.159%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSmall-molecule%252Binhibitors%252Bof%252BWnt%252Bsignaling%252Bpathway%25253A%252Btowards%252Bnovel%252Banticancer%252Btherapeutics%26aulast%3DZheng%26aufirst%3DShilong%26date%3D2015%26volume%3D7%26issue%3D18%26spage%3D2485%26epage%3D2505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mari  Masuda</span>, <span class="hlFld-ContribAuthor ">Masaaki  Sawa</span>, <span class="hlFld-ContribAuthor ">Tesshi  Yamada</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2015,</strong> <em>156 </em>, 1-9. <a href="https://doi.org/10.1016/j.pharmthera.2015.10.009" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2015.10.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2015.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2015.10.009%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DTherapeutic%252Btargets%252Bin%252Bthe%252BWnt%252Bsignaling%252Bpathway%25253A%252BFeasibility%252Bof%252Btargeting%252BTNIK%252Bin%252Bcolorectal%252Bcancer%26aulast%3DMasuda%26aufirst%3DMari%26date%3D2015%26volume%3D156%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Ma</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Jia</span>, <span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Mei-Sze  Chua</span>, <span class="hlFld-ContribAuthor ">Samuel  So</span>. </span><span class="cited-content_cbyCitation_article-title">Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2015,</strong> <em>6 </em>
                                    (28)
                                     , 25390-25401. <a href="https://doi.org/10.18632/oncotarget.4455" title="DOI URL">https://doi.org/10.18632/oncotarget.4455</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.4455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.4455%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DTankyrase%252Binhibitors%252Battenuate%252BWNT%25252F%2525CE%2525B2-catenin%252Bsignaling%252Band%252Binhibit%252Bgrowth%252Bof%252Bhepatocellular%252Bcarcinoma%252Bcells%26aulast%3DMa%26aufirst%3DLi%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D28%26spage%3D25390%26epage%3D25401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helen A.  Paine</span>, <span class="hlFld-ContribAuthor ">Amit  Nathubhai</span>, <span class="hlFld-ContribAuthor ">Esther C.Y.  Woon</span>, <span class="hlFld-ContribAuthor ">Peter T.  Sunderland</span>, <span class="hlFld-ContribAuthor ">Pauline J.  Wood</span>, <span class="hlFld-ContribAuthor ">Mary F.  Mahon</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Lloyd</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Thompson</span>, <span class="hlFld-ContribAuthor ">Teemu  Haikarainen</span>, <span class="hlFld-ContribAuthor ">Mohit  Narwal</span>, <span class="hlFld-ContribAuthor ">Lari  Lehtiö</span>, <span class="hlFld-ContribAuthor ">Michael D.  Threadgill</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of the nicotinamide-binding site of the tankyrases, identifying 3-arylisoquinolin-1-ones as potent and selective inhibitors in vitro. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (17)
                                     , 5891-5908. <a href="https://doi.org/10.1016/j.bmc.2015.06.061" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.06.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.06.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.06.061%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DExploration%252Bof%252Bthe%252Bnicotinamide-binding%252Bsite%252Bof%252Bthe%252Btankyrases%25252C%252Bidentifying%252B3-arylisoquinolin-1-ones%252Bas%252Bpotent%252Band%252Bselective%252Binhibitors%252Bin%252Bvitro%26aulast%3DPaine%26aufirst%3DHelen%2BA.%26date%3D2015%26volume%3D23%26issue%3D17%26spage%3D5891%26epage%3D5908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yves  Nkizinkiko</span>, <span class="hlFld-ContribAuthor ">B.V.S.  Suneel Kumar</span>, <span class="hlFld-ContribAuthor ">Variam Ullas  Jeankumar</span>, <span class="hlFld-ContribAuthor ">Teemu  Haikarainen</span>, <span class="hlFld-ContribAuthor ">Jarkko  Koivunen</span>, <span class="hlFld-ContribAuthor ">Chanduri  Madhuri</span>, <span class="hlFld-ContribAuthor ">Perumal  Yogeeswari</span>, <span class="hlFld-ContribAuthor ">Harikanth  Venkannagari</span>, <span class="hlFld-ContribAuthor ">Ezeogo  Obaji</span>, <span class="hlFld-ContribAuthor ">Taina  Pihlajaniemi</span>, <span class="hlFld-ContribAuthor ">Dharmarajan  Sriram</span>, <span class="hlFld-ContribAuthor ">Lari  Lehtiö</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent and selective nonplanar tankyrase inhibiting nicotinamide mimics. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4139-4149. <a href="https://doi.org/10.1016/j.bmc.2015.06.063" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.06.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.06.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpotent%252Band%252Bselective%252Bnonplanar%252Btankyrase%252Binhibiting%252Bnicotinamide%252Bmimics%26aulast%3DNkizinkiko%26aufirst%3DYves%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4139%26epage%3D4149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katerina  Kumpan</span>, <span class="hlFld-ContribAuthor ">Amit  Nathubhai</span>, <span class="hlFld-ContribAuthor ">Chenlu  Zhang</span>, <span class="hlFld-ContribAuthor ">Pauline J.  Wood</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Lloyd</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Thompson</span>, <span class="hlFld-ContribAuthor ">Teemu  Haikarainen</span>, <span class="hlFld-ContribAuthor ">Lari  Lehtiö</span>, <span class="hlFld-ContribAuthor ">Michael D.  Threadgill</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design, synthesis and evaluation in vitro of arylnaphthyridinones, arylpyridopyrimidinones and their tetrahydro derivatives as inhibitors of the tankyrases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (13)
                                     , 3013-3032. <a href="https://doi.org/10.1016/j.bmc.2015.05.005" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.05.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.05.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bin%252Bvitro%252Bof%252Barylnaphthyridinones%25252C%252Barylpyridopyrimidinones%252Band%252Btheir%252Btetrahydro%252Bderivatives%252Bas%252Binhibitors%252Bof%252Bthe%252Btankyrases%26aulast%3DKumpan%26aufirst%3DKaterina%26date%3D2015%26volume%3D23%26issue%3D13%26spage%3D3013%26epage%3D3032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">György G  Ferenczy</span>, <span class="hlFld-ContribAuthor ">György M  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">The impact of binding thermodynamics on medicinal chemistry optimizations. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (10)
                                     , 1285-1303. <a href="https://doi.org/10.4155/fmc.15.63" title="DOI URL">https://doi.org/10.4155/fmc.15.63</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.15.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.15.63%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bimpact%252Bof%252Bbinding%252Bthermodynamics%252Bon%252Bmedicinal%252Bchemistry%252Boptimizations%26aulast%3DFerenczy%26aufirst%3DGy%25C3%25B6rgy%2BG%26date%3D2015%26volume%3D7%26issue%3D10%26spage%3D1285%26epage%3D1303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arianna  Nencini</span>, <span class="hlFld-ContribAuthor ">Carmela  Pratelli</span>, <span class="hlFld-ContribAuthor ">Joanna M.  Quinn</span>, <span class="hlFld-ContribAuthor ">Massimiliano  Salerno</span>, <span class="hlFld-ContribAuthor ">Patrizia  Tunici</span>, <span class="hlFld-ContribAuthor ">Alessandra  De Robertis</span>, <span class="hlFld-ContribAuthor ">Silvia  Valensin</span>, <span class="hlFld-ContribAuthor ">Federica  Mennillo</span>, <span class="hlFld-ContribAuthor ">Marco  Rossi</span>, <span class="hlFld-ContribAuthor ">Annette  Bakker</span>, <span class="hlFld-ContribAuthor ">Tiziana  Benicchi</span>, <span class="hlFld-ContribAuthor ">Federico  Cappelli</span>, <span class="hlFld-ContribAuthor ">Elisa  Turlizzi</span>, <span class="hlFld-ContribAuthor ">Martina  Nibbio</span>, <span class="hlFld-ContribAuthor ">Nicola P.  Caradonna</span>, <span class="hlFld-ContribAuthor ">Ugo  Zanelli</span>, <span class="hlFld-ContribAuthor ">Matteo  Andreini</span>, <span class="hlFld-ContribAuthor ">Matteo  Magnani</span>, <span class="hlFld-ContribAuthor ">Maurizio  Varrone</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationship and properties optimization of a series of Quinazoline-2,4-diones as inhibitors of the canonical Wnt pathway. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>95 </em>, 526-545. <a href="https://doi.org/10.1016/j.ejmech.2015.03.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationship%252Band%252Bproperties%252Boptimization%252Bof%252Ba%252Bseries%252Bof%252BQuinazoline-2%25252C4-diones%252Bas%252Binhibitors%252Bof%252Bthe%252Bcanonical%252BWnt%252Bpathway%26aulast%3DNencini%26aufirst%3DArianna%26date%3D2015%26volume%3D95%26spage%3D526%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard J. R.  Elliott</span>, <span class="hlFld-ContribAuthor ">Ashley  Jarvis</span>, <span class="hlFld-ContribAuthor ">Mohan B.  Rajasekaran</span>, <span class="hlFld-ContribAuthor ">Malini  Menon</span>, <span class="hlFld-ContribAuthor ">Leandra  Bowers</span>, <span class="hlFld-ContribAuthor ">Ray  Boffey</span>, <span class="hlFld-ContribAuthor ">Melanie  Bayford</span>, <span class="hlFld-ContribAuthor ">Stuart  Firth-Clark</span>, <span class="hlFld-ContribAuthor ">Rebekah  Key</span>, <span class="hlFld-ContribAuthor ">Rehan  Aqil</span>, <span class="hlFld-ContribAuthor ">Stewart B.  Kirton</span>, <span class="hlFld-ContribAuthor ">Dan  Niculescu-Duvaz</span>, <span class="hlFld-ContribAuthor ">Laura  Fish</span>, <span class="hlFld-ContribAuthor ">Filipa  Lopes</span>, <span class="hlFld-ContribAuthor ">Robert  McLeary</span>, <span class="hlFld-ContribAuthor ">Ines  Trindade</span>, <span class="hlFld-ContribAuthor ">Elisenda  Vendrell</span>, <span class="hlFld-ContribAuthor ">Felix  Munkonge</span>, <span class="hlFld-ContribAuthor ">Rod  Porter</span>, <span class="hlFld-ContribAuthor ">Trevor  Perrior</span>, <span class="hlFld-ContribAuthor ">Caroline  Springer</span>, <span class="hlFld-ContribAuthor ">Antony W.  Oliver</span>, <span class="hlFld-ContribAuthor ">Laurence H.  Pearl</span>, <span class="hlFld-ContribAuthor ">Alan  Ashworth</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Lord</span>. </span><span class="cited-content_cbyCitation_article-title">Design and discovery of 3-aryl-5-substituted-isoquinolin-1-ones as potent tankyrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (9)
                                     , 1687-1692. <a href="https://doi.org/10.1039/C5MD00210A" title="DOI URL">https://doi.org/10.1039/C5MD00210A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00210A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00210A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDesign%252Band%252Bdiscovery%252Bof%252B3-aryl-5-substituted-isoquinolin-1-ones%252Bas%252Bpotent%252Btankyrase%252Binhibitors%26aulast%3DElliott%26aufirst%3DRichard%2BJ.%2BR.%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D9%26spage%3D1687%26epage%3D1692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai-Jye  Lou</span>, <span class="hlFld-ContribAuthor ">Stephen  Parmley</span>, <span class="hlFld-ContribAuthor ">Mark  Zipkin</span>. </span><span class="cited-content_cbyCitation_article-title">Translational tidbits. </span><span class="cited-content_cbyCitation_journal-name">Science-Business eXchange</span><span> <strong>2014,</strong> <em>7 </em>
                                    (44)
                                     , 1282-1282. <a href="https://doi.org/10.1038/scibx.2014.1282" title="DOI URL">https://doi.org/10.1038/scibx.2014.1282</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/scibx.2014.1282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fscibx.2014.1282%26sid%3Dliteratum%253Aachs%26jtitle%3DScience-Business%2520eXchange%26atitle%3DTranslational%252Btidbits%26aulast%3DLou%26aufirst%3DKai-Jye%26date%3D2014%26volume%3D7%26issue%3D44%26spage%3D1282%26epage%3D1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julian  Blagg</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical biology approaches to target validation in cancer. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2014,</strong> <em>17 </em>, 87-100. <a href="https://doi.org/10.1016/j.coph.2014.07.007" title="DOI URL">https://doi.org/10.1016/j.coph.2014.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2014.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2014.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DChemical%252Bbiology%252Bapproaches%252Bto%252Btarget%252Bvalidation%252Bin%252Bcancer%26aulast%3DBlagg%26aufirst%3DJulian%26date%3D2014%26volume%3D17%26spage%3D87%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atwood K.  Cheung</span>, <span class="hlFld-ContribAuthor ">Feng  Cong</span>. </span><span class="cited-content_cbyCitation_article-title">Finding a Needle in a Haystack. Identification of Tankyrase, a Novel Therapeutic Target of the Wnt Pathway Using Chemical Genetics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 249-264. <a href="https://doi.org/10.1002/9783527687503.ch17" title="DOI URL">https://doi.org/10.1002/9783527687503.ch17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527687503.ch17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527687503.ch17%26sid%3Dliteratum%253Aachs%26atitle%3DFinding%252Ba%252BNeedle%252Bin%252Ba%252BHaystack.%252BIdentification%252Bof%252BTankyrase%25252C%252Ba%252BNovel%252BTherapeutic%252BTarget%252Bof%252Bthe%252BWnt%252BPathway%252BUsing%252BChemical%252BGenetics%26aulast%3DCheung%26aufirst%3DAtwood%2BK.%26date%3D2014%26date%3D2014%26spage%3D249%26epage%3D264%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DConcepts%252Band%252BCase%252BStudies%252Bin%252BChemical%252BBiology%26aulast%3DWaldmann%26aufirst%3DHerbert%26date%3D2014%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie  Schoumacher</span>, <span class="hlFld-ContribAuthor ">Kristen E.  Hurov</span>, <span class="hlFld-ContribAuthor ">Joseph  Lehár</span>, <span class="hlFld-ContribAuthor ">Yan  Yan-Neale</span>, <span class="hlFld-ContribAuthor ">Yuji  Mishina</span>, <span class="hlFld-ContribAuthor ">Dmitriy  Sonkin</span>, <span class="hlFld-ContribAuthor ">Joshua M.  Korn</span>, <span class="hlFld-ContribAuthor ">Daisy  Flemming</span>, <span class="hlFld-ContribAuthor ">Michael D.  Jones</span>, <span class="hlFld-ContribAuthor ">Brandon  Antonakos</span>, <span class="hlFld-ContribAuthor ">Vesselina G.  Cooke</span>, <span class="hlFld-ContribAuthor ">Janine  Steiger</span>, <span class="hlFld-ContribAuthor ">Jebediah  Ledell</span>, <span class="hlFld-ContribAuthor ">Mark D.  Stump</span>, <span class="hlFld-ContribAuthor ">William R.  Sellers</span>, <span class="hlFld-ContribAuthor ">Nika N.  Danial</span>, <span class="hlFld-ContribAuthor ">Wenlin  Shao</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting Tankyrases Sensitizes KRAS-Mutant Cancer Cells to MEK Inhibitors via FGFR2 Feedback Signaling. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2014,</strong> <em>74 </em>
                                    (12)
                                     , 3294-3305. <a href="https://doi.org/10.1158/0008-5472.CAN-14-0138-T" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-14-0138-T</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-14-0138-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-14-0138-T%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DInhibiting%252BTankyrases%252BSensitizes%252BKRAS-Mutant%252BCancer%252BCells%252Bto%252BMEK%252BInhibitors%252Bvia%252BFGFR2%252BFeedback%252BSignaling%26aulast%3DSchoumacher%26aufirst%3DMarie%26date%3D2014%26date%3D2014%26volume%3D74%26issue%3D12%26spage%3D3294%26epage%3D3305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alleyn T.  Plowright</span>, <span class="hlFld-ContribAuthor ">Ola  Engkvist</span>, <span class="hlFld-ContribAuthor ">Adrian  Gill</span>, <span class="hlFld-ContribAuthor ">Laurent  Knerr</span>, <span class="hlFld-ContribAuthor ">Qing-Dong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Herzregeneration: Chancen und Aufgaben für die Wirkstoff-Forschung mit neuartigen chemischen und therapeutischen Methoden oder Agentien. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2014,</strong> <em>126 </em>
                                    (16)
                                     , 4138-4159. <a href="https://doi.org/10.1002/ange.201307034" title="DOI URL">https://doi.org/10.1002/ange.201307034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201307034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201307034%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DHerzregeneration%25253A%252BChancen%252Bund%252BAufgaben%252Bf%2525C3%2525BCr%252Bdie%252BWirkstoff-Forschung%252Bmit%252Bneuartigen%252Bchemischen%252Bund%252Btherapeutischen%252BMethoden%252Boder%252BAgentien%26aulast%3DPlowright%26aufirst%3DAlleyn%2BT.%26date%3D2014%26date%3D2014%26volume%3D126%26issue%3D16%26spage%3D4138%26epage%3D4159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alleyn T.  Plowright</span>, <span class="hlFld-ContribAuthor ">Ola  Engkvist</span>, <span class="hlFld-ContribAuthor ">Adrian  Gill</span>, <span class="hlFld-ContribAuthor ">Laurent  Knerr</span>, <span class="hlFld-ContribAuthor ">Qing-Dong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Heart Regeneration: Opportunities and Challenges for Drug Discovery with Novel Chemical and Therapeutic Methods or Agents. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2014,</strong> <em>53 </em>
                                    (16)
                                     , 4056-4075. <a href="https://doi.org/10.1002/anie.201307034" title="DOI URL">https://doi.org/10.1002/anie.201307034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201307034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201307034%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DHeart%252BRegeneration%25253A%252BOpportunities%252Band%252BChallenges%252Bfor%252BDrug%252BDiscovery%252Bwith%252BNovel%252BChemical%252Band%252BTherapeutic%252BMethods%252Bor%252BAgents%26aulast%3DPlowright%26aufirst%3DAlleyn%2BT.%26date%3D2014%26date%3D2014%26volume%3D53%26issue%3D16%26spage%3D4056%26epage%3D4075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc  de la Roche</span>, <span class="hlFld-ContribAuthor ">Ashraf E.K.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Juliusz  Mieszczanek</span>, <span class="hlFld-ContribAuthor ">Mariann  Bienz</span>. </span><span class="cited-content_cbyCitation_article-title">LEF1 and B9L Shield β-Catenin from Inactivation by Axin, Desensitizing Colorectal Cancer Cells to Tankyrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2014,</strong> <em>74 </em>
                                    (5)
                                     , 1495-1505. <a href="https://doi.org/10.1158/0008-5472.CAN-13-2682" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-13-2682</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-13-2682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-13-2682%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DLEF1%252Band%252BB9L%252BShield%252B%2525CE%2525B2-Catenin%252Bfrom%252BInactivation%252Bby%252BAxin%25252C%252BDesensitizing%252BColorectal%252BCancer%252BCells%252Bto%252BTankyrase%252BInhibitors%26aulast%3Dde%2Bla%2BRoche%26aufirst%3DMarc%26date%3D2014%26date%3D2014%26volume%3D74%26issue%3D5%26spage%3D1495%26epage%3D1505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Palani  Kirubakaran</span>, <span class="hlFld-ContribAuthor ">Pitchaimani  Arunkumar</span>, <span class="hlFld-ContribAuthor ">Kumpati  Premkumar</span>, <span class="hlFld-ContribAuthor ">Karthikeyan  Muthusamy</span>. </span><span class="cited-content_cbyCitation_article-title">Sighting of tankyrase inhibitors by structure- and ligand-based screening and in vitro approach. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2014,</strong> <em>10 </em>
                                    (10)
                                     , 2699. <a href="https://doi.org/10.1039/C4MB00309H" title="DOI URL">https://doi.org/10.1039/C4MB00309H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MB00309H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MB00309H%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DSighting%252Bof%252Btankyrase%252Binhibitors%252Bby%252Bstructure-%252Band%252Bligand-based%252Bscreening%252Band%252Bin%252Bvitro%252Bapproach%26aulast%3DKirubakaran%26aufirst%3DPalani%26date%3D2014%26date%3D2014%26volume%3D10%26issue%3D10%26spage%3D2699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Yu'ning  Song</span>, <span class="hlFld-ContribAuthor ">Yukihiro  Itoh</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Suzuki</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the structure-based rational design of TNKSIs. </span><span class="cited-content_cbyCitation_journal-name">Mol. BioSyst.</span><span> <strong>2014,</strong> <em>10 </em>
                                    (11)
                                     , 2783-2799. <a href="https://doi.org/10.1039/C4MB00385C" title="DOI URL">https://doi.org/10.1039/C4MB00385C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MB00385C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MB00385C%26sid%3Dliteratum%253Aachs%26jtitle%3DMol.%2520BioSyst.%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bstructure-based%252Brational%252Bdesign%252Bof%252BTNKSIs%26aulast%3DZhan%26aufirst%3DPeng%26date%3D2014%26date%3D2014%26volume%3D10%26issue%3D11%26spage%3D2783%26epage%3D2799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teemu  Haikarainen</span>, <span class="hlFld-ContribAuthor ">Jarkko  Koivunen</span>, <span class="hlFld-ContribAuthor ">Mohit  Narwal</span>, <span class="hlFld-ContribAuthor ">Harikanth  Venkannagari</span>, <span class="hlFld-ContribAuthor ">Ezeogo  Obaji</span>, <span class="hlFld-ContribAuthor ">Päivi  Joensuu</span>, <span class="hlFld-ContribAuthor ">Taina  Pihlajaniemi</span>, <span class="hlFld-ContribAuthor ">Lari  Lehtiö</span>. </span><span class="cited-content_cbyCitation_article-title">para
              -Substituted 2-Phenyl-3,4-dihydroquinazolin-4-ones As Potent and Selective Tankyrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2013,</strong> <em>8 </em>
                                    (12)
                                     , 1978-1985. <a href="https://doi.org/10.1002/cmdc.201300337" title="DOI URL">https://doi.org/10.1002/cmdc.201300337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300337%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3Dpara%252B-Substituted%252B2-Phenyl-3%25252C4-dihydroquinazolin-4-ones%252BAs%252BPotent%252Band%252BSelective%252BTankyrase%252BInhibitors%26aulast%3DHaikarainen%26aufirst%3DTeemu%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D12%26spage%3D1978%26epage%3D1985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0023.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Select TNKS inhibitors that have been reported in the literature.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of A-Ring Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) K<sub>2</sub>CO<sub>3</sub>, MeOH, 75 °C; (b) DIEA, THF; (c) KOEt, 140 °C, 20 min.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Dihydropyran C-Ring Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>K<sub>2</sub>CO<sub>3</sub>, MeOH, reflux overnight.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Dihydropyran C-Ring Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TEA, 2-chloroacetamidine, MeOH; (b) i. NaN<sub>3</sub>, H<sub>2</sub>O/acetone, ii. Ph<sub>3</sub>P, THF; (c) R<sup>2</sup>-CHO, SiCNBH<sub>3</sub>, AcOH, EtOH; RSO<sub>2</sub>Cl, TEA, DCM or RCO<sub>2</sub>Cl, TEA, DCM or RCO<sub>2</sub>H, EDCI, HOBt, TEA, DCM; (d) i. BocNHR<sup>2</sup>, NaH, THF or DMF; ii. HCl, dioxane, MeOH; (e) R<sub>3</sub>NH<sub>2</sub>, TEA, 120 °C, 5 min, or R<sub>3</sub>NH<sub>2</sub>, TEA or DIEA, EtOH, 65 °C; (f) RCO<sub>2</sub>Cl, TEA, DCM; (g) RCO<sub>2</sub>H, EDCI, HOBt, TEA, DCM.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of <b>19</b> (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI6">4LI6</a>) suggested potential polar interactions that might be gained, as (1) the hydroxyl of Ser1186 and the backbone carbonyl of D1198 were in close proximity to the phenyl ring and (2) a crystallographic water molecule was bound via the backbone NH of D1198.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Superposition of crystal structures <b>19</b> (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI6">4LI6</a>, cyan), <b>33</b> (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI7">4LI7</a>, green), and <b>35</b> (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI8">4LI8</a>, magenta) bound to TNKS1. Grafting of the nicotinamide/nook binding portion of <b>19</b> with the adenosine binding portion of <b>33</b> led to <b>35</b>, the first known three-pocket tankyrase binder, a compound with excellent potency, highly favorable physicochemical properties, and metabolic stability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Ethyl 2-bromoacetate, Et<sub>3</sub>N, CH<sub>3</sub>CN, reflux 5 h; (b) NaOH, H<sub>2</sub>O, EtOH, 24 h; (c) EDCI, HOBt or HATU, TEA or DIPEA, DCM or DMF.</p></p></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Superposition of the crystal structures of <b>35</b> (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI8">4LI8</a>, magenta) and <b>2</b> (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UDD">3UDD</a>, yellow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. PK/PD relationship of <b>43</b> in MMTV-Wnt1 tumor bearing athymic nude mice. Following a single oral dose of <b>43</b> at 350 mg/kg, plasma and tumor samples were collected at various time points (0.5, 1, 2, 4, 8, 16, and 24 h; <i>n</i> = 3) for PK and PD analysis. The data are represented as <b>43</b> concentration in plasma (nM) and %Axin2 mRNA in tumor relative to untreated controls (mean ± SEM, <i>n</i> = 3 animals/time point). <i>p</i> < 0.05 compared to untreated controls using a one-way ANOVA followed by a posthoc Tukey test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/medium/jm-2013-00807n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Isothermal calorimetry data for select compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm400807n/production/images/large/jm-2013-00807n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400807n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i98">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Schreiber, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dantzer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ame, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Murcia, G.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose): nNovel functions for an old molecule</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1038%2Fnrm1963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=16829982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1Ohsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=517-528&author=V.+Schreiberauthor=F.+Dantzerauthor=J.+C.+Ameauthor=G.+de+Murcia&title=Poly%28ADP-ribose%29%3A+nNovel+functions+for+an+old+molecule"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose): novel functions for an old molecule</span></div><div class="casAuthors">Schreiber, Valerie; Dantzer, Francoise; Ame, Jean-Christophe; de Murcia, Gilbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">517-528</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The addn. to proteins of the neg. charged polymer of ADP-ribose, which is synthesized by poly(ADP-ribose) polymerase (PARPs) from NAD, is a unique post-translational modification.  It regulates not only cell survival and cell-death programs, but also an increasing no. of other biol. functions with which novel members of the PARP family have been assocd.  These functions include transcriptional regulation, telomere cohesion and mitotic spindle formation during cell division, intracellular trafficking, and energy metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLsI4_BKfjdrVg90H21EOLACvtfcHk0lhdE8_j_WLNNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1Ohsb4%253D&md5=676e83755491500f3bf2137f348dfa1b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm1963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1963%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DV.%26aulast%3DDantzer%26aufirst%3DF.%26aulast%3DAme%26aufirst%3DJ.%2BC.%26aulast%3Dde%2BMurcia%26aufirst%3DG.%26atitle%3DPoly%2528ADP-ribose%2529%253A%2520nNovel%2520functions%2520for%2520an%2520old%2520molecule%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D517%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hsiao, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span> </span><span class="NLM_article-title">Tankyrase function at telomeres, spindle poles, and beyond</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2008&pages=83-92&author=S.+J.+Hsiaoauthor=S.+Smith&title=Tankyrase+function+at+telomeres%2C+spindle+poles%2C+and+beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DS.%2BJ.%26aulast%3DSmith%26aufirst%3DS.%26atitle%3DTankyrase%2520function%2520at%2520telomeres%252C%2520spindle%2520poles%252C%2520and%2520beyond%26jtitle%3DBiochimie%26date%3D2008%26volume%3D90%26spage%3D83%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Seimiya, H.</span><span> </span><span class="NLM_article-title">The telomeric PARP, tankyrases, as targets for cancer therapy</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1038%2Fsj.bjc.6602951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=16421589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFGqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=341-345&author=H.+Seimiya&title=The+telomeric+PARP%2C+tankyrases%2C+as+targets+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The telomeric PARP, tankyrases, as targets for cancer therapy</span></div><div class="casAuthors">Seimiya, H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">341-345</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The requirement for the maintenance of telomeres by telomerase by most cancer cells for continued proliferation is a target in anticancer strategies.  Tankyrases are poly(ADP-ribose) polymerases that enhance telomerase access to telomeres.  Tankyrase 1 modulates telomerase inhibition in human cancer cells and is reviewed in this report as a potential telomere-directed anticancer target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr10pYfhlLTiLVg90H21EOLACvtfcHk0ljaHy4QzotACw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFGqsL4%253D&md5=06d25a6a317ba92dc1137ea1c1417d8a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6602951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6602951%26sid%3Dliteratum%253Aachs%26aulast%3DSeimiya%26aufirst%3DH.%26atitle%3DThe%2520telomeric%2520PARP%252C%2520tankyrases%252C%2520as%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26spage%3D341%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Levaot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voytyuk, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitriou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sircoulomb, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrakumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krzyzanowski, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scotter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janmohamed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cong, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoncic, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottapel, R.</span><span> </span><span class="NLM_article-title">Loss of tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">1324</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2011&pages=1324-1339&author=N.+Levaotauthor=O.+Voytyukauthor=I.+Dimitriouauthor=F.+Sircoulombauthor=A.+Chandrakumarauthor=M.+Deckertauthor=P.+M.+Krzyzanowskiauthor=A.+Scotterauthor=S.+Guauthor=S.+Janmohamedauthor=F.+Congauthor=P.+D.+Simoncicauthor=Y.+Uekiauthor=R.+J.+Laauthor=R.+Rottapel&title=Loss+of+tankyrase-mediated+destruction+of+3BP2+is+the+underlying+pathogenic+mechanism+of+cherubism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevaot%26aufirst%3DN.%26aulast%3DVoytyuk%26aufirst%3DO.%26aulast%3DDimitriou%26aufirst%3DI.%26aulast%3DSircoulomb%26aufirst%3DF.%26aulast%3DChandrakumar%26aufirst%3DA.%26aulast%3DDeckert%26aufirst%3DM.%26aulast%3DKrzyzanowski%26aufirst%3DP.%2BM.%26aulast%3DScotter%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DS.%26aulast%3DJanmohamed%26aufirst%3DS.%26aulast%3DCong%26aufirst%3DF.%26aulast%3DSimoncic%26aufirst%3DP.%2BD.%26aulast%3DUeki%26aufirst%3DY.%26aulast%3DLa%26aufirst%3DR.%2BJ.%26aulast%3DRottapel%26aufirst%3DR.%26atitle%3DLoss%2520of%2520tankyrase-mediated%2520destruction%2520of%25203BP2%2520is%2520the%2520underlying%2520pathogenic%2520mechanism%2520of%2520cherubism%26jtitle%3DCell%26date%3D2011%26volume%3D147%26spage%3D1324%26epage%3D1339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Huang, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishina, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegmeier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaud, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlat, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiellette, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiessner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hild, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mickanin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serluca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shultz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghidelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschner, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallarico, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouwmeester, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cong, F.</span><span> </span><span class="NLM_article-title">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">461</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1038%2Fnature08356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=19759537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=614-620&author=S.+M.+Huangauthor=Y.+M.+Mishinaauthor=S.+Liuauthor=A.+Cheungauthor=F.+Stegmeierauthor=G.+A.+Michaudauthor=O.+Charlatauthor=E.+Wielletteauthor=Y.+Zhangauthor=S.+Wiessnerauthor=M.+Hildauthor=X.+Shiauthor=C.+J.+Wilsonauthor=C.+Mickaninauthor=V.+Myerauthor=A.+Fazalauthor=R.+Tomlinsonauthor=F.+Serlucaauthor=W.+Shaoauthor=H.+Chengauthor=M.+Shultzauthor=C.+Rauauthor=M.+Schirleauthor=J.+Schleglauthor=S.+Ghidelliauthor=S.+Fawellauthor=C.+Luauthor=D.+Curtisauthor=M.+W.+Kirschnerauthor=C.+Lengauerauthor=P.+M.+Finanauthor=J.+A.+Tallaricoauthor=T.+Bouwmeesterauthor=J.+A.+Porterauthor=A.+Bauerauthor=F.+Cong&title=Tankyrase+inhibition+stabilizes+axin+and+antagonizes+Wnt+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span></div><div class="casAuthors">Huang, Shih-Min A.; Mishina, Yuji M.; Liu, Shanming; Cheung, Atwood; Stegmeier, Frank; Michaud, Gregory A.; Charlat, Olga; Wiellette, Elizabeth; Zhang, Yue; Wiessner, Stephanie; Hild, Marc; Shi, Xiaoying; Wilson, Christopher J.; Mickanin, Craig; Myer, Vic; Fazal, Aleem; Tomlinson, Ronald; Serluca, Fabrizio; Shao, Wenlin; Cheng, Hong; Shultz, Michael; Rau, Christina; Schirle, Markus; Schlegl, Judith; Ghidelli, Sonja; Fawell, Stephen; Lu, Chris; Curtis, Daniel; Kirschner, Marc W.; Lengauer, Christoph; Finan, Peter M.; Tallarico, John A.; Bouwmeester, Tewis; Porter, Jeffery A.; Bauer, Andreas; Cong, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7264</span>),
    <span class="NLM_cas:pages">614-620</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The stability of the Wnt pathway transcription factor β-catenin is tightly regulated by the multi-subunit destruction complex.  Deregulated Wnt pathway activity has been implicated in many cancers, making this pathway an attractive target for anticancer therapies.  However, the development of targeted Wnt pathway inhibitors has been hampered by the limited no. of pathway components that are amenable to small mol. inhibition.  Here, we used a chem. genetic screen to identify a small mol., XAV939, which selectively inhibits β-catenin-mediated transcription.  XAV939 stimulates β-catenin degrdn. by stabilizing axin, the concn.-limiting component of the destruction complex.  Using a quant. chem. proteomic approach, we discovered that XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2.  Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degrdn. through the ubiquitin-proteasome pathway.  Thus, our study provides new mechanistic insights into the regulation of axin protein homeostasis and presents new avenues for targeted Wnt pathway therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom3c1M4OoOarVg90H21EOLACvtfcHk0ljaHy4QzotACw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP&md5=6a76dfa7ed2a57b29e0c1ee367bd652c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature08356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08356%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BM.%26aulast%3DMishina%26aufirst%3DY.%2BM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DMichaud%26aufirst%3DG.%2BA.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DWiellette%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWiessner%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWilson%26aufirst%3DC.%2BJ.%26aulast%3DMickanin%26aufirst%3DC.%26aulast%3DMyer%26aufirst%3DV.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DTomlinson%26aufirst%3DR.%26aulast%3DSerluca%26aufirst%3DF.%26aulast%3DShao%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DShultz%26aufirst%3DM.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DGhidelli%26aufirst%3DS.%26aulast%3DFawell%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DCurtis%26aufirst%3DD.%26aulast%3DKirschner%26aufirst%3DM.%2BW.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DCong%26aufirst%3DF.%26atitle%3DTankyrase%2520inhibition%2520stabilizes%2520axin%2520and%2520antagonizes%2520Wnt%2520signalling%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D614%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Guettler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRose, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petsalaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scotter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottapel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicheri, F.</span><span> </span><span class="NLM_article-title">Structural basis and sequence rules for substrate recognition by tankyrase explain the basis for cherubism disease</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">1340</span><span class="NLM_x">–</span> <span class="NLM_lpage">1354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2011&pages=1340-1354&author=S.+Guettlerauthor=J.+LaRoseauthor=E.+Petsalakiauthor=G.+Gishauthor=A.+Scotterauthor=T.+Pawsonauthor=R.+Rottapelauthor=F.+Sicheri&title=Structural+basis+and+sequence+rules+for+substrate+recognition+by+tankyrase+explain+the+basis+for+cherubism+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuettler%26aufirst%3DS.%26aulast%3DLaRose%26aufirst%3DJ.%26aulast%3DPetsalaki%26aufirst%3DE.%26aulast%3DGish%26aufirst%3DG.%26aulast%3DScotter%26aufirst%3DA.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DRottapel%26aufirst%3DR.%26aulast%3DSicheri%26aufirst%3DF.%26atitle%3DStructural%2520basis%2520and%2520sequence%2520rules%2520for%2520substrate%2520recognition%2520by%2520tankyrase%2520explain%2520the%2520basis%2520for%2520cherubism%2520disease%26jtitle%3DCell%26date%3D2011%26volume%3D147%26spage%3D1340%26epage%3D1354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-ref7_1"><span><span class="NLM_contrib-group">Cheung, A. K.; Chin, D. N.; Fan, J.; Shultz, M. D.; Tomlinson, R. C.</span><span> </span><span class="NLM_article-title">4-Oxo-3,5,7,8-Tetrahydro-4h-Pyrano {4,3-D} Pyrminidinyl Compounds For Use As Tankyrase Inhibitors</span>. WO 2013010092, US 2011-507313P,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+K.+Cheung&author=D.+N.+Chin&author=J.+Fan&author=M.+D.+Shultz&author=R.+C.+Tomlinson&title=4-Oxo-3%2C5%2C7%2C8-Tetrahydro-4h-Pyrano+%7B4%2C3-D%7D+Pyrminidinyl+Compounds+For+Use+As+Tankyrase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref7_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DA.%2BK.%26atitle%3D4-Oxo-3%252C5%252C7%252C8-Tetrahydro-4h-Pyrano%2520%257B4%252C3-D%257D%2520Pyrminidinyl%2520Compounds%2520For%2520Use%2520As%2520Tankyrase%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span> </span><span class="NLM_article-title">Novel binding mode of a potent and selective tankyrase inhibitor</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e33740</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1371%2Fjournal.pone.0033740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=22438990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVaht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e33740&author=H.+Gunaydinauthor=Y.+Guauthor=X.+Huang&title=Novel+binding+mode+of+a+potent+and+selective+tankyrase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel binding mode of a potent and selective tankyrase inhibitor</span></div><div class="casAuthors">Gunaydin, Hakan; Gu, Yan; Huang, Xin</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e33740</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Tankyrases (TNKS1 and TNKS2) are key regulators of cellular processes such as telomere pathway and Wnt signaling.  IWRs (inhibitors of Wnt response) have recently been identified as potent and selective inhibitors of tankyrases.  However, it is not clear how these IWRs interact with tankyrases.  Here we report the crystal structure of the catalytic domain of human TNKS1 in complex with IWR2, which reveals a novel binding site for tankyrase inhibitors.  The TNKS1/IWR2 complex provides a mol. basis for their strong and specific interactions and suggests clues for further development of tankyrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqidLqR8KN4obVg90H21EOLACvtfcHk0lgS5zKeyy6MeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVaht70%253D&md5=7ab7c96221b170534538c51605e76e85</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0033740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0033740%26sid%3Dliteratum%253Aachs%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DNovel%2520binding%2520mode%2520of%2520a%2520potent%2520and%2520selective%2520tankyrase%2520inhibitor%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De33740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Shultz, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blank, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlat, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cong, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, W.</span><span> </span><span class="NLM_article-title">[1,2,4]Triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: Antagonists of the Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1127</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2011222" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1127-1136&author=M.+D.+Shultzauthor=C.+A.+Kirbyauthor=T.+Stamsauthor=D.+N.+Chinauthor=J.+Blankauthor=O.+Charlatauthor=H.+Chengauthor=A.+Cheungauthor=F.+Congauthor=Y.+Fengauthor=P.+D.+Fortinauthor=T.+Hoodauthor=V.+Tyagiauthor=M.+Xuauthor=B.+Zhangauthor=W.+Shao&title=%5B1%2C2%2C4%5DTriazol-3-ylsulfanylmethyl%29-3-phenyl-%5B1%2C2%2C4%5Doxadiazoles%3A+Antagonists+of+the+Wnt+pathway+that+inhibit+tankyrases+1+and+2+via+novel+adenosine+pocket+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm2011222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2011222%26sid%3Dliteratum%253Aachs%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DKirby%26aufirst%3DC.%2BA.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DChin%26aufirst%3DD.%2BN.%26aulast%3DBlank%26aufirst%3DJ.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DCong%26aufirst%3DF.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DHood%26aufirst%3DT.%26aulast%3DTyagi%26aufirst%3DV.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DShao%26aufirst%3DW.%26atitle%3D%255B1%252C2%252C4%255DTriazol-3-ylsulfanylmethyl%2529-3-phenyl-%255B1%252C2%252C4%255Doxadiazoles%253A%2520Antagonists%2520of%2520the%2520Wnt%2520pathway%2520that%2520inhibit%2520tankyrases%25201%2520and%25202%2520via%2520novel%2520adenosine%2520pocket%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1127%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Waaler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korinek, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulsen, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eide, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machonova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voronkov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kries, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, S.</span><span> </span><span class="NLM_article-title">A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">2822</span><span class="NLM_x">–</span> <span class="NLM_lpage">2832</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1158%2F0008-5472.CAN-11-3336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=22440753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2822-2832&author=J.+Waalerauthor=O.+Machonauthor=L.+Tumovaauthor=H.+Dinhauthor=V.+Korinekauthor=S.+R.+Wilsonauthor=J.+E.+Paulsenauthor=N.+M.+Pedersenauthor=T.+J.+Eideauthor=O.+Machonovaauthor=D.+Gradlauthor=A.+Voronkovauthor=J.+P.+von+Kriesauthor=S.+Krauss&title=A+novel+tankyrase+inhibitor+decreases+canonical+Wnt+signaling+in+colon+carcinoma+cells+and+reduces+tumor+growth+in+conditional+APC+mutant+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice</span></div><div class="casAuthors">Waaler, Jo; Machon, Ondrej; Tumova, Lucie; Dinh, Huyen; Korinek, Vladimir; Wilson, Steven Ray; Paulsen, Jan Erik; Pedersen, Nina Marie; Eide, Tor J.; Machonova, Olga; Gradl, Dietmar; Voronkov, Andrey; von Kries, Jens Peter; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2822-2832</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This preclin. proof-of-concept study suggests a new strategy to treat colon cancer by increasing the degrdn. of β-catenin, which drives this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokQ3hrnF8gMLVg90H21EOLACvtfcHk0lgS5zKeyy6MeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D&md5=9814ad25dc1d5da6d9babaff8df19327</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-3336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-3336%26sid%3Dliteratum%253Aachs%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DTumova%26aufirst%3DL.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DPaulsen%26aufirst%3DJ.%2BE.%26aulast%3DPedersen%26aufirst%3DN.%2BM.%26aulast%3DEide%26aufirst%3DT.%2BJ.%26aulast%3DMachonova%26aufirst%3DO.%26aulast%3DGradl%26aufirst%3DD.%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DA%2520novel%2520tankyrase%2520inhibitor%2520decreases%2520canonical%2520Wnt%2520signaling%2520in%2520colon%2520carcinoma%2520cells%2520and%2520reduces%2520tumor%2520growth%2520in%2520conditional%2520APC%2520mutant%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2822%26epage%3D2832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Distler, A.; Deloch, L.; Huang, J.; Dees, C.; Lin, N. Y.; Palumbo-Zerr, K.;  Beyer, C.; Weidemann, A.; Distler, O.; Schett, G.; Distler, J. H.</span><span> </span><span class="NLM_article-title"> Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span>doi: <span class="refDoi"> DOI: 10.1136/annrheumdis-2012-202275</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1136%2Fannrheumdis-2012-202275" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+Distler&author=L.+Deloch&author=J.+Huang&author=C.+Dees&author=N.+Y.+Lin&author=K.+Palumbo-Zerr&author=C.++Beyer&author=A.+Weidemann&author=O.+Distler&author=G.+Schett&author=J.+H.+Distler&title=+Inactivation+of+tankyrases+reduces+experimental+fibrosis+by+inhibiting+canonical+Wnt+signalling&doi=10.1136%2Fannrheumdis-2012-202275"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2012-202275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2012-202275%26sid%3Dliteratum%253Aachs%26aulast%3DDistler%26aufirst%3DA.%26atitle%3D%2520Inactivation%2520of%2520tankyrases%2520reduces%2520experimental%2520fibrosis%2520by%2520inhibiting%2520canonical%2520Wnt%2520signalling%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2012%26doi%3D10.1136%2Fannrheumdis-2012-202275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamauchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamakura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goshima, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, Y.</span><span> </span><span class="NLM_article-title">Herpes simplex virus requires poly(ADP-ribose) polymerase activity for efficient replication and induces extracellular signal-related kinase-dependent phosphorylation and ICP0-dependent nuclear localization of tankyrase 1</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1128%2FJVI.05897-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=22013039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVKksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2012&pages=492-503&author=Z.+Liauthor=Y.+Yamauchiauthor=M.+Kamakuraauthor=T.+Murayamaauthor=F.+Goshimaauthor=H.+Kimuraauthor=Y.+Nishiyama&title=Herpes+simplex+virus+requires+poly%28ADP-ribose%29+polymerase+activity+for+efficient+replication+and+induces+extracellular+signal-related+kinase-dependent+phosphorylation+and+ICP0-dependent+nuclear+localization+of+tankyrase+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Herpes simplex virus requires poly(ADP-ribose) polymerase activity for efficient replication and induces extracellular signal-related kinase-dependent phosphorylation and ICP0-dependent nuclear localization of tankyrase 1</span></div><div class="casAuthors">Li, Zhuan; Yamauchi, Yohei; Kamakura, Maki; Murayama, Tsugiya; Goshima, Fumi; Kimura, Hiroshi; Nishiyama, Yukihiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">492-503</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Tankyrase 1 is a poly(ADP-ribose) polymerase (PARP) which localizes to multiple subcellular sites, including telomeres and mitotic centrosomes.  Poly(ADP-ribosyl)ation of the nuclear mitotic app. (NuMA) protein by tankyrase 1 during mitosis is essential for sister telomere resoln. and mitotic spindle pole formation.  In interphase cells, tankyrase 1 resides in the cytoplasm, and its role therein is not well understood.  In this study, we found that herpes simplex virus (HSV) infection induced extensive modification of tankyrase 1 but not tankyrase 2.  This modification was dependent on extracellular signal-regulated kinase (ERK) activity triggered by HSV infection.  Following HSV-1 infection, tankyrase 1 was recruited to the nucleus.  In the early phase of infection, tankyrase 1 colocalized with ICP0 and thereafter localized within the HSV replication compartment, which was blocked in cells infected with the HSV-1 ICP0-null mutant R7910.  In the absence of infection, ICP0 interacted with tankyrase 1 and efficiently promoted its nuclear localization.  HSV did not replicate efficiently in cells depleted of both tankyrases 1 and 2.  Moreover, XAV939, an inhibitor of tankyrase PARP activity, decreased viral titers to 2 to 5% of control values.  We concluded that HSV targets tankyrase 1 in an ICP0- and ERK-dependent manner to facilitate its replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLtDPmy0QelrVg90H21EOLACvtfcHk0lgeAr5MVf8gqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVKksLo%253D&md5=84fa225605d6aa39b181d2484ae06447</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FJVI.05897-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.05897-11%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYamauchi%26aufirst%3DY.%26aulast%3DKamakura%26aufirst%3DM.%26aulast%3DMurayama%26aufirst%3DT.%26aulast%3DGoshima%26aufirst%3DF.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DNishiyama%26aufirst%3DY.%26atitle%3DHerpes%2520simplex%2520virus%2520requires%2520poly%2528ADP-ribose%2529%2520polymerase%2520activity%2520for%2520efficient%2520replication%2520and%2520induces%2520extracellular%2520signal-related%2520kinase-dependent%2520phosphorylation%2520and%2520ICP0-dependent%2520nuclear%2520localization%2520of%2520tankyrase%25201%26jtitle%3DJ.%2520Virol.%26date%3D2012%26volume%3D86%26spage%3D492%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Tenbaum, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ordonez-Moran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puig, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chicote, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arques, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landolfi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herance, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gispert, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendizabal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cajal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivancos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabernero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, H. G.</span><span> </span><span class="NLM_article-title">Beta-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1038%2Fnm.2772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=22610277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC38XntF2hsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=892-901&author=S.+P.+Tenbaumauthor=P.+Ordonez-Moranauthor=I.+Puigauthor=I.+Chicoteauthor=O.+Arquesauthor=S.+Landolfiauthor=Y.+Fernandezauthor=J.+R.+Heranceauthor=J.+D.+Gispertauthor=L.+Mendizabalauthor=S.+Aguilarauthor=S.+Cajalauthor=S.+Schwartzauthor=A.+Vivancosauthor=E.+Espinauthor=S.+Rojasauthor=J.+Baselgaauthor=J.+Taberneroauthor=A.+Munozauthor=H.+G.+Palmer&title=Beta-catenin+confers+resistance+to+PI3K+and+AKT+inhibitors+and+subverts+FOXO3a+to+promote+metastasis+in+colon+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer</span></div><div class="casAuthors">Tenbaum, Stephan P.; Ordonez-Moran, Paloma; Puig, Isabel; Chicote, Irene; Arques, Oriol; Landolfi, Stefania; Fernandez, Yolanda; Herance, Jose Raul; Gispert, Juan D.; Mendizabal, Leire; Aguilar, Susana; Cajal, Santiago Ramon y; Schwartz, Simo; Vivancos, Ana; Espin, Eloy; Rojas, Santiago; Baselga, Jose; Tabernero, Josep; Munoz, Alberto; Palmer, Hector G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">892-901</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Wnt-β-catenin and PI3K-AKT-FOXO3a pathways have a central role in cancer.  AKT phosporylates FOXO3a, relocating it from the cell nucleus to the cytoplasm, an effect that is reversed by PI3K and AKT inhibitors.  Simultaneous hyperactivation of the Wnt-β-catenin pathway and inhibition of PI3K-AKT signaling promote nuclear accumulation of β-catenin and FOXO3a, resp., promoting cell scattering and metastasis by regulating a defined set of target genes.  Indeed, the anti-tumoral AKT inhibitor API-2 promotes nuclear FOXO3a accumulation and metastasis of cells with high nuclear β-catenin content.  Nuclear β-catenin confers resistance to the FOXO3a-mediated apoptosis induced by PI3K and AKT inhibitors in patient-derived primary cultures and in corresponding xenograft tumors in mice.  This resistance is reversed by XAV-939, an inhibitor of Wnt-β-catenin signaling.  In the presence of high nuclear β-catenin content, activation of FOXO3a by PI3K or AKT inhibitors makes it behave as a metastasis inductor rather than a proapoptotic tumor suppressor.  We show that it is possible to evaluate the β-catenin status of patients' carcinomas and the response of patient-derived cells to target-directed drugs that accumulate FOXO3a in the nucleus before deciding on a course of treatment.  We propose that this evaluation could be essential to the provision of a safer and more effective personalized treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfghc13e9HzbVg90H21EOLACvtfcHk0lgeAr5MVf8gqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntF2hsr4%253D&md5=06a507a1f35f4ee380f36d10c9112c1b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnm.2772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2772%26sid%3Dliteratum%253Aachs%26aulast%3DTenbaum%26aufirst%3DS.%2BP.%26aulast%3DOrdonez-Moran%26aufirst%3DP.%26aulast%3DPuig%26aufirst%3DI.%26aulast%3DChicote%26aufirst%3DI.%26aulast%3DArques%26aufirst%3DO.%26aulast%3DLandolfi%26aufirst%3DS.%26aulast%3DFernandez%26aufirst%3DY.%26aulast%3DHerance%26aufirst%3DJ.%2BR.%26aulast%3DGispert%26aufirst%3DJ.%2BD.%26aulast%3DMendizabal%26aufirst%3DL.%26aulast%3DAguilar%26aufirst%3DS.%26aulast%3DCajal%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DS.%26aulast%3DVivancos%26aufirst%3DA.%26aulast%3DEspin%26aufirst%3DE.%26aulast%3DRojas%26aufirst%3DS.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DMunoz%26aufirst%3DA.%26aulast%3DPalmer%26aufirst%3DH.%2BG.%26atitle%3DBeta-catenin%2520confers%2520resistance%2520to%2520PI3K%2520and%2520AKT%2520inhibitors%2520and%2520subverts%2520FOXO3a%2520to%2520promote%2520metastasis%2520in%2520colon%2520cancer%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D892%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Ulsamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, H. A.</span><span> </span><span class="NLM_article-title">Axin pathway activity regulates in vivo pY654-beta-catenin accumulation and pulmonary fibrosis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">5164</span><span class="NLM_x">–</span> <span class="NLM_lpage">5172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=5164-5172&author=A.+Ulsamerauthor=Y.+Weiauthor=K.+K.+Kimauthor=K.+Tanauthor=S.+Wheelerauthor=Y.+Xiauthor=R.+S.+Thiesauthor=H.+A.+Chapman&title=Axin+pathway+activity+regulates+in+vivo+pY654-beta-catenin+accumulation+and+pulmonary+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUlsamer%26aufirst%3DA.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DK.%2BK.%26aulast%3DTan%26aufirst%3DK.%26aulast%3DWheeler%26aufirst%3DS.%26aulast%3DXi%26aufirst%3DY.%26aulast%3DThies%26aufirst%3DR.%2BS.%26aulast%3DChapman%26aufirst%3DH.%2BA.%26atitle%3DAxin%2520pathway%2520activity%2520regulates%2520in%2520vivo%2520pY654-beta-catenin%2520accumulation%2520and%2520pulmonary%2520fibrosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D5164%26epage%3D5172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Fancy, S. P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silbereis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baranzini, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otero, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nusse, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, R. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowitch, D. H.</span><span> </span><span class="NLM_article-title">Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1U99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1038%2Fnn.2855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=21706018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotV2hsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=1009-1U99&author=S.+P.+J.+Fancyauthor=E.+P.+Harringtonauthor=T.+J.+Yuenauthor=J.+C.+Silbereisauthor=C.+Zhaoauthor=S.+E.+Baranziniauthor=C.+C.+Bruceauthor=J.+J.+Oteroauthor=E.+J.+Huangauthor=R.+Nusseauthor=R.+J.+M.+Franklinauthor=D.+H.+Rowitch&title=Axin2+as+regulatory+and+therapeutic+target+in+newborn+brain+injury+and+remyelination"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination</span></div><div class="casAuthors">Fancy, Stephen P. J.; Harrington, Emily P.; Yuen, Tracy J.; Silbereis, John C.; Zhao, Chao; Baranzini, Sergio E.; Bruce, Charlotte C.; Otero, Jose J.; Huang, Eric J.; Nusse, Roel; Franklin, Robin J. M.; Rowitch, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1009-1016</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Permanent damage to white matter tracts, comprising axons and myelinating oligodendrocytes, is an important component of brain injuries of the newborn that cause cerebral palsy and cognitive disabilities, as well as multiple sclerosis in adults.  However, regulatory factors relevant in human developmental myelin disorders and in myelin regeneration are unclear.  We found that AXIN2 was expressed in immature oligodendrocyte progenitor cells (OLPs) in white matter lesions of human newborns with neonatal hypoxic-ischemic and gliotic brain damage, as well as in active multiple sclerosis lesions in adults.  Axin2 is a target of Wnt transcriptional activation that neg. feeds back on the pathway, promoting β-catenin degrdn.  We found that Axin2 function was essential for normal kinetics of remyelination.  The small mol. inhibitor XAV939, which targets the enzymic activity of tankyrase, acted to stabilize Axin2 levels in OLPs from brain and spinal cord and accelerated their differentiation and myelination after hypoxic and demyelinating injury.  Together, these findings indicate that Axin2 is an essential regulator of remyelination and that it might serve as a pharmacol. checkpoint in this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbvJsaEtdCN7Vg90H21EOLACvtfcHk0lhmg6KrbV2aDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotV2hsb4%253D&md5=204d38465ca799604b20e8df173b498c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnn.2855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2855%26sid%3Dliteratum%253Aachs%26aulast%3DFancy%26aufirst%3DS.%2BP.%2BJ.%26aulast%3DHarrington%26aufirst%3DE.%2BP.%26aulast%3DYuen%26aufirst%3DT.%2BJ.%26aulast%3DSilbereis%26aufirst%3DJ.%2BC.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DBaranzini%26aufirst%3DS.%2BE.%26aulast%3DBruce%26aufirst%3DC.%2BC.%26aulast%3DOtero%26aufirst%3DJ.%2BJ.%26aulast%3DHuang%26aufirst%3DE.%2BJ.%26aulast%3DNusse%26aufirst%3DR.%26aulast%3DFranklin%26aufirst%3DR.%2BJ.%2BM.%26aulast%3DRowitch%26aufirst%3DD.%2BH.%26atitle%3DAxin2%2520as%2520regulatory%2520and%2520therapeutic%2520target%2520in%2520newborn%2520brain%2520injury%2520and%2520remyelination%26jtitle%3DNat.%2520Neurosci.%26date%3D2011%26volume%3D14%26spage%3D1009%26epage%3D1U99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Bregman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span> </span><span class="NLM_article-title">Discovery of a class of novel tankyrase inhibitors that bind to both the nicotinamide pocket and the induced pocket</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1341</span><span class="NLM_x">–</span> <span class="NLM_lpage">1345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301607v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1341-1345&author=H.+Bregmanauthor=H.+Gunaydinauthor=Y.+Guauthor=S.+Schneiderauthor=C.+Wilsonauthor=E.+F.+DiMauroauthor=X.+Huang&title=Discovery+of+a+class+of+novel+tankyrase+inhibitors+that+bind+to+both+the+nicotinamide+pocket+and+the+induced+pocket"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm301607v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301607v%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520a%2520class%2520of%2520novel%2520tankyrase%2520inhibitors%2520that%2520bind%2520to%2520both%2520the%2520nicotinamide%2520pocket%2520and%2520the%2520induced%2520pocket%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1341%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lau, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waaler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambrone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korinek, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polakis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, M.</span><span> </span><span class="NLM_article-title">A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">3132</span><span class="NLM_x">–</span> <span class="NLM_lpage">3144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1158%2F0008-5472.CAN-12-4562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=23539443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=3132-3144&author=T.+Lauauthor=E.+Chanauthor=M.+Callowauthor=J.+Waalerauthor=J.+Boggsauthor=R.+A.+Blakeauthor=S.+Magnusonauthor=A.+Sambroneauthor=M.+Schuttenauthor=R.+Firesteinauthor=O.+Machonauthor=V.+Korinekauthor=E.+Chooauthor=D.+Diazauthor=M.+Merchantauthor=P.+Polakisauthor=D.+D.+Holsworthauthor=S.+Kraussauthor=M.+Costa&title=A+novel+tankyrase+small-molecule+inhibitor+suppresses+APC+mutation-driven+colorectal+tumor+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation-Driven Colorectal Tumor Growth</span></div><div class="casAuthors">Lau, Ted; Chan, Emily; Callow, Marinella; Waaler, Jo; Boggs, Jason; Blake, Robert A.; Magnuson, Steven; Sambrone, Amy; Schutten, Melissa; Firestein, Ron; Machon, Ondrej; Korinek, Vladimir; Choo, Edna; Diaz, Dolores; Merchant, Mark; Polakis, Paul; Holsworth, Daniel D.; Krauss, Stefan; Costa, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3132-3144</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Most colorectal cancers (CRC) are initiated by mutations of APC, leading to increased β-catenin-mediated signaling.  However, continued requirement of Wnt/P-catenin signaling for tumor progression in the context of acquired KRAS and other mutations is less well-established.  To attenuate Wnt/β-catenin signaling in tumors, we have developed potent and specific small-mol. tankyrase inhibitors, G007-LK and G244-LM, that reduce Wnt./p-catenin signaling by preventing poly(ADP-ribosyl)ation-dependent AXIN degrdn., thereby promoting β-catenin destabilization.  We show that novel tankyrase inhibitors completely block ligand-driven Wnt/β-catenin signaling in cell culture and display approx. 50% inhibition of APC mutation-driven signaling in most CRC cell lines.  It was previously unknown whether the level of AXIN protein stabilization by tankyrase inhibition is sufficient to impact tumor growth in the absence of normal APC activity.  Compd. G007-LK displays favorable pharmacokinetic properties and inhibits in vivo tumor growth in a subset of APC-mutant CRC xenograft models.  In the xenograft model most sensitive to tankyrase inhibitor, COLO-320DM, G007-LK inhibits cell-cycle progression, reduces colony formation, and induces differentiation, suggesting that β-catenin-dependent maintenance of an undifferentiated state may be blocked by tankyrase inhibition.  The full potential of the antitumor activity of G007-LK may be limited by intestinal toxicity assocd. with inhibition of Wnt/β-catenin signaling and cell proliferation in intestinal crypts.  These results establish proof-of-concept antitumor efficacy for tankyrase inhibitors in APC-mutant CRC models and uncover potential diagnostic and safety concerns to be overcome as tankyrase inhibitors are advanced into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbDZ01XGjOaLVg90H21EOLACvtfcHk0lhmg6KrbV2aDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D&md5=9f1d7b05b92ba8df593ccca9e7ea2cdf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-4562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-4562%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DCallow%26aufirst%3DM.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DSchutten%26aufirst%3DM.%26aulast%3DFirestein%26aufirst%3DR.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DChoo%26aufirst%3DE.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DM.%26atitle%3DA%2520novel%2520tankyrase%2520small-molecule%2520inhibitor%2520suppresses%2520APC%2520mutation-driven%2520colorectal%2520tumor%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D3132%26epage%3D3144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Voronkov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waaler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perdreau-Dahl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morth, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, S.</span><span> </span><span class="NLM_article-title">Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3012</span><span class="NLM_x">–</span> <span class="NLM_lpage">3023</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4000566" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3012-3023&author=A.+Voronkovauthor=D.+D.+Holsworthauthor=J.+Waalerauthor=S.+R.+Wilsonauthor=B.+Ekbladauthor=H.+Perdreau-Dahlauthor=H.+Dinhauthor=G.+Drewesauthor=C.+Hopfauthor=J.+P.+Morthauthor=S.+Krauss&title=Structural+basis+and+SAR+for+G007-LK%2C+a+lead+stage+1%2C2%2C4-triazole+based+specific+tankyrase+1%2F2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis and SAR for G007-LK, a Lead Stage 1,2,4-Triazole Based Specific Tankyrase 1/2 Inhibitor</span></div><div class="casAuthors">Voronkov, Andrew; Holsworth, Daniel D.; Waaler, Jo; Wilson, Steven R.; Ekblad, Bie; Perdreau-Dahl, Harmonie; Dinh, Huyen; Drewes, Gerard; Hopf, Carsten; Morth, Jens P.; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3012-3023</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 (TNKS1/2) are promising pharmacol. biotargets with possible applications for the development of novel anticancer therapeutics.  A focused structure-activity relationship study was conducted based on the tankyrase inhibitor JW74 (1).  Chem. analoging of 1 improved the 1,2,4-triazole based core and led to 4-{5-[(E)-2-{4-(2-chlorophenyl)-5-[5-(methylsulfonyl)pyridin-2-yl]-4H-1,2,4-triazol-3-yl}ethenyl]-1,3,4-oxadiazol-2-yl}benzonitrile (G007-LK), a potent, "rule of 5" compliant and a metabolically stable TNKS1/2 inhibitor.  G007-LK (66) displayed high selectivity toward tankyrases 1 and 2 with biochem. IC50 values of 46 nM and 25 nM, resp., and a cellular IC50 value of 50 nM combined with an excellent pharmacokinetic profile in mice.  The PARP domain of TNKS2 was cocrystd. with 66, and the X-ray structure was detd. at 2.8 Å resoln. in the space group P3221.  The structure revealed that 66 binds to unique structural features in the extended adenosine binding pocket which forms the structural basis for the compd.'s high target selectivity and specificity.  Our study provides a significantly optimized compd. for targeting TNKS1/2 in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvUxhCxkLuYbVg90H21EOLACvtfcHk0lhAuZxilvqrjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D&md5=f2bee61f0fdc326e3e798b3705072e9d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm4000566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000566%26sid%3Dliteratum%253Aachs%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DEkblad%26aufirst%3DB.%26aulast%3DPerdreau-Dahl%26aufirst%3DH.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DMorth%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DStructural%2520basis%2520and%2520SAR%2520for%2520G007-LK%252C%2520a%2520lead%2520stage%25201%252C2%252C4-triazole%2520based%2520specific%2520tankyrase%25201%252F2%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3012%26epage%3D3023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lhJ3poBGQJTxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eYTpNebZkauXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Arnott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planey, S. L.</span><span> </span><span class="NLM_article-title">The influence of lipophilicity in drug discovery and design</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1517%2F17460441.2012.714363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=22992175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=863-875&author=J.+A.+Arnottauthor=S.+L.+Planey&title=The+influence+of+lipophilicity+in+drug+discovery+and+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of lipophilicity in drug discovery and design</span></div><div class="casAuthors">Arnott, John A.; Planey, Sonia Lobo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">863-875</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The role of lipophilicity in drug discovery and design is a crit. one.  Lipophilicity is a key physicochem. property that plays a crucial role in detg. ADMET (absorption, distribution, metab., excretion, and toxicity) properties and the overall suitability of drug candidates.  There is increasing evidence to suggest that control of physicochem. properties such as lipophilicity, within a defined optimal range, can improve compd. quality and the likelihood of therapeutic success.Areas covered: This review focuses on understanding lipophilicity, techniques used to measure lipophilicity, and summarizes the importance of lipophilicity in drug discovery and development, including a discussion of its impact on individual ADMET parameters as well as its overall influence on the drug discovery and design process, specifically within the past 15 years.Expert opinion: A current review of the literature reveals a continued reliance on the synthesis of novel structures with increased potency, rather than a focus on maintaining optimal physicochem. properties assocd. with ADMET throughout drug optimization.  Particular attention to the optimum region of lipophilicity, as well as monitoring of lipophilic efficiency indexes, may contribute significantly to the overall quality of candidate drugs at different stages of discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolWJgvv9yK87Vg90H21EOLACvtfcHk0lhJ3poBGQJTxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsbvJ&md5=4dc5d7268216c9a59fcbd841fbf66735</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.714363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.714363%26sid%3Dliteratum%253Aachs%26aulast%3DArnott%26aufirst%3DJ.%2BA.%26aulast%3DPlaney%26aufirst%3DS.%2BL.%26atitle%3DThe%2520influence%2520of%2520lipophilicity%2520in%2520drug%2520discovery%2520and%2520design%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D863%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Griffen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. J.</span><span> </span><span class="NLM_article-title">Matched molecular pairs as a medicinal chemistry tool</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7739</span><span class="NLM_x">–</span> <span class="NLM_lpage">7750</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200452d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7739-7750&author=E.+Griffenauthor=A.+G.+Leachauthor=G.+R.+Robbauthor=D.+J.+Warner&title=Matched+molecular+pairs+as+a+medicinal+chemistry+tool"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Medicinal Chemistry Tool</span></div><div class="casAuthors">Griffen, Ed; Leach, Andrew G.; Robb, Graeme R.; Warner, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7739-7750</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">At the very heart of the role of a medicinal chemist or drug designer is the ability to link chem. structure to mol. properties.  This is the structure-activity relationship(SAR) or structure-property relationship(SPR).  Drug discovery projects often discover that a particular structural change causes a change to a property of interest.  The authors of this paper have been involved in developing and implementing some variations on the original theme of MMPA (matched mol. pairs anal.) and felt this to be the time to highlight some of these and to point toward future developments.  All of them are involved in the process of drug design, and it is within this context that they will set their comments.  In outline, they introduce matched mol. pair anal. and highlight why it fits so well with the kind of problem solving that is required in the process of drug design.  This will be followed by some comments concerning when the application of the methodol. is appropriate.  Then in a section intended for those with more computational interests, the authors describe the various ways that have been devised for identifying such matched pairs.  Throughout the paper, the authors have elected to use a publicly available data set to illustrate some of the comments: the ChEMBL database of inhibitors of the epidermal growth factor receptor tyrosine kinase (EGFR).  This consists of 2899 measurements of an IC50 annotated as a binding measurement on 2348 unique compds.  These measurements are drawn from a no. of sources, having been abstracted from the scientific literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMGFfO8Flm5bVg90H21EOLACvtfcHk0lhJ3poBGQJTxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK&md5=fab3344d790d1c0ae688ec65830d9143</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm200452d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200452d%26sid%3Dliteratum%253Aachs%26aulast%3DGriffen%26aufirst%3DE.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DWarner%26aufirst%3DD.%2BJ.%26atitle%3DMatched%2520molecular%2520pairs%2520as%2520a%2520medicinal%2520chemistry%2520tool%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7739%26epage%3D7750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Trunzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerlin, A.</span><span> </span><span class="NLM_article-title">Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8008663" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFChsLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=329-335&author=M.+Trunzerauthor=B.+Fallerauthor=A.+Zimmerlin&title=Metabolic+soft+spot+identification+and+compound+optimization+in+early+discovery+phases+using+MetaSite+and+LC-MS%2FMS+validation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Soft Spot Identification and Compound Optimization in Early Discovery Phases Using MetaSite and LC-MS/MS Validation</span></div><div class="casAuthors">Trunzer, Markus; Faller, Bernard; Zimmerlin, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">329-335</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metabolic stability is a key property to enable drugs to reach therapeutic concns.  Microsomal clearance assays are used to dial out labile compds. in early discovery phases.  However, because they do not provide any information on soft spots, the rational design of more stable compds. remains challenging.  A robust soft spot identification procedure combining in silico prediction ranking using MetaSite and mass-spectrometric confirmation is described.  MetaSite's first rank order predictions were exptl. confirmed for only about 55% of the compds.  For another 29% of the compds., the second (20%) or the third (9%) rank order predictions were detected.  This automatic and high-throughput reprioritization of a likely soft-spot increases the likelihood of working on the right soft spot from about 50% to more than 80%.  With this information, the structure-metab. relationships are likely to be understood faster and earlier in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV4vzsZ7zQ_rVg90H21EOLACvtfcHk0lhgb2jT6WElhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFChsLfJ&md5=8628722a0cd75b0c6497cc383bd4ec16</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm8008663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8008663%26sid%3Dliteratum%253Aachs%26aulast%3DTrunzer%26aufirst%3DM.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DZimmerlin%26aufirst%3DA.%26atitle%3DMetabolic%2520soft%2520spot%2520identification%2520and%2520compound%2520optimization%2520in%2520early%2520discovery%2520phases%2520using%2520MetaSite%2520and%2520LC-MS%252FMS%2520validation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D329%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Cruciani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosati, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethirajulu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, R.</span><span> </span><span class="NLM_article-title">MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6970</span><span class="NLM_x">–</span> <span class="NLM_lpage">6979</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050529c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6970-6979&author=G.+Crucianiauthor=E.+Carosatiauthor=B.+B.+Deauthor=K.+Ethirajuluauthor=C.+Mackieauthor=T.+Howeauthor=R.+Vianello&title=MetaSite%3A+understanding+metabolism+in+human+cytochromes+from+the+perspective+of+the+chemist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm050529c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050529c%26sid%3Dliteratum%253Aachs%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DCarosati%26aufirst%3DE.%26aulast%3DDe%26aufirst%3DB.%2BB.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DVianello%26aufirst%3DR.%26atitle%3DMetaSite%253A%2520understanding%2520metabolism%2520in%2520human%2520cytochromes%2520from%2520the%2520perspective%2520of%2520the%2520chemist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6970%26epage%3D6979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">T’jollyn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boussery, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortishire-Smith, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Bocxlaer, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannens, G.</span><span> </span><span class="NLM_article-title">Evaluation of three state-of-the-art metabolite prediction software packages (Meteor, MetaSite, and StarDrop) through independent and synergistic use</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2066</span><span class="NLM_x">–</span> <span class="NLM_lpage">2075</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=2066-2075&author=H.+T%E2%80%99jollynauthor=K.+Bousseryauthor=R.+J.+Mortishire-Smithauthor=K.+Coeauthor=B.+B.+Deauthor=J.+F.+Van+Bocxlaerauthor=G.+Mannens&title=Evaluation+of+three+state-of-the-art+metabolite+prediction+software+packages+%28Meteor%2C+MetaSite%2C+and+StarDrop%29+through+independent+and+synergistic+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DT%25E2%2580%2599jollyn%26aufirst%3DH.%26aulast%3DBoussery%26aufirst%3DK.%26aulast%3DMortishire-Smith%26aufirst%3DR.%2BJ.%26aulast%3DCoe%26aufirst%3DK.%26aulast%3DDe%26aufirst%3DB.%2BB.%26aulast%3DVan%2BBocxlaer%26aufirst%3DJ.%2BF.%26aulast%3DMannens%26aufirst%3DG.%26atitle%3DEvaluation%2520of%2520three%2520state-of-the-art%2520metabolite%2520prediction%2520software%2520packages%2520%2528Meteor%252C%2520MetaSite%252C%2520and%2520StarDrop%2529%2520through%2520independent%2520and%2520synergistic%2520use%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D2066%26epage%3D2075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Shin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E.</span><span> </span><span class="NLM_article-title">Comparison of metabolic soft spot predictions of CYP3A4, CYP2C9 and CYP2D6 substrates using MetaSite and StarDrop</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.2174%2F138620711796957170" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=21605066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Cit7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=811-823&author=Y.+G.+Shinauthor=H.+Leauthor=C.+Khojastehauthor=C.+E.+Hop&title=Comparison+of+metabolic+soft+spot+predictions+of+CYP3A4%2C+CYP2C9+and+CYP2D6+substrates+using+MetaSite+and+StarDrop"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of metabolic soft spot predictions of CYP3A4, CYP2C9 and CYP2D6 substrates using MetaSite and StarDrop</span></div><div class="casAuthors">Shin, Young G.; Le, Hoa; Khojasteh, Cyrus; Hop, Cornelis E. C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">811-823</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Metabolite identification study plays an important role in detg. the sites of metabolic liability of new chem. entities (NCEs) in drug discovery for lead optimization.  Here we compare the two predictive software, MetaSite and StarDrop, available for this purpose.  They work very differently but are used to predict the site of oxidn. by major human cytochrome P 450 (CYP) isoforms.  Neither software can predict non-CYP catalyzed metab. nor the rates of metab.  For the purpose of comparing the two software packages, we tested known probe substrate for these enzymes, which included 12 substrates of CYP3A4 and 18 substrates of CYP2C9 and CYP2D6 were analyzed by each software and the results were compared.  It is possible that these known substrates were part of the training set but we are not aware of it.  To assess the performance of each software we assigned a point system for each correct prediction.  The total points assigned for each CYP isoform exptl. were compared as a percentage of the total points assigned theor. for the first choice prediction for all substrates for each isoform.  Our results show that MetaSite and StarDrop are similar in predicting the correct site of metab. by CYP3A4 (78% vs 83%, resp.).  StarDrop appears to do slightly better in predicting the correct site of metab. by CYP2C9 and CYP2D6 metab. (89% and 93%, resp.) compared to MetaSite (63% and 70%, resp.).  The sites of metab. (SOM) from 34 inhouse NCEs incubated in human liver microsomes or human hepatocytes were also evaluated using two prediction software packages and the results showed comparable SOM predictions.  What makes this comparison challenging is that the contribution of each isoform to the intrinsic clearance (Clint) is not known.  Overall the software were comparable except for MetaSite performing better for CYP2D6 and that MetaSite has a liver model that is absent in StarDrop that predicted with 82% accuracy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq00wGGTwAAibVg90H21EOLACvtfcHk0lhgb2jT6WElhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Cit7nK&md5=af53cda11a6e67b832002fdada6af924</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F138620711796957170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620711796957170%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DY.%2BG.%26aulast%3DLe%26aufirst%3DH.%26aulast%3DKhojasteh%26aufirst%3DC.%26aulast%3DHop%26aufirst%3DC.%2BE.%26atitle%3DComparison%2520of%2520metabolic%2520soft%2520spot%2520predictions%2520of%2520CYP3A4%252C%2520CYP2C9%2520and%2520CYP2D6%2520substrates%2520using%2520MetaSite%2520and%2520StarDrop%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2011%26volume%3D14%26spage%3D811%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Storni, A.</span>Carboxamides. EP 124476, Nov 7,<span class="NLM_x"> </span><span class="NLM_year">1984</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&author=A.+Storni&title=Carboxamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DStorni%26aufirst%3DA.%26jtitle%3DCarboxamides%26date%3D1984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Bregman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egge, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullady, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafino, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strathdee, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span> </span><span class="NLM_article-title">Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4320</span><span class="NLM_x">–</span> <span class="NLM_lpage">4342</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4000038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4320-4342&author=H.+Bregmanauthor=N.+Chakkaauthor=A.+Guzman-Perezauthor=H.+Gunaydinauthor=Y.+Guauthor=X.+Huangauthor=V.+Berryauthor=J.+Liuauthor=Y.+Tefferaauthor=L.+Huangauthor=B.+Eggeauthor=E.+L.+Mulladyauthor=S.+Schneiderauthor=P.+S.+Andrewsauthor=A.+Mishraauthor=J.+Newcombauthor=R.+Serafinoauthor=C.+A.+Strathdeeauthor=S.+M.+Turciauthor=C.+Wilsonauthor=E.+F.+DiMauro&title=Discovery+of+novel%2C+induced-pocket+binding+oxazolidinones+as+potent%2C+selective%2C+and+orally+bioavailable+tankyrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel, Induced-Pocket Binding Oxazolidinones as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors</span></div><div class="casAuthors">Bregman, Howard; Chakka, Nagasree; Guzman-Perez, Angel; Gunaydin, Hakan; Gu, Yan; Huang, Xin; Berry, Virginia; Liu, Jingzhou; Teffera, Yohannes; Huang, Liyue; Egge, Bryan; Mullady, Erin L.; Schneider, Steve; Andrews, Paul S.; Mishra, Ankita; Newcomb, John; Serafino, Randy; Strathdee, Craig A.; Turci, Susan M.; Wilson, Cindy; DiMauro, Erin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4320-4342</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase (TNKS) is a poly-ADP-ribosylating protein (PARP) whose activity suppresses cellular axin protein levels and elevates β-catenin concns., resulting in increased oncogene expression.  The inhibition of tankyrase (TNKS1 and 2) may reduce the levels of β-catenin-mediated transcription and inhibit tumorigenesis.  Compd. I is a previously described moderately potent tankyrase inhibitor that suffers from poor pharmacokinetic properties.  Herein, we describe the utilization of structure-based design and mol. modeling toward novel, potent, and selective tankyrase inhibitors with improved pharmacokinetic properties (II, III).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNxO4sATmyjbVg90H21EOLACvtfcHk0lhe5MUpyhy8EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D&md5=c22d14a6a93ab185e3c13ccd04af9451</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm4000038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000038%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DEgge%26aufirst%3DB.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DStrathdee%26aufirst%3DC.%2BA.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26atitle%3DDiscovery%2520of%2520novel%252C%2520induced-pocket%2520binding%2520oxazolidinones%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4320%26epage%3D4342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Tsukamoto, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosschedl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parslow, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varmus, H. E.</span><span> </span><span class="NLM_article-title">Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1988&pages=619-625&author=A.+S.+Tsukamotoauthor=R.+Grosschedlauthor=R.+C.+Guzmanauthor=T.+Parslowauthor=H.+E.+Varmus&title=Expression+of+the+int-1+gene+in+transgenic+mice+is+associated+with+mammary+gland+hyperplasia+and+adenocarcinomas+in+male+and+female+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsukamoto%26aufirst%3DA.%2BS.%26aulast%3DGrosschedl%26aufirst%3DR.%26aulast%3DGuzman%26aufirst%3DR.%2BC.%26aulast%3DParslow%26aufirst%3DT.%26aulast%3DVarmus%26aufirst%3DH.%2BE.%26atitle%3DExpression%2520of%2520the%2520int-1%2520gene%2520in%2520transgenic%2520mice%2520is%2520associated%2520with%2520mammary%2520gland%2520hyperplasia%2520and%2520adenocarcinomas%2520in%2520male%2520and%2520female%2520mice%26jtitle%3DCell%26date%3D1988%26volume%3D55%26spage%3D619%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Freire, E.</span><span> </span><span class="NLM_article-title">Do enthalpy and entropy distinguish first in class from best in class?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm400807n&amp;key=10.1016%2Fj.drudis.2008.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm400807n&amp;key=18703160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCgu7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=869-874&author=E.+Freire&title=Do+enthalpy+and+entropy+distinguish+first+in+class+from+best+in+class%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Do enthalpy and entropy distinguish first in class from best in class?</span></div><div class="casAuthors">Freire, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19/20</span>),
    <span class="NLM_cas:pages">869-874</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A drug mol. should bind to its target with high affinity and selectivity.  Because the binding affinity is a combined function of the binding enthalpy and the binding entropy, extremely high affinity requires that both terms contribute favorably to binding.  The binding enthalpy, however, is notoriously more difficult to optimize than the binding entropy, a fact that has resulted in thermodynamically unbalanced mols. that do not achieve optimal potency.  In fact, with current technologies, the enthalpic optimization of drug candidates may take years and only appear in second-generation products.  Within that context, it is not surprising that structure/activity relationships (SARs) that explicitly incorporate the interplay between enthalpy and entropy and accelerate the optimization process are being developed and gaining popularity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5swEhu922BbVg90H21EOLACvtfcHk0lhe5MUpyhy8EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCgu7fN&md5=357358107c5686a1863a83291c1cdd92</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2008.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2008.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DFreire%26aufirst%3DE.%26atitle%3DDo%2520enthalpy%2520and%2520entropy%2520distinguish%2520first%2520in%2520class%2520from%2520best%2520in%2520class%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D869%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Conroy, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C. T.</span><span> </span><span class="NLM_article-title">Using the electrostatic field effect to design a new class of inhibitors for cysteine proteases</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">4285</span><span class="NLM_x">–</span> <span class="NLM_lpage">4291</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9641867" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADyaK2sXivVWqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=4285-4291&author=J.+L.+Conroyauthor=T.+C.+Sandersauthor=C.+T.+Seto&title=Using+the+electrostatic+field+effect+to+design+a+new+class+of+inhibitors+for+cysteine+proteases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Using the Electrostatic Field Effect to Design a New Class of Inhibitors for Cysteine Proteases</span></div><div class="casAuthors">Conroy, Jeffrey L.; Sanders, Tanya C.; Seto, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4285-4291</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of competitive inhibitors for the cysteine protease papain is described.  These inhibitors are based upon a 4-heterocyclohexanone ring and are designed to react with the enzyme active site nucleophile to give a reversibly formed hemithioketal.  The electrophilicity of the ketone in these inhibitors is enhanced by ring strain and by through-space electrostatic repulsion with the heteroatom at the 1-position of the ring.  Equil. consts. for addn. of water and 3-mercaptopropionic acid to several 4-heterocyclohexanones were measured by 1H NMR spectroscopy.  These reactions model addn. of the active site nucleophile to the corresponding inhibitors.  The equil. consts. give a linear correlation with the field substituent const. F for the functional group at the 1-position of the heterocyclohexanone.  These equil. consts. also correlate well with the inhibition consts. for the 4-heterocyclohexanone-based inhibitors, which range from 11 to 120 μM.  Thus, the model system can be used to predict the potency of structurally related enzyme inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqvOC-4OuTB7Vg90H21EOLACvtfcHk0liiDAxCLv9wGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivVWqtrk%253D&md5=d40497b24f57a94d5bb36e6491dec934</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja9641867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9641867%26sid%3Dliteratum%253Aachs%26aulast%3DConroy%26aufirst%3DJ.%2BL.%26aulast%3DSanders%26aufirst%3DT.%2BC.%26aulast%3DSeto%26aufirst%3DC.%2BT.%26atitle%3DUsing%2520the%2520electrostatic%2520field%2520effect%2520to%2520design%2520a%2520new%2520class%2520of%2520inhibitors%2520for%2520cysteine%2520proteases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D4285%26epage%3D4291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Karlberg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammarstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, H.</span><span> </span><span class="NLM_article-title">Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5352</span><span class="NLM_x">–</span> <span class="NLM_lpage">5355</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100249w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400807n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVeht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5352-5355&author=T.+Karlbergauthor=N.+Markovaauthor=I.+Johanssonauthor=M.+Hammarstromauthor=P.+Schutzauthor=J.+Weigeltauthor=H.+Schuler&title=Structural+basis+for+the+interaction+between+tankyrase-2+and+a+potent+Wnt-signaling+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Interaction between Tankyrase-2 and a Potent Wnt-Signaling Inhibitor</span></div><div class="casAuthors">Karlberg, Tobias; Markova, Natalia; Johansson, Ida; Hammarstrom, Martin; Schutz, Patrick; Weigelt, Johan; Schuler, Herwig</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5352-5355</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report two crystal structures of the PARP domain of human tankyrase-2 (TNKS2).  Tankyrases are involved in fundamental cellular processes such as telomere homeostasis and Wnt signaling.  The complex of TNKS2 with the potent inhibitor XAV939 provides insights into the mol. basis of the strong interaction and suggests routes for further development of tankyrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB8HUahD927bVg90H21EOLACvtfcHk0liiDAxCLv9wGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVeht7Y%253D&md5=3b037afbe6f4dc86a492855fa800fb44</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm100249w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100249w%26sid%3Dliteratum%253Aachs%26aulast%3DKarlberg%26aufirst%3DT.%26aulast%3DMarkova%26aufirst%3DN.%26aulast%3DJohansson%26aufirst%3DI.%26aulast%3DHammarstrom%26aufirst%3DM.%26aulast%3DSchutz%26aufirst%3DP.%26aulast%3DWeigelt%26aufirst%3DJ.%26aulast%3DSchuler%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520for%2520the%2520interaction%2520between%2520tankyrase-2%2520and%2520a%2520potent%2520Wnt-signaling%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5352%26epage%3D5355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI6','PDB','4LI6'); return false;">PDB: 4LI6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI7','PDB','4LI7'); return false;">PDB: 4LI7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI8','PDB','4LI8'); return false;">PDB: 4LI8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UDD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UDD','PDB','3UDD'); return false;">PDB: 3UDD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UH2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UH2','PDB','3UH2'); return false;">PDB: 3UH2</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i87"><a href="/doi/suppl/10.1021/jm400807n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_37225"></div></div></div></div></div><hr /></hr><p class="last">Graphs of calculated versus measured log <i>P</i> as well as thermodynamic data. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400807n/suppl_file/jm400807n_si_001.pdf">jm400807n_si_001.pdf (191.75 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes for the TNKS1 structures in complex with <b>19</b>, <b>33</b>, and <b>35</b> are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI6">4LI6</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI7">4LI7</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LI8">4LI8</a>, respectively.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400807n&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-16%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm400807n%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400807n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799ab3d1e173dbe","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
